Theiler's murine encephalomyelitis protein 2C and its effect on membrane trafficking by Moës, Elien
THEILER’S MURINE ENCEPHALOMYELITIS PROTEIN 2C AND
ITS EFFECT ON MEMBRANE TRAFFICKING
Elien Moës
A Thesis Submitted for the Degree of PhD
at the
University of St. Andrews
2008
Full metadata for this item is available in the St Andrews
Digital Research Repository
at:
https://research-repository.st-andrews.ac.uk/
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10023/540
This item is protected by original copyright
This item is licensed under a
Creative Commons License
  
 
 
 
Theiler’s murine encephalomyelitis protein 2C 
and its effect on membrane trafficking 
 
 
 
 
 
 
 
By 
Elien Moës B.Sc. (Hons) 
Centre for Biomolecular Sciences 
University of St. Andrews 
 
 
 
 
 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
 
January, 2008 
Declarations 
I, Elien Moës, hereby certify that this thesis, which is approximately 56 000 words in 
length, has been written by me, that it is the record of work carried out by me and that it has 
not been submitted in any previous application for a higher degree. 
Signature:       Date:     
 
 
I was admitted as a research student in October 2004 and as a candidate for the degree of 
Doctor of Philosophy in October 2004; the higher study for which this is a record was 
carried out in the University of St Andrews between 2004 and 2008. 
Signature:       Date:     
 
 
I hereby certify that the candidate has fulfilled the conditions of the Resolution and 
Regulations appropriate for the degree of Doctor of Philosophy in the University of St 
Andrews and that the candidate is qualified to submit this thesis in application for that 
degree. 
Signature:       Date:     
 
 
In submitting this thesis to the University of St Andrews I understand that I am giving 
permission for it to be made available for use in accordance with the regulations of the 
University Library for the time being in force, subject to any copyright vested in the work 
not being affected thereby. I also understand that the title and abstract will be published, 
and that a copy of the work may be made and supplied to any bona fide library or research 
worker, that my thesis will be electronically accessible for personal or research use, and that 
the library has the right to migrate my thesis into new electronic forms as required to ensure 
continued access to the thesis. I have obtained any third-party copyright permissions that 
may be required in order to allow such access and migration. 
Signature:       Date:     
 i
Acknowledgements 
 
“If I have seen farther than other men, it is because I stood on the shoulders of giants.” 
Sir Isaac Newton 
 
Firstly, I am most grateful to my supervisor, Dr. Martin Ryan, for his guidance, advice and 
encouragement. Thank you for the many helpful discussions, for sharing your knowledge, 
and for your consistent support. 
 
I would like to thank my colleagues, who provided me with guidance and useful 
suggestions and made my time in the lab very enjoyable. 
 
Many thanks to the Biotechnology and Biological Sciences Research Council 
for funding my work. 
 
I would like to deeply thank my family for their belief and encouragement. 
I would like to thank my friends at home for their understanding and 
for bearing my little availability. 
I would also like to thank my friends in St Andrews for making this time, 
although away from home, very pleasurable. I will miss you! 
 
Last but most importantly, a special thanks to my parents, Paul and Brigitte Moës, whose 
love, care and consideration made all this possible. Papa en mama, jullie hebben mij steeds 
gesteund in alles wat ik deed. Ik wil jullie graag danken omdat jullie er steeds voor me zijn. 
Ik zie jullie graag! 
 ii
Abstract 
Picornaviruses replicate in association with cytoplasmic membranes of infected cells. 
Poliovirus 2C and 2BC play an important role in the formation of membranous vesicles, and 
induce dramatic changes in membrane trafficking. Theiler’s murine encephalomyelitis virus 
protein 2C was localized in infected cells using an anti-TMEV-2C antibody. Early upon 
infection, TMEV 2C was localized in the cytoplasm in an ER-like pattern. At later stages, 2C 
redistributed to a juxtanuclear site, which represents the viral replication site. Co-localization 
with the Golgi complex could not be observed. TMEV 2C seems to interact in vitro with 
reticulon 3, a highly conserved ER-associated protein. It was not possible to confirm a 
previously identified interaction with AKAP10, a protein kinase anchoring protein, presumably 
reflecting conformational constraints of the interaction. Two mutations in the AKAP10 binding 
site of TMEV 2C were identified, which inhibit the completion of the infectious cycle of 
TMEV. The intracellular changes that occur during TMEV infection were observed. Both actin 
filaments and microtubules may be used at early stages of infection; however both cytoskeleton 
components accumulate at the periphery of the cell during late stages of infection. A computer-
based analysis has demonstrated that TMEV 2C is highly similar to katanin, a microtubule-
severing protein, and may play a similar role in the reorganization of microtubules during 
infection. The Golgi complex turns from a solid, crescent-shaped organelle, into a series of 
punctuate fluorescent points forming an expanding balloon-like structure surrounding the 
concomitantly expanding site of virus replication. The remnants of the Golgi complex are 
finally dispersed throughout the cytoplasm. Live imaging confirmed these findings. It was 
observed that PKA also undergoes displacement to the cell periphery during infection. 
However, BIG1 seems to locate to the viral replication site during infection, suggesting it may 
play a role during viral replication. The localization of PKA and BIG1 in the infected cell may 
in part explain the observed dispersion of the Golgi complex. 
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1. Introduction 
1.1. Viruses: a general overview 
A virus (from the Latin virus, meaning toxin or poison) is a sub-microscopic particle that is 
able to infect cells of a living organism. Viruses have a predatory nature, in that to replicate, 
they must first infect a cell. A virus particle consists of genetic material contained within a 
protective protein coat (capsid). Viruses infect a wide variety of organisms; both eu- and 
prokaryotes, as well as archaea. Many severe human diseases, such as AIDS, influenza and 
rabies, are caused by viruses. The aim of this introduction is to present a general overview 
of the characteristics of viruses with the focus on the Picornaviridae and the replication of 
the Cardiovirus Theiler’s virus. 
 
1.1.1 Discovery of viruses 
For many centuries, humans have been affected by viral diseases. There is hieroglyphical 
evidence of polio in the ancient Egyptian empire. In the late 18th century, Edward Jenner 
observed and studied Miss Sarah Nelmes, a milkmaid who had previously caught cowpox 
and was subsequently found to be immune to smallpox. 
 
Adolf Mayer (1843-1942), a German scientist, is considered as a pioneer in the field of 
modern virology. In 1879, he began his research on diseases of tobacco and named the 
disease “tobacco mosaic disease” after the pattern of dark and light spots seen on infected 
leaves. In 1882 he described the first experimental transmission of a viral disease of plants. 
He inoculated healthy tobacco plants with filtered juice from infected tobacco plants. The 
plants soon showed the mosaic symptoms characteristic of the disease (reviewed by Levine, 
1996). The next step towards the discovery of viruses was taken by a young Russian 
scientist, Dimitri Ivanovsky (1864-1920), who, in 1892, described a pathogenic agent 
smaller than any known before. He presented a paper before the Academy of Sciences in St. 
Petersburg stating that “the sap of leaves infected with tobacco mosaic disease retains its 
infectious properties even after filtration through Chamberland filter candles” (Ivanovsky, 
1892). Similar findings were published in 1898 by Martinus Beijerinck (1851-1931), a 
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Dutch microbiologist. Unaware of Ivanovsky’s work, he demonstrated that the infectious 
agent causing tobacco mosaic disease was indeed filterable and determined that the agent 
could reproduce itself within living plants. He observed that the pathogen causing tobacco 
mosaic virus returned to its original strength after dilution, suggesting that the pathogen is 
not a chemical substance but an agent that replicates within living cells. The concept of a 
filterable agent, too small to observe in the light microscope but able to cause disease by 
reproducing in living cells, was born. Loeffler and Frosh (1898) rapidly described and 
isolated the first filterable agent from animals, the foot-and-mouth disease virus, and yellow 
fever virus was the first human virus to be recognized in 1901 by Reed and colleagues 
(reviewed by: Lustig & Levine, 1992; Levine, 1996). 
 
Since the 19th century virologists have made great progress in unraveling the properties of 
viruses. Some definite characteristics have been elucidated. Viruses are very small, 
infectious, obligate intracellular molecular parasites. The viral genome can consist of RNA 
or DNA. After infection of an appropriate host cell, the viral genome is replicated and the 
virion components are synthesized. The newly synthesized components are assembled into 
progeny virions, which are responsible for the transmission of the viral genome to other 
cells or organisms. 
 
1.1.2 Classification of viruses 
The earliest experiments involving viruses were designed to measure a single 
physiochemical characteristic, that being the small size of viruses as assessed by 
“filterability”. Most studies of viruses were related to their ability to cause infections and 
diseases. Therefore, the earliest attempts to classify viruses were based on perceived 
common pathogenic properties, host range, and transmission. When more evidence of the 
structure and composition of virions became known, a classification based on shared virion 
properties was suggested. A single universal taxonomic scheme was needed. Therefore, the 
International Committee on Nomenclature of Viruses (ICNV) was established in 1966, now 
called the International Committee of Taxonomy of viruses (ICTV). Virion characteristics 
are considered as criteria to group viruses into orders, families, in some cases subfamilies, 
and genera (Strauss & Strauss, 1988, Murphy, 1996). The 8th report of the ICTV, published 
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in 2005, records a taxonomy scheme comprising 3 orders, 73 families, 9 subfamilies, 287 
genera, 1938 species and more than 6000 member viruses (Fauquet et al., 2005). However, 
GenBank contains a staggering additional 3,142 "species" unaccounted for by the ICTV 
report (Fauquet & Fargette, 2005). 
 
1.1.3 Structure of viruses 
A virus particle is a structure that has evolved to transfer nucleic acid from one cell to another. 
A virion in its most basic form consists of nucleic acid surrounded by a protective coat of many 
identical proteins encoded by the viral genome, known as the capsid (Crick & Watson, 1956). 
More complex virus particles include virions that contain several molecules of nucleic acid, 
express several or many different proteins, and have internal bodies of definite shape and 
complex envelopes with spikes that usually contain glycoproteins and lipids. 
 
Helical capsids are composed of a single type of subunit stacked around a central axis to 
form a helical structure which may have a central cavity containing the viral nucleic acid. 
This arrangement results in filamentous virions. Icosahedral capsid symmetry results in a 
spherical appearance, but actually consists of capsomers arranged in a regular geometrical 
pattern. Capsomers are structures constructed from several copies of protomers, which are 
associated via non-covalent binding to enclose the viral nucleic acid. There is an important 
distinction between enveloped viruses and non-enveloped viruses. The distinction 
corresponds to a difference in the way the virus enters and leaves a cell. Enveloped viruses 
are, in addition to the protein capsid, surrounded with a lipid bilayer membrane. The 
membrane is studded with proteins, including glycoproteins that can function as receptor 
molecules, resulting in the uptake of the virion into the cell. Most enveloped viruses depend 
upon their envelope for infectivity (reviewed by Harrison et al., 1996). 
 
1.1.4 Viral genetic systems 
Viruses are mainly concerned with the duplication of their genome and the expression of the 
information encoded by the genome. All viruses must perform messenger RNA (mRNA) 
synthesis which will be translated by using cellular ribosomes and soluble factors. The 
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specific mechanism for mRNA synthesis depends on the structure of the viral genome. The 
Baltimore Classification describes six basic genetic strategies (figure 1.1, Baltimore, 1971). 
 
Class I consists of viruses which have double-stranded (ds) DNA. They carry out an 
asymmetric transcription of their DNA to give rise to mRNA. Viruses grouped in Class II 
contain a single-stranded (ss) DNA genome of the same polarity as mRNA. Class III 
consists of viruses containing a ds RNA genome. The mRNA for these viruses represents 
an asymmetric transcript of the genome. The known viruses of this type have multiple 
segments of ds RNA, each of which express a single protein. Class IV includes ssRNA 
viruses whose mRNA is identical to the viral RNA. Class V consists of viruses with a 
ssRNA genome which is complimentary to the mRNA. Class VI contains viruses with a 
ssRNA genome which have a DNA intermediate in their replication. 
 
 
Figure 1.1: The Baltimore classification of viruses, a classification system which clusters 
viruses based on their genetic contents and their replication strategies. The central theme 
in this classification system is that all viruses must generate positive strand mRNA, in order 
to produce viral proteins and replicate. 
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1.1.5 Replication of viruses 
The pathological effects of viral diseases result from the toxic effects of viral proteins on 
the host cell metabolism, the reactions of the host to infected cells expressing viral proteins, 
and the modifications of host gene expression by interactions with the viral genetic 
material. The symptoms of acute viral disease are directly related to the destruction of host 
cells by the infecting virus. A virus must first infect a cell to be able to replicate. At the start 
of infection, the viral genetic material is introduced into the cell. There is great diversity in 
sizes, compositions and gene organization of viral genomes. Each type of viral genome 
requires unique proteins for its replication and must encode one or more of these proteins 
needed to replicate the viral genome. The strategies used by viruses to ensure replication 
vary. In some cases, the viral proteins merely assist host proteins to replicate the viral 
nucleic acid. In most cases, however, the viral proteins replicate the viral genome. In all 
instances, the viral proteins are responsible for packaging the viral genome into virions 
(Roizman & Palese, 1996). 
 
1.1.5.1 Lytic or lysogenic cycle 
The effects of viral replication may range from cell death to changes in function and 
antigenic specificity of the infected cell. Viruses that carry out a lytic cycle will induce 
virus reproduction in the infected cell. After replication and packaging of the viral genome, 
the virus will cause the cell to lyse in order to release the progeny virus particles, resulting 
in cell death. Some viruses exit the cell via exocytosis, taking a small portion of the cell 
membrane with them as a viral envelope. A lysogenic cycle does not result in immediate 
cell lysis. The viral genome integrates into the host cell genome and is replicated along with 
it. This allows the host cell to survive and reproduce, and the virus is passed on to the 
offspring of the host cell. After several replication cycles the virus may become active and 
will enter the lytic phase (Roizman & Palese, 1996). 
 
1.1.5.2 DNA viruses 
Members of the DNA virus families are fully or at least partially double stranded, with the 
exception of the ssDNA genome of Parvoviruses and the circular ssDNA genome of 
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Circoviruses. Parvovirus virions contain linear ssDNA. Papovaviruses have closed circular 
DNA molecules, whereas the DNA molecules of Herpesviruses, Adenoviruses and 
Poxviruses are linear. However, Adenoviruses contain a protein covalently linked to the 5’ 
end of their DNA strands and the ends of the double stranded poxvirus genome are 
covalently joined. The DNA of Hepadnaviruses is a circular, double stranded molecule in 
which there are single stranded gaps (figure 1.2; Roizman & Palese, 1996). 
 
 
 
Figure 1.2: Schematic representation of viral genomes. Examples of viruses containing 
the different types of genomes are given in between brackets. 
 
Several dsDNA viruses (Papovaviruses, Adenoviruses, Herpesviruses) replicate in the host 
cell nucleus and can therefore use the transcriptional enzymes of the host cell for the 
generation of mRNA. Other dsDNA viruses, such as Poxviruses, have been detected in the 
nucleus but replicate in the cytoplasm. Poxviruses evolve all the necessary factors for 
transcription and replication of the viral genome. Parvoviruses are ssDNA viruses, which 
essentially form two groups. The members of one group are autonomous Parvoviruses that 
are capable of independent replication. The second group contains the Adeno-associated 
virus, which remains latent by integration at specific sites in the human chromosome. It is 
capable of independent replication, but only after infection of the cell by a helper virus 
(Adenoviruses or Herpes Simplex viruses). Replication requires the synthesis of a 
complementary DNA strand in the nucleus and transcription of the genome (Roizman & 
Palese, 1996). 
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1.1.5.3 RNA viruses 
RNA viruses have mostly single stranded genomes, with the exception of the members of the 
Reovirus family that contain a double stranded genome (figure 1.2). All RNA genomes are 
linear molecules. Some contain a covalently linked polypeptide at the 5’ end of the genome. 
Positive strand RNA viruses are viruses whose genome serves as mRNA. These positive 
stranded RNA viruses are divided into viruses coding for a single genome-sized mRNA and 
viruses that are able to make subgenomic mRNAs. Picornaviruses and Flaviviruses contain a 
single genome-sized mRNA that is translated into a single polyprotein, which is 
proteolytically cleaved during and after translation. The genomic RNA serves as a template 
for the synthesis of the complementary minus strand by a viral polymerase. The minus strand 
will serve as a template to make more positive strand RNA. Togaviruses are positive strand 
RNA viruses that code for subgenomic mRNA. At first, only the 5’ end of the genomic RNA 
is available for translation. The function of the encoded proteins is to copy the genomic RNA, 
after which the complementary minus strand is synthesized. The minus RNA will serve as a 
template for subgenomic mRNAs. Retroviruses are a third group of positive stranded RNA 
viruses. Their virions uniquely contain two identical copies of genomic RNA (Roizman & 
Palese, 1996). 
 
Negative strand RNA viruses can be devided into two groups. The first group contains the 
nonsegmented negative strand RNA viruses, such as Paramyxo-, Rhabdo- and Filoviruses. 
Their genomes must be transcribed into mRNA, therefore all negative strand RNA viruses 
package a transcriptase in the virion along with the viral genome. Bunyaviruses (3 
segments) and Orthomyxoviruses (7 to 8 segments) are segmented negative strand RNA 
viruses. The virion associated polymerase synthesizes mRNA of each segment of the 
genomic RNA. A unique characteristic of segmented negative strand RNA viruses is their 
ability to reassort their genes in cells infected by more than one virus of the same family 
(Roizman & Palese, 1996). 
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1.2. Positive stranded RNA viruses 
All positive stranded RNA viruses, infecting eukaryotic cells, replicate in association with 
cellular membranes. The RNA replication complex of many virus families is associated 
with membranes derived from the endoplasmic reticulum (ER). Other organelles of the 
secretory pathway, mitochondria, endosomes and lysosomes, however, are also used as 
sites for RNA replication. The membrane association offers protection for the viral RNA 
against host cell defence mechanisms and it links the RNA replication to a confined space 
within the infected host cell, increasing concentrations of components necessary for viral 
RNA replication. The process of membrane binding and targeting to specific intracellular 
organelles of the replication complexes of different viruses is not yet completely 
understood. However, extensive studies of viral non-structural proteins have shown that 
certain non-structural proteins, rather than the viral RNA, are responsible for the association 
of the replication complex with membranes and the targeting to particular cellular 
organelles (reviewed by Salonen et al., 2004). Picornaviruses comprise a major family of 
positive stranded RNA viruses, which synthesize their structural and nonstructural proteins 
in association with cytoplasmic membranes in close vicinity to the RNA replication site. 
This family of viruses will be discussed in detail in the following section 1.3, and a general 
overview of membrane trafficking will be included. 
 
1.2.1 Togaviridae 
The Togaviridae family belongs to the alphavirus-like superfamily, which additionally includes 
several families of plant RNA viruses. The Alphaviruses belong to the Togaviridae family 
together with the Rubiviruses. The virus particles are enveloped and the capsid within is 
icosahedral. The Togaviridae belong to group IV of the Baltimore classification of viruses 
(figure 1.1). The RNA replication of Alphaviruses and Rubiviruses takes place in association 
with specific cytopathic vacuoles (reviewed by Salonen et al., 2004). 
 
1.2.1.1 Alphaviruses 
Alphaviruses infect a variety of vertebrates such as humans, rodents and birds and infection is 
usually spread by insect vectors. Semliki Forest virus (SFV) and Sindbis virus are members of 
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the alphavirus genus and infect birds. Association of SFV-specific RNA synthesis with 
membranes was demonstrated in the late 1960s. Electron microscopic studies revealed 
cytoplasmic structures typical for alphavirus-infected cells. These were designated as 
cytopathic vacuoles (CPVs). Their surface consisted of small vesicular invaginations or 
spherules and it was suggested they were involved in virus-specific RNA synthesis (Grimley et 
al., 1968). Froshauer and colleagues (1988) demonstrated that CPVs were modified endosomes 
and lysosomes with replicase-specific nonstructural proteins (nsP3 and nsP4, figure 1.3) located 
on their surface. It was suggested that CPVs are not only the site of viral RNA synthesis, but 
also of translation of structural proteins and the assembly of nucleocapsids (Froshauer et al. 
1988). However, it has been demonstrated that the endosomal targeting of the replication 
complexes must be a posttranslational event (Peränen & Kääriäinen, 1991). Alphavirus 
nonstructural proteins are synthesized as a polyprotein precursor P1234, which is processed into 
the individual components nsP1-nsP4 (figure 1.3). 
 
 
 
Figure 1.3: The genome organization of Alphaviruses. The translation and processing 
products relevant for replication are shown. 
 
Nonstructural protein nsP1 is necessary for the synthesis of the complementary RNA early in 
infection, nsP2 is involved in the regulation of the subgenomic mRNA coding for the structural 
proteins of the virion, nsP3 is essential for the formation and the functioning of the replication 
complex, and nsP4 is the catalytic RNA-dependent RNA polymerase (reviewed by Salonen et 
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al., 2004; Frolova et al., 2006). It has been suggested that all nsPs are associated with CVPs, 
indicating that these structures are the sites of RNA replication. However, only a fraction of 
nsPs are present in the replication complexes: nsP2 has been located in the nucleus, nsP1 at the 
plasma membrane, and nsP3 and nsP4 in the cytoplasm (Kujala et al., 2001). Only nsP1 has a 
specific association with membranes and was therefore a strong candidate as the membrane 
anchor of the replication complex. It has been shown that nsP1 was very tightly membrane 
bound, with a high affinity for endosomes and lysosomes (Peränen et al., 1995). 
 
1.2.1.2 Rubiviruses 
Rubella virus is the type species of the Rubiviruses, part of the Togaviridae family. Rubella 
virus shares a similar replication strategy with the Alphaviruses. During a rubella virus 
infection, cytoplasmic membrane structures are present that resemble Alphavirus replication 
complexes (Lee et al., 1992). These structures comprise vacuoles which are internally lined 
with membrane-bound vesicles or spherules. Antibodies against dsRNA have been used to 
localize dsRNA to these structures suggesting that they function as replication complex (Lee et 
al., 1994). Magliano and colleagues (1998) have demonstrated that rubella virus replication 
complexes are virus-modified lysosomes (Magliano et al., 1998). These results where 
confirmed by Kujala and colleagues (1999), who demonstrated that the rubella virus replicase 
protein is associated with vesicles and vacuoles of endo-lysosomal origin, and specifically with 
the spherules lining the interior of these structures, suggesting that these are the sites of viral 
RNA synthesis (Kujala et al., 1999; reviewed by Salonen et al., 2004). 
 
The alphavirus-like superfamily contains a number of plant viruses that replicate on various 
intracellular membranes. Brome mosaic virus (BMV) and Tobacco mosaic virus replicate on 
the ER, Alfalfa Mosaic virus on the vacuolar membrane, and Turnip Yellow Mosaic virus on 
the chloroplast envelope. The targeting determinant of the replication complex of BMV has 
been mapped to the 1a protein, and more specifically to the N-terminal domain, part of which is 
distantly related to the alphavirus nsP1. Structures closely resembling the spherules, described 
previously for Alpha- and Rubiviruses, have been detected in BMV-infected cells. It has been 
shown that BMV protein 1a alone, in the absence of other viral components, can induce 
spherule formation (reviewed by Salonen et al., 2004). 
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1.2.2 Flaviviridae 
The Flaviviridae family contains three genera: the Flavi-, the Hepaci-, and the Pestiviruses. 
hepatitis C virus (HCV, Hepaciviruses) and Kunjin virus (Flaviviruses) are the best studied 
in the context of membrane-associated replication. The positive stranded RNA genome of 
the Flaviviridae is translated to a large polyprotein. The structural proteins consist of a 
capsid protein and envelope glycoproteins followed by the nonstructural proteins (figure 
1.4). The nonstructural proteins of HCV associate to the ER membrane. It has been shown 
that nonstructural proteins NS2, NS4A, NS4B, NS5A, and NS5B associate with the ER 
membrane independent of the expression of other HCV proteins. The soluble 
protease/helicase NS3, however, associates with the ER membrane by interaction with 
NS4A. When expressed alone, NS3 is found diffusely throughout the cytoplasm and the 
nucleus, but when co-expressed with NS4A, NS3 is found in association with ER or ER-
like membranes. Deletion analysis revealed that the hydrophobic amino-terminal domain of 
NS4A is necessary for ER targeting of NS3 (Wölk et al., 2000; reviewed by Dubuisson et 
al., 2002). NS2 is a hydrophobic, polytopic integral membrane protein, which is targeted to 
the ER membrane by internal signal sequences. The function of NS2 is unclear. Deletion of 
NS2 did not abolish the replication of HCV RNA, which indicates that NS2 is not essential 
for viral RNA replication. Before cleavage from the polyprotein, however, NS2 is involved 
in an autoprotease activity that is responsible for the cleavage between NS2 and NS3 
(Yamaga & Ou, 2002; reviewed by Dubuisson et al., 2002). NS4B is a relatively 
hydrophobic protein of unknown function. It has, however, been demonstrated that the 
interaction of NS4B with NS3 and NS5B modulates the RNA polymerase activity 
(Piccininni et al., 2002). NS4B is predicted to be a polytopic membrane protein that is 
cotranslationally inserted into the ER membrane by internal signal sequences (Hügle et al., 
2001). Expression of the HCV polyprotein induces the formation of a special ER-derived 
membranous web. This membranous web has been proposed as a candidate HCV 
replication complex. Expression of NS4B alone induced the formation of the web, 
indicating that NS4B might have a function in inducing a specific membrane alteration 
necessary for the formation of the replication complex (Egger et al., 2002). 
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Figure 1.4: The genome organization of hepatitis C virus. The structural proteins, the 
capsid protein (C), and the envelope glycoproteins E1 and E2, are present in the N-terminal 
part of the polyprotein. The function of the p7 polypeptide is still to be determined. The 
nonstructural proteins NS1, NS2, NS3, NS4A, NS4B, NS5A, and NS5B are involved in the 
membrane-associated replication. 
 
The genome organization of Kunjin virus and HCV is similar, but there are some 
differences as well. Kunjin virus has a nonstructural glycoprotein NS1, which is 
translocated into the lumen of the ER and transported through the secretory pathway to the 
exterior of the cell. It also plays an essential role in RNA replication, by recognizing the 
other replicase proteins associating with the ER membrane. The Kunjin virus polyprotein 
also contains two small membrane-bound proteins NS2A and NS2B, preceding the NS3 
protein. NS2B acts as a cofactor for the NS3 protease (reviewed by Westaway et al., 2002). 
Kunjin virus nonstructural proteins NS1, NS2A, NS3, NS4A, and NS5 have been 
associated with dsRNA, which serves as a marker for replication complexes (Westaway et 
al., 1997). Dramatic changes in the organization of the ER membrane have been observed 
in Kunjin virus-infected cells. Convoluted membranes, paracrystalline structures and 
vesicle packets (VP) of smooth membrane appear during infection. The majority of 
nonstructural proteins and dsRNA have been localized to these VPs, which are derived 
from trans-Golgi membranes, which suggest that these VPs are sites of replication 
(Mackenzie et al., 1999; reviewed by Westaway et al., 2002, 2003). 
 
1.2.3 Nidovirales 
The Coronaviridae and the Arteriviridae families are grouped in the order Nidovirales. The 
expression of their replicase-transcriptase genes is mediated by the translation from two large 
open reading frames; ORF1a and ORF1b (figure 1.5). Initially two large polyproteins pp1a 
and pp1ab are synthesized. The synthesis of pp1ab involves a programmed ribosomal frame 
shift during translation of ORF1a. The ORF1a/ORF1b overlap region contains two signals 
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which are assumed to promote this event: a “slippery” sequence, which is the actual 
frameshift site, and a downstream RNA pseudoknot structure. Complex proteolytic 
processing of the polyproteins leads to 12 or more nonstructural proteins. Coronaviruses 
contain 16 nonstructural proteins: nsp1 to nsp11 are encoded in ORF1a, and nsp12 to nsp16 
are encoded in ORF1b. Arteriviruses, however, only contain 12 nonstructural proteins: nsp1 
to nsp8 are encoded in ORF1a, and nsp9 to nsp12 are encoded in ORF1b (reviewed by: 
Snijder & Meulenberg, 1998, Sawicki et al., 2007). 
 
 
 
Figure 1.5: The genome organization of Coronaviruses. The nonstructural proteins are 
encoded in ORF1a and ORF1b and are synthesized initially as two large polyproteins, 
pp1a and pp1ab. The synthesis of pp1ab involves ribosomal frame shifting during 
translation of ORF1a. These polyproteins are cleaved in 16 nonstructural proteins. The 
major structural proteins are the spike glycoprotein (S), the small envelope protein (E), the 
membrane glycoprotein (M), and the nucleocapsid protein (N). The 5’ end of the genome 
contains a leader sequence (L). 
 
The replicase-transcriptase proteins of Coronaviruses, together with other viral proteins 
assemble into replication complexes. These complexes accumulate at the perinuclear regions 
and are associated with double-membrane vesicles (DMV; Brockway et al., 2003, Snijder et 
al., 2006). The origin of these DMVs is unclear. The nonstructural proteins and the viral 
RNA of mouse hepatitis virus, a member of the Coronaviridae, have been localized to late 
endosomal membranes (van der Meer et al., 1999). It has also been shown that the replicase 
proteins of Equine Arteritis virus (EAV), a member of the Arteriviridae, as well as newly 
synthesized RNA, accumulates in perinuclear vesicles, which are of ER origin (van der Meer 
et al., 1998). EAV-infected cells revealed DMVs carrying the replication complex, which 
appear to be derived from paired ER membranes. They are most likely formed by protrusion 
and detachment of vesicular structures with a double membrane (Pedersen et al., 1999). 
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Snijder and colleagues (2001) have demonstrated that DMV formation during EAV 
infection does not depend on RNA synthesis. DMVs resembling those seen in EAV-
infected cells can be induced by expression of the nsp2-nsp3 region of the polyprotein, 
suggesting that nsp2 and nsp3 play a crucial role in the membrane association of the virus 
replication complex (Snijder et al., 2001). The nsp2 protein contains a long central 
hydrophobic sequence, which might act as its membrane anchor. Both nsp3 and nsp5 
contain several hydrophobic sequences, suggesting that they are polytopic membrane 
proteins. These nonstructural proteins and their precursors act as integral membrane 
proteins (van der Meer et al., 1998). Coronavirus nonstructural proteins nsp3, nsp4 and 
nsp6 contain hydrophobic transmembrane domains, suggesting that they serve to anchor the 
pp1a/pp1ab polyproteins to membranes during the first step of replication complex 
formation. All coronavirus nonstructural proteins are associated with the replication 
complex, however, at later times of infection, the nonstructural proteins encoded in ORF1a 
remain tightly bound to the replication complex, while proteins encoded in ORF1b detach 
and diffuse to the cytosol (reviewed by Sawicki et al., 2007). 
 
1.2.4 Caliciviridae 
The Caliciviridae are a major cause of gastroenteritis in humans and cause a wide variety of 
other diseases in animals. The Calicivirus family contains four genera: the Lago-, the Noro-, 
the Sapo-, and the Vesiviruses (Green et al., 2000). The human enteric Caliciviruses (Noro- 
and Sapoviruses) have not yet been successfully cultivated. In contrast, Feline Calicivirus 
(FCV), a virus belonging to the Vesivirus genus, and other animal Caliciviruses can be 
propagated in culture, and, as such, provide good model systems for other members of the 
family Caliciviridae. The Caliciviruses belong to the picornavirus-like supergroup of the 
positive-strand RNA viruses, which is characterized by the conservation of three major 
enzymes: a nucleoside triphosphatase (NTPase; 2C in Picornaviruses), a proteinase with a 
chymotrypsin-like fold (3C), and an RNA-dependent RNA polymerase (3D) (Koonin & 
Dolja, 1993). All calicivirus genomes are organized with a large nonstructural polyprotein 
gene (ORF1) that precedes a single structural capsid protein gene. Furthermore, they all 
contain a small 3’ terminal ORF encoding a basic and hydrophilic protein. In addition, a 
protein, called VPg, is covalently linked to the 5’ end of the RNA. Two fundamentally 
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different genome organizations are contained within the four calicivirus genera. ORF1 is 
either fused to and contiguous with the capsid ORF, forming a single polyprotein, or the 
capsid gene is encoded in a separate reading frame (ORF2) that overlaps the 3’ terminus of 
ORF1. In both cases, viral replication analysis in infected cells, has demonstrated that the 
major capsid protein is also encoded by a separate subgenomic RNA molecule (figure 1.6; 
reviewed in Thiel & Köning, 1999; Clarke & Lamden, 2000). 
 
Studdert and O’Shea, and Love and Sabine (1975) first reported a possible association of 
FCV replication with cellular membranes. Feline cells infected with FCV showed extensive 
rearrangements of intracellular membranes (Studdert & O’Shea, 1975, Love & Sabine, 
1975). The rearrangements of intracellular membranes were also seen in FCV-infected 
CRFK cells (Crandell-Rees feline kidney cells). Furthermore, a membranous fraction that 
could synthesize viral RNA in vitro was isolated from FCV-infected CRFK cells. The 
enzymatically active component of this membranous fraction was specified as the FCV 
replication complexes (Green et al., 2002). Analysis of the protein-protein interactions in 
the FCV replication complex has demonstrated that the p32 protein (picornavirus 2B 
analogue) interacts with p39 (viral helicase/NTPase, 2C analogue), p30 (3A analogue), and 
p76 (viral ProPol, 3CD analogue). The FCV protease/RNA polymerase p76 interacts with 
VPg and ORF2, which encodes the major capsid protein (Kaiser et al., 2006). The Norwalk 
virus (Norovirus) protein p48, a N-terminal nonstructural protein analogue to picornavirus 
protein 2B, interacts with the Golgi complex, suggesting that it may play a role in the 
induction of intracellular membrane rearrangements associated with positive-strand RNA 
replication (Fernandez-Vega et al., 2004). The FCV protein p32, the p48 homologue, 
however, did not demonstrate an interaction with the Golgi complex (Kaiser et al., 2006). A 
direct interaction of the Norwalk protein p48 with the SNARE regulator vesicle-associated 
membrane protein-associated protein A (VAP-A) has also been reported, suggesting that 
p48 interferes with intracellular protein trafficking (Ettayebi & Hardy, 2003). FCV 
replication in cells results in changes characteristic of apoptosis, including caspase 
activation, chromatin condensation and cleavage of poly(ADP-ribose) polymerase. It has 
been demonstrated that the mitochondrial pathway of apoptosis is triggered during FCV 
infection (Sosnovtsev et al., 2003, Natoni et al., 2006). 
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Figure 1.6: The genome organization of Caliciviruses. The genomic organization and 
reading frame usage are shown for the different Calicivirus genera. The genome size varies 
between 7.4 and 8.3 kb. The predicted RNA helicase (Hel), protease (Pro), and polymerase 
(Pol) regions present in all Caliciviruses are indicated. For the genus Vesivirus the black 
box illustrates the leader sequence of the capsid precursor protein which is post-
translationally cleaved off. The subgenomic-sized transcript RNA (2.2 to 2.4 kb), detected 
in cells infected with animal Caliciviruses, is shown. 
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1.3. Picornaviruses 
The Picornaviridae comprise a significant family of human and agricultural pathogens, 
such as poliovirus, human hepatitis A virus, foot-and-mouth disease virus (FMDV) and the 
human Rhinoviruses. These viruses are both medically important and economically 
significant. For example, Human Rhinoviruses are a major cause of the common cold. Foot-
and-mouth disease is one of the most infectious pathogens of livestock known and is 
responsible for worldwide outbreaks of foot-and-mouth disease in cloven-hoofed animals 
(reviewed by Rueckert, 1996). 
 
1.3.1. Classification 
Currently, the Picornaviridae family consists of nine genera: Entero-, Rhino-, Cardio-, 
Aphtho-, Hepato-, Parecho-, Erbo-, Kobu- and Teschoviruses; and three proposed genera 
provisionally named “Sapeloviruses”, “Senecaviruses”, and “Tremoviruses”. Additionally, 
the two human rhinovirus species are to be moved to the enterovirus genus, after which the 
rhinovirus genus will disappear. The classification is based on phylogenetic properties, 
which reflect evolutionary history. The general hosts of the Picornaviridae are vertebrates. 
Members of the picornavirus family have similar genome organization and are believed to 
follow a similar replication strategy (King et al., 2000; reviewed by Stanway et al., 2002). 
 
The Enteroviruses include not only the Poliovirus (PV type 1, 2 and 3), which is the type 
species, but also the Coxsackieviruses A (CVA, 23 serotypes) and B (CVB, 6 serotypes), 
and the Echoviruses (28 serotypes). Furthermore, more than 100 serotypes of human 
enteroviruses have been identified. The enterovirus genus also contains some nonhuman 
enteric viruses such as bovine enteroviruses (type 1 and 2) and porcine enteroviruses (3 
serotypes) (reviewed by Rueckert, 1996; King et al., 2000; Oberste et al., 2001). The 
Rhinoviruses are the most important aetiological agent of the common cold in adults and 
children and currently 103 serotypes have been identified. They are named Rhinoviruses 
because they replicate in the nasopharynx. This genus includes the species human 
Rhinovirus A and human Rhinovirus B (reviewed by Racaniello, 2001). 
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1.3.1.1 Cardioviruses 
The Cardiovirus genus currently comprises two virus species: Encephalomyocarditis virus 
(EMCV) and Theilovirus (ThV). The EMCV species is represented by a single serotype of 
the same name and furthermore contains the Columbia-SK virus, the Maus-Elberfeld virus, 
and Mengovirus. EMCV infects many animal species: primarily rodents, cattle, elephants, 
raccoons, and more rarely primates. The main reservoir host is the rat although mice may also 
spread the virus, passing it to other species through faecal-oral transmission (Grobler et al., 
1995, Knowles et al., 1998, Spyrou et al., 2004, Bakkali Kassimi et al., 2006). The 
Theilovirus species includes the Theiler’s Murine Encephalomyelitis virus (TMEV), Vilyuisk 
Human Encephalomyelitis virus (VHEV), and Theiler-like virus of rats (King et al., 2000; 
reviewed by: Rueckert, 1996, Racaniello, 2001; Ohsawa et al., 2003). 
 
Strains of TMEV were first isolated by Max Theiler and early investigations showed that 
TMEV was a picornavirus causing a subclinical enteric infection in mice. On occasion, 
TMEV spreads to the central nervous system to cause paralysis and more rarely 
encephalitis. There are two clusters of TMEV strains based on the differences in biological 
activities. Strains of the GDVII subgroup, GDVII and FA, are highly virulent and produce 
an acute and usually fatal encephalomyelitis in mice, which resembles poliomyelitis. The 
second group, known as Theiler’s original (TO), includes the DA, BeAN, WW, and Yale 
strains (Lipton, 1978). These strains are less virulent and cause a chronic biphasic 
neurological disease in some mouse strains, which is an animal model of human 
demyelinating diseases such as multiple sclerosis (Lipton, 1975, Roos, 2002; reviewed by: 
Racaniello, 2001, Oleszak et al., 2004). 
 
In the late 1950s, an outbreak of degenerative neurological disease occurred within the 
Yakut population of Siberia. The disease was manifested as either an acute or chronic form 
of diffuse meningoencephalitis, dementia-schizophrenia, or amyotrophic lateral sclerosis. 
Autopsy revealed widespread inflammatory-degenerative changes in the nervous system, 
especially the cerebral cortex and basal ganglia. The suspected etiologic agent, VHEV or 
Vilyuisk virus, was isolated from the cerebrospinal fluid of a chronic case of 
encephalomyelitis, and was subsequently characterized as a picornavirus highly similar to 
TMEV (Lipton et al., 1983, Pritchard et al., 1992). Recently, a novel picornavirus, known 
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as Saffold virus (SAF-V), has been described. It was isolated in the US (1981) from the 
stools of an 8-month infant presenting with fever of unknown origin. Molecular 
evolutionary analysis has demonstrated that SAF-V is a new member of the Cardiovirus 
genus. Phylogenetic analysis of the full length genome sequences has shown that SAF-V is 
most closely related to Theiler-like virus, followed by TMEV (Jones et al., 2007). 
 
1.3.1.2 Aphthoviruses 
Foot-and-mouth disease virus (FMDV) is the type species of the Aphthoviruses, which 
infect cloven-hoofed animals such as cattle, pigs and sheep. Seven FMDV serotypes have 
been identified: types A, C, O, Asia 1, and the South African Territory types SAT 1, SAT 2, 
and SAT 3. The Aphthovirus genus also includes the Equine Rhinitis A virus (Belsham, 
1993; King et al., 2000; reviewed by: Rueckert, 1996; Racaniello, 2001). 
 
FMDV is the causative agent of foot-and-mouth disease (FMD). FMD was first described 
in Italy in the 1500s. The disease is still prevalent, despite many countries being declared 
FMD-free. Endemic regions of the disease include areas of Europe (UK), Asia, and South 
America. Eradication in these areas has been difficult, despite the availability of a vaccine. 
The cause of FMD was first demonstrated to be viral in 1898 by Loeffler and Frosh. Blood 
of infected animals was passed through a Chamberland filter, and it was found that the 
filtered fluid was able to infect healthy animals (reviewed by Levine, 1996). The average 
incubation period is 3 to 8 days and the disease is characterized by high fever, blisters 
inside the mouth and on the feet. Most animals recover eventually, but FMD can lead to 
myocarditis and death. Some animals remain asymptomatic; however, as carriers of the 
virus they can still transmit the virus to other animals. Humans can be infected with FMDV 
through contact with infected animals, but this is extremely rare. Symptoms include 
malaise, fever, vomiting, red ulcerative lesions of the oral tissues, and sometimes vesicular 
lesions of the skin. 
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1.3.2. Viral genome 
Picornavirus genomes are positive, single-stranded, linear RNA molecules varying in length 
from 7.1 kilobases (kb) to 8.2 kb. They are composed of three parts: the 5’ noncoding region 
(5’NCR) (600 to 1200 nucleotides [nts]), the coding region (6500 to 7000 nts), and the 3’ 
noncoding region (3’NCR), which contains a heteropolymeric segment (up to 100 nts) and a 
poly(A) tract (figure 1.7; reviewed by: Rueckert, 1996, Racaniello, 2001, Agol, 2002, 
Stanway et al., 2002). The genome encodes four major functions: generation of structural and 
non-structural proteins, RNA replication, virion assembly, and progeny release from the cell 
(reviewed by Agol, 2002). 
 
The 5’NCRs are long (around 10% of the genome) and highly structured. RNAs possess no 
cap but instead the 5’NCR is covalently associated with a small virus-specific protein termed 
VPg, which appears to play an important role in initiation of RNA synthesis. VPg is encoded 
by a single gene, 3B, in all picornaviruses except the genome of FMDV, which encodes three 
VPg genes. The 5’NCR contains sequences that control genome replication and translation. It 
contains a 5’-terminal stem-loop or cloverleaf-structure and it contains the internal ribosome 
entry site (IRES), which is an element that directs translation of the mRNA by internal 
ribosome binding. Multiple classes of picornavirus IRES elements have been characterized. 
The type 1 IRES element is seen only in enteroviruses and rhinoviruses, while aphthoviruses 
and cardioviruses have a type 2 IRES element (reviewed by: Reuckert, 1996, Racaniello, 
2001, Stanway et al., 2002). The Hepatitis A virus IRES is generally considered to represent 
a third type of IRES. In contrast to other picornavirus IRES elements, it requires the intact 
translation initiation eIF4F complex. Recently, a new class of picornavirus IRES elements has 
been identified. This class contains the IRES elements from Porcine Teschoviurs 1 (PTV-1), 
Simian virus 2 (SV2), Porcine Enterovirus 8 (PEV-8), and Avian Encephalomyelitis virus. 
These IRES elements show significant similarity to the hepatitis C virus IRES in sequence, 
function, and predicted secondary structure (Chard et al., 2006, Bakhshesh et al., 2008). The 
5’NCR of EMCV contains a poly(C) tract, the 5’NCR of TMEV, however, does not. In 
poliovirus the cloverleaf binds protein 3CD in the presence of 3AB or in the presence of 
cellular protein poly(rC) binding protein 2 (PCBP2; Andino et al., 1990, 1993, Harris et al., 
1994, Parsley et al., 1997, Gamarnik & Andino, 2000). The J and K stem-loops of the 
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cardiovirus IRES binds the cellular translation initiation factor 4G (eIF4G), conferring a cap-
independent mode of translation (Kolupaeva et al., 1998, 2003, Clark et al., 2003). Other 
cellular proteins, such as the La autoantigen, pyrimidine tract binding protein (PTB) and 
PCBP2 have also been shown to bind picornavirus IRESes and enhance translation (Ali & 
Saddiqui, 1997, Blyn et al., 1997, Hunt et al., 1999). The strongly conserved 3’NCR contains 
a secondary structure, a pseudoknot, which seems to carry signals for controlling viral RNA 
synthesis. picornaviruses carry a 3’ stretch of poly(A), which has an average length of 35 to 
100 nucleotides. Viral RNA from which the poly(A) tract is removed is non-infectious 
(reviewed by Racaniello, 2001). 
 
 
 
Figure 1.7: The genome organization of Picornaviruses. The RNA secondary structures 
in the 5’ NCR are shown, together with the polyprotein. The polyprotein contains the capsid 
proteins 1A (VP4), 1B (VP2), 1C (VP3), and 1D (VP1), and the RNA replication proteins 
2A to 2C and 3A to 3D. The L protein can only be found in the genome of Aphthoviruses 
and Cardioviruses. The L* protein is only present in persistent strains of Theiler’s virus 
(DA, BeAn). 
 
Picornaviruses contain a single, long, open reading frame, which encodes a single polyprotein 
(around 2200 amino acids [aa]) that is processed to form individual viral proteins. The 
polyprotein is cleaved during translation, so that the full-length polyprotein is not observed 
(reviewed by: Racaniello, 2001, Agol, 2002, Stanway et al., 2002). The polyprotein is divided 
into three regions: P1, P2 and P3 (figure 1.7). The P1 region is the structural region and encodes 
the viral capsid proteins: VP4 (1A), VP2 (1B), VP3 (1C), and VP1 (1D) (figure 1.7). The P2 
and P3 regions encode proteins involved in protein processing and genome replication: P2 
contains information for polypeptides 2A, 2B, and 2C; P3 encodes four polypeptides, 3A to 3D 
(reviewed by: Racaniello, 2001, 2002, Stanway et al., 2002). 
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1.3.3. Viral polyprotein and proteolytic processing of the polyprotein 
Picornavirus proteins are encoded in a single, long, open reading frame (ORF). A single 
polypeptide, designated the viral polyprotein, is generated from this ORF. Viral replication 
depends on the activity of proteinases encoded within the polyprotein to process it into the 
mature viral proteins. The polyprotein corresponding to the complete ORF is never observed in 
infected cells because virally encoded proteinases initiate polyprotein cleavage 
cotranslationally. These primary cleavages in cis (intramolecular) are followed by secondary 
reactions in cis and trans (intermolecular). Picornavirus genomes encode three proteinases: Lpro, 
2Apro, and 3Cpro (reviewed by: Ryan & Flint, 1997, Racaniello, 2001, Leong et al., 2002, Skern 
et al., 2002). 
 
1.3.3.1 Proteolytic processing of the viral polyprotein 
Several picornavirus genera encode a 2A protein with proteolytic activity that is responsible for 
carrying out the initial cleavage between the capsid precursor P1 and the precursor of the non-
structural proteins, P2-P3. In cells infected with rhino- or enteroviruses 2Apro cleaves their 
respective polyproteins between the C terminus of VP1 and their own N terminus. In contrast, 
2A of cardio- and aphthoviruses performs the primary cleavage between the C terminus of 2A 
and the N terminus of 2B, generating a P1-2A precursor. The 2A protein of hepato- and 
parechoviruses does not have proteolytic activity. They encode only a single proteolytic 
enzyme, 3Cpro, which carries out both primary cleavage events. The initial cleavage occurs 
between the P2 proteins 2A and 2B and the second between 2C and 3A. The aphtho- and 
cardioviruses encode an L protein at the N terminus of their polyprotein. The Lpro of FMDV is a 
proteinase that releases itself from the polyprotein by cleaving between its own C terminus and 
the N terminus of VP4. In cardioviruses, however, the L protein does not possess any detectable 
proteolytic activity and cleavage between its C terminus and the P1 precursor is mediated by 
3Cpro in a secondary cleavage (figure 1.8; reviewed by: Ryan & Flint, 1997, Racaniello, 2001, 
Leong et al., 2002, Skern et al., 2002). 
 
The majority of the secondary processing steps on the polyprotein are performed by 3Cpro. 
This proteolytic enzyme carries out a primary cleavage between 2C and 3A and it also 
carries out secondary cleavages of the P1 and P2 precursors. In poliovirus, however, two 
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cleavages are carried out by the precursor of 3Cpro, 3CDpro, which is released from the P3 
precursor by autocatalytic cleavage. These are between the capsid proteins VP0 (precursor 
of VP2 and VP4) and VP3 and between VP3 and VP1. Both 3Cpro and 3CDpro can process 
proteins of the P3 region. The final cleavage to take place is that between the capsid 
proteins VP4 and VP2. The precursor VP0 is assembled into new viral particles and during 
maturation of these viral particles, a yet unknown proteolytic activity carries out the 
cleavage of VP0 (reviewed by: Racaniello, 2001, Leong et al., 2002, Skern et al., 2002). 
 
 
 
Figure 1.8: Picornavirus polyprotein primary cleavages. The single open reading frame for 
the different Picornavirus genera is shown and the primary cleavages are indicated. The L 
protein of Aphthoviruses is a protease, the L protein of Cardioviruses, however, does not show 
proteolytic activity. Furthermore, the 2A protein of Hepato- and Parechoviruses does not 
possess proteolytic activity. The shading of the 2A protein of the other Picornavirus genera 
reflects the differences in mechanism of cleavage. 
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1.3.3.2 L protein 
Some picornaviruses, such as aphthoviruses and cardioviruses, encode a leader (L) protein at 
the N terminus of their polyprotein (figure 1.7, 1.8). The aphthovirus L protein (173 to 201 aa) 
is an autocatalytic protease (explained in more detail in section 1.3.4.1). The cardiovirus L 
protein (67 to 76 aa) is a much shorter protein without any recognizable proteolytic motifs and 
no protease activity. It contains sequences consistent with N-terminal zinc-binding motifs, 
centrally located tyrosine kinase phosphorylation sites, and C-terminal acid-rich domains. The 
L protein is phosphorylated during viral infection by casein kinase II (CK-2), suggesting that 
the L protein may play a role in regulation of viral genome translation through a triggering 
phosphorylation event (Dvorak et al., 2001). It has been demonstrated that the L protein of 
Theiler’s virus plays an important role in blocking the production of alpha/beta interferon by 
infected cells, and that the zinc-finger motif plays a crucial part in this function (van Pesch et 
al., 2001, van Pesch & Michiels, 2003). Theiler’s L protein also interferes with trafficking of 
the cytoplasmic interferon regulatory factor 3 (IRF-3), a factor critical for transcriptional 
activation of alpha/beta interferon genes (Delhaye et al., 2004). Furthermore, it interacts with 
Ran-GTPase and disrupts nucleocytoplasmic transport (Porter et al., 2006). The L protein is 
dispensable for virus replication in vitro, but crucial for long-term persistence of the virus in the 
central nervous system of the mouse (Paul & Michiels, 2006). The L* protein is a unique 
feature amongst picornaviruses (figure 1.7). It is only present in persistent forms of Theiler’s 
virus (DA, BeAn). The ORF initiates 13 nt downstream of the AUF initiating the polyprotein 
(Kong & Roos, 1991, Yamasaki et al., 1999). The L* ORF facilitates the infection of 
macrophage cell lines. This effect is due to the L* protein itself, rather than to competition for 
the translation of the two overlapping ORFs (van Eyll & Michiels, 2000). 
 
1.3.3.3 Capsid proteins 
The capsid proteins 1A-D comprise an icosahedral, non-enveloped particle, approximately 30 
nm in diameter. The virion is assembled from 60 protomers arranged as 12 pentamers to form 
the icosahedral protein shell. Each protomer is composed of four structural proteins: viral 
protein 1 (VP1 or 1D), VP2 (1B), VP3 (1C) and VP4 (1A). VP1 to VP3 are the major structural 
components of the virion and have a molecular weight of around 30 kDa. They form an eight-
stranded antiparallel β-barrel (made up of two antiparallel β-sheets). VP4 is much smaller and 
 24
forms, in conjunction with the amino terminal ends of VP1 and VP2, an interface between the 
capsid and the internal RNA genome. The surface of the virions consists of a prominent star-
shaped plateau (mesa), surrounded by a deep depression (canyon). The canyon may act as a 
receptor binding site; however, not all picornaviruses have canyons. The capsid serves several 
key functions such as protecting the viral RNA genome from nucleases, binding receptors in the 
plasma membrane, avoiding cellular immune response, providing a proteinase involved in the 
maturation of the virion, and delivering the RNA genome through the cell membrane into the 
cytosol of susceptible host cells (reviewed by: Hellen & Wimmer, 1995, Rueckert, 1996, 
Racaniello, 2001, Rossmann, 2002). 
 
 
 
Figure 1.9: Illustration of picornavirus virion structure. (A) Depth-cued image of TMEV 
strain BeAn showing the surface topography (Luo et al., 1992); (B) Atomic structure of TMEV 
strain DA showing the 5-fold axis; (C) Organization of the FMDV external capsid proteins in 
an icosahedron. 
 
1.3.3.4 Protein 2A 
Early work on poliovirus polyprotein processing revealed that the primary cleavage separating 
the capsid protein region (P1) from the replicative protein domain (P2) is mediated by the 2A 
proteinase cleaving at its own N terminus (as described in section 1.3.4.1). Sequence analysis of 
the 2A region of different picornaviruses showed that the entero- and rhinoviruses possessed 
highly similar 2A proteinases. The cardiovirus 2A proteins are similar in size to that of entero- 
and Rhinoviruses, but show no apparent sequence similarity. The 2A region of aphthoviruses is 
extremely short but does, however, demonstrate sequence similarity with the C-terminal region 
of the longer cardiovirus 2A proteins. The cardio- and aphthovirus 2A proteins are associated 
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with an unusual processing activity involving an NPGP motif. The importance of the 
conservation of the sequence of the cleavage site, and the cleavage site itself (NPG|P) was 
demonstrated (reviewed by Ryan et al., 2002). The C-terminal region of TMEV-2A is 
responsible for mediating a primary polyprotein cleavage at its own C-terminus (Donnelly et 
al., 2001). This apparent cleavage is not proteolysis, but a translational effect involving the 
NPGP motif (reviewed by Ryan et al., 2002). Host-cell translation is stopped during cardiovirus 
infection and this is correlated with activation of translation initiation factor 4E binding protein 
1 (4E-BP1), which is a repressor of cap-dependent translation (Gingras et al., 1996, Svitkin et 
al., 2005). In the case of EMCV this activity has been mapped to protein 2A (Aminev et al., 
2003). Protein 2A of hepato- and parechoviruses is not believed to be involved in processing. 
Cleavage of the 2A/2B junction in hepato- and parechoviruses is carried out by 3Cpro (Gosert et 
al., 1996). Parechovirus 2A proteins are homologous to 2A of kobuviruses and moreover 
related to the H-rev107 family of proteins possibly involved in the control of cell proliferation 
(Hughes & Stanway, 2000). It has also been demonstrated that protein 2A of hepatitis A virus 
participates in virion morphogenesis (Cohen et al., 2002). The 2A proteins of erbo- and 
teschoviruses contain the NPGP motif, which suggest that they function like the “translational-
type” 2A of aphtho- and cardioviruses. 
 
1.3.3.5 Protein 2B 
Picornavirus protein 2B is a rather small protein of about 100 amino acids (AA). It contains 
two hydrophobic regions, one amphipatic α-helix and a potential transmembrane domain 
with a β-sheet configuration (figure 1.14). The sequence of protein 2B is one of the least 
conserved among picornaviruses. The precise function of 2B in the picornavirus replication is 
not yet defined. PV with mutations in the 2B gene is defective in genome replication. It has 
also been reported that PV 2B is located mainly in the central portion of the cytoplasm, 
associated with the membranous vesicles that surround the replication complexes. The 
expression of PV 2B showed a disassembly of the Golgi complex (reviewed by: Racaniello, 
2001, Carrasco et al., 2002, Leong et al., 2002). Furthermore it has been demonstrated that 
expression of PV protein 2B inhibits vesicular protein transport (Doedens & Kirkegaard, 
1995). Protein 2B of enteroviruses has been shown to be a “viroporin”. Viroporins are 
hydrophobic proteins encoded by animal viruses that are able to disturb membrane integrity, 
 26
favoring the release of viral progeny. The presence of amphipatic α-helices is a general 
feature of these membrane-disturbing proteins. Protein 2B of enteroviruses forms pores in ER 
and Golgi membranes, which results in a decrease of ER and Golgi Ca2+ content, which in 
turn reduces the Ca2+ accumulation in the neighboring mitochondria. It has been suggested 
that this might interfere with Ca2+-dependent vesicular fusion events, which in turn might 
contribute to the accumulation of the membrane vesicles required for viral RNA replication. 
Enterovirus protein 2B is involved in suppressing apoptosis of the infected cells. The 
disturbance of the intracellular Ca2+ homeostasis is probably involved in this anti-apoptotic 
function, as it has been shown that Ca2+ fluxes between ER and mitochondria play an 
important role in ER-dependent apoptosis (Campanella et al., 2004, reviewed by van 
Kuppeveld et al., 2005). 
 
1.3.3.6 Protein 2C 
Protein 2C (~36 kDa) is one of the most conserved picornavirus proteins. Based on sequence 
alignments it was proposed that protein 2C contained NTP binding motifs and could also be a 
helicase. The helicase activity has not been demonstrated, but protein 2C does have 
ATPase/GTPase activities (Rodriguez & Carrasco, 1993, Mirzayan & Wimmer, 1994). 
Expression of 2C induces membrane proliferation and blocks the exocytic pathway (Barco & 
Carrasco, 1995, 1998). Protein 2C and its effect on membranes and membrane trafficking 
during infection will be discussed in detail in section 1.3.7. 
 
1.3.3.7 Protein 3A 
The small hydrophobic protein 3A associates with intracellular membranes, and is also 
observed in its precursor form 3AB. The genome-linked protein VPg (3B) is covalently linked 
to the 5’ end of both plus and minus RNA strands, and is essential for viral genome replication. 
Precursor 3AB plays a role in delivering VPg to the RNA replication complexes. Protein 3AB 
interacts with membranes both in vivo and in vitro and behaves as an integral membrane 
protein. Protein 3A contains a conserved hydrophobic region of 22 AA near the C-terminus, 
which is responsible for association with membranes. The introduction of charged residues into 
this hydrophobic sequence disrupts the 3AB membrane interaction. Thus, the hydrophobic 
region might serve to anchor 3AB to the membrane replication complex. Heterologous 
 27
expression of 3A in E. coli showed that 3A affected membrane permeability and proliferation 
(Lama & Carrasco, 1992, Weber et al., 1996, reviewed by: Carrasco et al., 2002, Leong et al., 
2002). Protein 3A is also a potent and specific inhibitor of protein secretion, blocking 
anterograde protein traffic from the ER to the Golgi complex. This function of 3A is extremely 
sensitive to mutations near the N-terminus of the protein (Doedens & Kirkegaard, 1995, 
Doedens et al., 1997, Dodd et al., 2001, Neznanov et al., 2001). Furthermore, it has been 
demonstrated that protein 3A affects MHC I-dependent antigen presentation (Deitz et al., 
2000). FMDV protein 3A, however, does not seem to interfere with ER to Golgi traffic (Moffat 
et al., 2005). Expression of poliovirus 3A revealed a possible function of 3A as a co-factor for 
3D polymerase activity (Lama et al., 1994). Richards and Ehrenfeld (1998) proposed that this 
activity of 3A is required for stabilizing weak interactions that occur during initiation events in 
the viral RNA replication complex (Richards & Ehrenfeld, 1998). Sequence analysis of wild-
type (wt) and attenuated strains of FMDV revealed nucleotide deletions in the 3A coding 
region, suggesting that protein 3A may contribute to virulence in cattle (Giraudo et al., 1990). 
This was subsequently confirmed by analysis of FMDV strains, similarly attenuated, from 
Asian outbreaks (Beard & Mason, 2000, Knowles et al., 2001, Pacheco et al., 2003). A single 
mutation within 3A mediated adaptation of FMDV to guinea pigs, whilst mutations within PV 
3A also affected host-range (Lama et al., 1998, Nunez et al., 2001). 
 
1.3.3.8 Protein 3B 
Protein 3B, also known as VPg, is covalently linked to the 5’ end of the genome. A precise 
function is not yet known, but it has been demonstrated that protein 3B is not required for viral 
RNA infectivity. It has been shown that VPg can be uridylylated by the viral polymerase 3D, 
and that this uridylylated VPg can serve as a primer for RNA replication by the RNA-
dependent RNA polymerase (reviewed by Leong et al., 2002). An essential RNA structure 
known as the cis-acting replicative element (cre) has been identified within the protein-coding 
region of several picornaviruses. The cre is a short hairpin loop which contains a conserved 
AAACA motif and functions as a template for uridylylation of protein 3B. These cre elements 
are located in different regions of the genomes of several picornaviruses: 1B for cardioviruses, 
5’ UTR for FMDV, 2C for poliovirus, P1 for HRV-14, and 2A for HRV-2 (Lobert et al., 1999, 
Rieder et al., 2000, Mason et al., 2002, Yang et al., 2002). 
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1.3.3.9 Proteinase 3C 
Protein 3C is the virus-encoded proteinase responsible for the majority of the processing of the 
picornavirus polyprotein (reviewed by Ryan & Flint, 1997). All precursors containing 3C 
(3ABCD, 3BCD, 3CD) are active as proteinases. Protein 3C also has an RNA-binding domain 
and precursor 3CD binds the 5’ RNA cloverleaf structure, which is an essential step during 
replication. Atomic structures are available for poliovirus, hepatitis A virus, human rhinovirus 
2, and FMDV 3Cproteinases (figure 1.10). 
 
 
 
Figure 1.10: Atomic structure of FMDV 3C proteinase. The N- and C-terminal α-helices 
(red) and several β-sheets (blue) are indicated. This structural figure was prepared using 
WebLab Viewer Lite (Accelrys, Cambridge, UK). 
 
1.3.3.10 Polymerase 3D 
Protein 3D (~52 kDa) is highly conserved amongst picornaviruses. It serves as the RNA-
dependent RNA polymerase, and is responsible for the synthesis of positive and negative 
strand RNAs. It has been demonstrated that the polymerase activity of protein 3D is 
positively influenced by the viral protein 3AB. Interactions between 3D and 3AB may 
facilitate localization of the polymerase to replication complexes. Protein 3D also catalyzes 
the VPg uridylylation reaction essential for RNA replication (reviewed by Leong et al., 
2002). The polymerase has no proof-reading activity and in the absence of any post-
replicative mismatch repair, the error-rate of transcription is ~10-4. The protein architecture 
contains the classical “fingers”, “palm”, and “thumb” domains. Atomic structures are 
available for poliovirus polymerase (with a 68aa N-terminal truncation), poliovirus 3CD, 
and FMDV polymerase in complex with an RNA primer or VPg (figure 1.11). 
 29
 
 
Figure 1.11: Atomic structure of FMDV 3D polymerase. Several α-helices (red) and β-
sheets (blue) are indicated. The protein architecture contains the classical “fingers”, “palm”, 
and “thumb” domains. This structural figure was prepared using WebLab Viewer Lite 
(Accelrys, Cambridge, UK). 
 
1.3.4. Replication cycle 
1.3.4.1 Attachment and entry into the cell 
Replication of picornaviruses takes place entirely in the cell cytoplasm. They initiate infection 
of cells by first attaching to the host cell membrane through a cell receptor. A wide variety of 
cell surface molecules are used by picornaviruses as cellular receptors. For some 
picornaviruses, such as polioviruses and rhinoviruses, a single type of receptor is sufficient 
for entry into cells. Other picornaviruses need a co-receptor for entry into cells (reviewed by 
Racaniello, 2001). 
 
The receptor of EMCV has been identified as the murine vascular cell adhesion molecule 
(VCAM-1). Monoclonal antibodies to VCAM-1 inhibited infection and lysis of endothelial 
cells with the D variant of EMCV (EMCV-D). CHO cells (Chinese hamster ovary cells) 
transfected with VCAM-1 were susceptible to EMCV-D lysis, while control CHO cells, not 
expressing VCAM-1, were resistant (Huber, 1994). The TMEV receptor is not known but 
radio-labelled TMEV (both BeAn and GDVII) bound predominantly to a 34 kDa 
glycoprotein, and to a lesser extent to 100 and 18 kDa membrane proteins (Kilpatrick & 
Lipton, 1991). Sialic acid is a (co-) receptor moiety only for the persistent TMEV strains and 
not for the non-persistent strains. Structural studies have demonstrated that sialyl-lactose 
binds to a pocket on the viral surface, composed mainly of the amino acid residues from 
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capsid protein VP2 puff B, in the vicinity of the VP1 CD loop and the C-terminus of VP3 
(Zhou et al., 2000). A persistent strain of DA produces a prominent cytopathic effect (CPE) 
in BHK-21 cells (baby hamster kidney cells) but is much less efficient at infecting L929 cells 
(mouse fibroblast cells). Adaptation of this DA strain to produce a rapid CPE in L929 cells 
involved mutations in amino acid residues in the CD loop of VP1, and the EF loop of VP2, 
which are both exposed at the surface of the capsid, suggesting that these amino acid residues 
could be involved in receptor recognition. These two clusters of amino acids are part of 
neutralization epitopes and differentiate persistent from neurovirulent strains of Theiler’s 
virus (Jnaoui & Michiels, 1998, 1999). Infectivity of both TMEV groups requires UDP-
galactose transporter (UGT), which belongs to a family of nucleotide-sugar transporter 
proteins involved in the biosynthesis of complex carbohydrate structures in the trans-Golgi 
network. UGT most likely mediates TMEV entry and infection by adding galactose to 
another receptor protein (Hertzler et al., 2001, Shah & Lipton, 2002, Reddi et al., 2003). 
 
Once picornaviruses have attached to their cellular receptor, the viral capsid must dissociate to 
release the RNA genome into the cell cytoplasm. For some picornaviruses, such as FMDV and 
rhinovirus, interaction with a cell receptor serves only to concentrate virus on the cell surface. 
These picornaviruses enter cells by receptor-mediated endocytosis. For other picornaviruses, 
such as Poliovirus, the cell receptor is also an unzipper and initiates conformational changes in 
the virus that lead to formation of a pore in the cell membrane through which the viral RNA can 
be released into the cytoplasm (reviewed by Racaniello, 2001). 
 
1.3.4.2 Translation of viral RNA 
Once the positive-stranded viral RNA is released into the cell cytoplasm, it must be translated 
because it cannot be copied by any cellular RNA polymerase. The viral protein VPg is 
removed by a cellular unlinking enzyme on entry of the RNA into the cell. Translation 
initiation is accomplished through a cap-independent mechanism involving an RNA segment 
called the IRES. The picornavirus IRES is a sequence that promotes translation initiation by 
internal ribosome binding and contains extensive regions of RNA secondary structure that is 
conserved within the type I and type II IRES (reviewed by: Racaniello, 2001, Agol, 2002). 
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The full-length polyprotein is not observed due to rapid primary, co-translational cleavages 
producing [L-P1-2A], [2BC], and [P3] precursor forms. Precursors are subsequently 
processed by the virus encoded proteinase 3C (discussed in detail in section 1.3.4.1, 
reviewed by Ryan & Flint, 1997). Picornavirus proteinases also carry out cleavage of host 
cell proteins to inhibit non-essential cap-dependent cellular translation. The viral proteinase 
2A of entero- and rhinoviruses carries out the cleavage of the eukaryotic initiation factor 
(eIF) 4GI and its homologue eIF4GII, which are essential components of the host cap-
dependent complex. This cleavage results in total shutoff of host protein synthesis. The 
FMDV Lpro protein also cleaves eIF4G during an infection. In both cases the cleavage leads 
to the inability of the host cell to initiate protein synthesis on its own capped mRNA. This is 
known as the host-cell protein shutoff (Gradi et al., 1998, Svitkin et al., 1999, reviewed by: 
Leong et al., 2002, Skern et al., 2002). It has been demonstrated that eIF4G interacts with 
the IRES for cap-independent translation. The 2A and Lpro protein induce cleavage of 
eIF4G on the C-terminal side of the binding site on eIF4G for eIF4E (the cap-binding 
protein) and hence, separated the IRES-binding region from the eIF4E interaction site 
(Clark et al., 2003). 
 
Two proteins are directly involved in the synthesis of viral RNA: the RNA-dependent RNA 
polymerase 3Dpol and VPg. VPg serves, after being uridylylated by 3Dpol, as a primer for the 
initiation of both positive and negative RNA strands. The synthesis of messenger RNA and 
genome occurs in the cell cytoplasm. The viral RNA polymerase is associated with a cellular 
membrane fraction, which was called the RNA replication complex. The RNA replication 
complex consists of small membranous vesicles and several other viral proteins, such as 2BC, 
2C, 3AB and 3Cpro, were detected in the RNA replication complexes (reviewed by: Racaniello, 
2001, Agol, 2002). 
 
In picornavirus-infected cells, the positive stranded genome is amplified through a negative 
stranded intermediate. The genomic RNA serves as the template for synthesis of negative-
stranded RNA. Initiation of the negative strand demands positioning of 3Dpol in close 
proximity to the 3’ end of the positive strand, represented by a poly(A) tract. The negative 
stranded intermediate then serves as a template for the synthesis of positive-stranded 
genomic RNA, which also serves as mRNA (reviewed by: Racaniello, 2001, Agol, 2002). 
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1.3.4.3 Virion assembly and release 
Once the capsid protein precursor is synthesized and released from the polyprotein by 
primary cleavage, the precursor will be cleaved into VP0, VP3 and VP1, which remain in a 
noncovalent complex, the protomer. Five protomers then assemble to form a pentamer. 
Pentamers can self-assemble into the icosahedral empty capsid. The final steps in the virion 
assembly are the packaging of the viral RNA into the empty particle followed by the 
maturation cleavage of VP0 into VP4 and VP2. The picornavirus encapsidation process is 
highly specific, resulting in packaging of only positive-stranded RNA. The capsid protein 
signals responsible for the recognition of the viral genome are not yet defined. Evidence 
exists that each component of a pentamer can be linked with the viral RNA in the replication 
complex, which means that encapsidation may already start at the pentamer level (reviewed 
by: Racaniello, 2001, Agol, 2002). 
 
The picornavirus RNA encodes functions ensuring the release of the mature virions. Many 
picornaviruses have the capacity to lyse the cell. The characteristic morphologic changes 
known as the cytopathic effects are: condensation of chromatin, nuclear blebbing, 
proliferation of membranous vesicles, changes in membrane permeability, leakage of 
intracellular components, and shrivelling of the entire cell. However, little is known about 
viral mechanisms involved in the cell lysis. Proteins involved in the shutoff of host protein 
synthesis are likely to be involved, as well as viral proteins responsible for the rearrangement 
of the cellular infrastructure and permeability changes. The exit of mature virions from the 
cell may also be accomplished by other mechanisms, such as vesicular transport and a kind of 
exocytosis. Picornavirus-infected cells may also die of apoptosis, which serves as a host 
defence to the virus-induced stress. The biological role of apoptosis perhaps consists of 
limiting virus spread by preventing the completion of the reproduction cycle and isolation of 
at least a portion of the mature virions within the apoptotic bodies. Picornaviruses possess 
anti-apoptotic functions to counteract this host cell defense. Several nonstructural proteins, 
such as 2B/2BC and 3A, appear to interfere with distinct apoptotic pathways. It has been 
demonstrated that poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced 
apoptosis by eliminating the TNF receptor from the cell surface. The depletion of this 
receptor appeared to result from the lack of its replenishment caused by the disruptions of the 
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Golgi-mediated trafficking. Poliovirus 2B/2BC and 2C exhibit suppressive anti-apoptotic 
activity, most likely due to the involvement of these proteins in the rearrangement of the 
intracellular membranes (Neznanov et al., 2001, reviewed by: Racaniello, 2001, Agol, 2002). 
The TMEV L* protein exhibits an anti-apoptotic effect in macrophages, and thereby 
suppressing apoptosis in response to viral infection (Ghadge et al., 1998). 
 
1.3.5. Picornavirus infection 
Picornavirus infection leads to profound alterations in the morphology and functioning of 
cellular membranes. These alterations occur at two well-defined moments during the 
replication cycle: at early times, when virus particles penetrate the cell, and at late times, 
when most of the viral proteins are being synthesized. At this late stage of infection several 
types of changes are observed: enhanced membrane permeability, proliferation of 
intracellular membranous vesicles, and inhibition of vesicular trafficking with blockage of 
protein glycosylation. Proliferation of cytoplasmic membrane vesicles is usually observed 
during the replication of picornaviruses. Viral genome replication depends on the synthesis of 
these membranous vesicles. Inhibition of membrane proliferation blocks the viral genome 
replication. Not only the synthesis of several viral nonstructural proteins, but also the 
formation of new cytoplasmic membranes, are involved in the appearance of picornavirus 
replication complexes. This also involves drastic changes in vesicular traffic (reviewed by 
Carrasco et al., 2002). 
 
Dales et al. showed the existence of a large number of membrane vesicles in the perinuclear 
region of poliovirus infected cells. These structures appear 3 hours post infection (p.i.) and 
proliferate extensively, occupying most of the cytoplasm by 7h p.i. (Dales et al., 1965). The 
proliferation of these membranous structures is now considered as a common morphological 
change induced by picornaviruses. The virus-induced vesicles vary in size: their diameters 
range from 50 to 400 nm. At the beginning of poliovirus infection small vesicles accumulate in 
the central part of the cytoplasm, while at the end of the replication cycle the vesicles are 
bigger, resembling autolytic vacuoles. The vesicles have a double lipid bilayer (Schlegel et al., 
1996). It has been considered for some time that these vesicles originate by budding from the 
ER (Bienz et al., 1987). Now, however, it has been suggested that the ER is not the sole source 
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of the intracellular membranes. Also the Golgi complex and lysosomes are involved in the 
generation of these membranes and it requires at least in part de novo synthesis of 
phospholipids (Guinea & Carrasco, 1990, Schlegel et al., 1996, reviewed by Carrasco et al., 
2002). After infection with PV, the stimulation of phospholipid synthesis leads to proliferation 
of membrane structures. PV infected cells synthesize smooth membranes that are not present in 
uninfected cells and PV RNA replication is associated with these smooth membranes. This has 
also been shown for other picornaviruses such as EMCV, FMDV, and Mengovirus. Protein 
2BC seems to play an important part in the mechanisms used by picornaviruses to generate 
these membrane vesicles (Polatnick & Wool, 1982, reviewed by Carrasco et al., 2002). 
 
Concomitant with the synthesis of new vesicles, there is also an important rearrangement of 
the intracellular membranous organelles of the secretory pathway, the disappearance of the 
Golgi complex, and a swelling of the ER together with a reorganization of the cytoskeletal 
framework (Lenk & Penman, 1979, Joachims & Etchison, 1992). Poliovirus infection causes 
the disassembly of the Golgi complex. This effect has been attributed to the expression of 
protein 2B (Sandoval & Carrasco, 1997). Proteins 2B, 2BC and 3A seem to cause a block in 
the secretion and transport of glycoproteins. 3A seems to block transport from the ER to the 
Golgi complex, while 2B and 2BC appear to act on a later stage in the exocytic pathway 
(Doedens & Kirkegaard, 1995, Sandoval & Carrasco, 1997, reviewed by Carrasco et al., 
2002). A detailed analysis of this process in yeast revealed that 2BC interferes with vesicular 
system trafficking at the level of the vesicles that arise from the ER and fuse with the Golgi 
complex (Barco & Carrasco, 1998). 
 
Picornaviruses synthesize their genomes in association with newly generated membranous 
vesicles that proliferate from the mid-phase of infection (Caliguiri & Tamm, 1969; 1970a; 
1970b). The viral RNA polymerase activity is associated with the smooth membranes of 
these vesicles and the replication complex was identified on the surface of the membrane 
structures, which are arranged in a rosette-like fashion (figure 1.12; Bienz et al., 1992, 
1994). The vesicles play a structural role in maintaining the replication complexes in the 
correct configuration for RNA synthesis. The association between the replication 
complexes and the membranes could be mediated by proteins 2B, 2C and 3AB (Bienz et 
al., 1987). There is not only a physical connection between membranes and replication. 
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Cerulenin, an inhibitor of phospholipid metabolism, blocks viral RNA synthesis, which 
indicates that continuous formation of phospholipids is needed for viral replication to occur 
(Guinea & Carrasco, 1990). Final evidence for the requirement of a membranous 
environment for viral RNA synthesis comes from the ability of brefeldin A (BFA), a fungal 
metabolite that primarily blocks protein transport and vesicular traffic between ER and 
Golgi apparatus in eukaryotic cells, to potently block PV RNA replication in infected cells. 
Although the exact mechanism is not understood, the alteration of membrane traffic in cells 
treated with BFA is thought to inhibit the formation of the virus-induced vesicles, thereby 
inhibiting viral RNA replication (Irurzun et al., 1992; Maynell et al., 1992; Cho et al., 
1994; reviewed by Carrasco et al., 2002). 
 
 
 
Figure 1.12: Electron micrograph of the Poliovirus replication complex. The PV 
replication complex surrounded by virus-induced vesicles, which are often arranged in a 
rosette-like fashion (Bienz et al., 1992). 
 
1.3.6 Membrane trafficking 
Eukaryotic cells have evolved an elaborate internal membrane system consisting of the 
endoplasmic reticulum (ER), the Golgi complex, endosomes, lysosomes and vacuoles. The 
secretory pathway allows soluble and membrane proteins to be transported from the ER 
through the Golgi complex and out to various locations including lysosomes, endosomes, 
secretory vesicles, and the plasma membrane. The endocytic pathway is used to take up 
substances from the cell surface into the interior of the cell by way of endosomes and 
lysosomes. All protein trafficking in the secretory and the endocytic pathways is governed by a 
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sole principle: transport of membrane and soluble proteins form one membrane-bounded 
compartment to another is mediated by transport vesicles. These vesicles collect proteins in 
buds arising from the membrane of a donor compartment and move through the cytoplasm to 
reach and fuse with the membrane of a target compartment (figure 1.13; reviewed by: Karp, 
2005, Lodish et al., 2007). 
 
The ER is divided into two subcompartments, the rough ER (rER) and the smooth ER (sER). 
They both comprise a system of membranes that enclose a lumen separated from the 
surrounding cytosol. The rER has ribosomes bound to its cytosolic surface, whereas the sER 
lacks associated ribosomes. The membranous elements of the sER are typically tubular and 
form an interconnecting system curving through the cytoplasm. The rER is composed of a 
network of cisternae and is continuous with the outer membrane of the nuclear envelope. The 
cisternae of the rER are interconnected, which facilitates the movement of materials from their 
site of synthesis to sites were they can exit the organelles. The first stage of the secretory 
pathway takes place in the rER. Newly synthesized soluble and membrane proteins are 
translocated into the ER, where they are folded into their proper conformation and receive 
covalent modifications. Secretory proteins are then packaged into anterograde transport vesicles 
and progress to the second stage of the secretory pathway, the transport through the Golgi. Soon 
after these vesicles bud from the ER membrane, transport vesicles fuse to form larger vesicles 
and interconnected tubules in the region between the ER and the Golgi apparatus. This region is 
known as the ER-to-Golgi intermediate compartment (ERGIC) and the vesicular-tubular 
clusters are called VTCs. The VTCs move further away from the ER toward the Golgi complex 
(reviewed by: Klumperman, 2000, Karp, 2005, Lodish et al., 2007). 
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Figure 1.13: An overview of the secretory and endocytic pathways. Proteins follow the 
secretory pathway from the ER, through the Golgi complex, out to a variety of intracellular 
sites such as lysosomes, endosomes, secretory vesicles, vacuoles, and the plasma membrane. 
Proteins follow the endocytic pathway from the cell surface to endosomes and lysosomes, 
where they are generally degraded by lysosomal enzymes (reviewed by Karp, 2005). 
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The Golgi complex has a characteristic morphology consisting primarily of membranous 
cisternae, which are arranged in an orderly stack. It is divided into several functionally distinct 
compartments arranged along an axis from the cis or entry face closest to the ER to the trans or 
exit face at the opposite end of the stack. The cis face is composed of an interconnected 
network of tubules referred to as the cis Golgi network (CGN), which is thought to function 
primarily as a sorting station that distinguishes between proteins that have to return to the ER 
and those that can proceed to the next Golgi station. The major part of the Golgi complex 
consists of a series of cisternae. The trans face contains a distinct network of tubules and 
vesicles called the trans Golgi network (TGN), which is also a sorting station were proteins are 
segregated into different types of vesicles heading either to the plasma membrane or to various 
intracellular destinations. Two contrasting views exist concerning the way materials move 
through the various compartments of the Golgi complex. The vesicular transport model 
proposes that the cisternae of a Golgi stack remain in place as stable compartments and material 
is transferred through the Golgi stack in small transport vesicles. Electron microscopy recently 
revealed many vesicles associated with the Golgi complex, transporting proteins from one 
Golgi compartment to another. However, these vesicles are most likely involved in retrograde 
transport, retrieving ER or Golgi proteins from a later compartment and transporting them to an 
earlier compartment in the secretory pathway. This retrograde pathway may, in addition to the 
recycling of membrane and proteins back to the ER, play a role in the anterograde cargo 
concentration (reviewed by Pelham, 2001; Martínez-Menárguez et al., 2001, Mironov et al., 
2001). The alternate model, known as the cisternal maturation model, proposes that Golgi 
cisternae are transient structures which are formed at the cis face of the stack by fusion of 
anterograde transport vesicles from the ER and the ERGIC. Each cisterna moves from the cis to 
the trans end of the stack, changing in composition as it progresses. This process does not 
involve budding off and fusion of anterograde transport vesicles. Each cisterna matures into the 
next cisterna along the stack (reviewed by: Klumperman, 2000, Pelham, 2001, Karp, 2005, 
Lodish et al., 2007). 
 
Three types of coated transport vesicles have been identified each with a different type of 
protein coat. They are named for their primary coat proteins and they transport cargo proteins 
from specific parent compartments to specific target compartments. COPII-coated vesicles 
transport proteins from the rER to the ERGIC and the Golgi complex. COPI-coated vesicles 
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mainly transport proteins in retrograde direction between Golgi cisternae and from the cis-Golgi 
and the ERGIC back to the rER. Clathrin-coated vesicles transport proteins form the plasma 
membrane and the TGN to late endosomes and lysosomes. All types of coated vesicles are 
formed by reversible polymerization of a distinct set of protein subunits onto a donor 
membrane to form vesicle buds that eventually pinch off from the membrane to release a 
complete vesicle. Shortly after vesicle release, the coat is shed and proteins required for fusion 
with the target membrane are exposed (reviewed by: Karp, 2005; Lodish et al., 2007). 
 
Although coat proteins differ considerably from one type of vesicle to another, the coats of all 
three types of vesicles contain a small GTP-binding protein that acts as a regulatory subunit to 
control coat assembly. Both COPI and clathrin vesicles contain the GTP-binding protein known 
as ARF protein. The related GTP-binding protein Sar1 is present in the coat of COPII vesicles. 
ARF and Sar1 are monomeric proteins. They both belong to the GTPase superfamily of 
proteins that switch between an inactive GDP-bound and an active GTP-bound form. The cycle 
of GTP binding and hydrolysis by ARF and Sar1 are thought to control the formation and 
dissociation of vesicle coats. The vesicle coat functions also in selecting specific proteins as 
cargo by means of direct binding to sorting signals contained within the cytosolic portion of 
membrane cargo proteins (reviewed by Lodish et al., 2007). 
 
As mentioned previously, shortly after the formation of a vesicle is completed, the coat is shed, 
exposing vesicle-specific membrane proteins crucial for the docking of the vesicle on its target 
membrane and the fusion of the vesicle membrane with the correct target membrane. A second 
set of GTP-binding proteins, the Rab proteins, engage in the targeting of vesicles to the 
appropriate target membrane. A different type of Rab protein appears to function for each type 
of vesicle and at every step of the secretory pathway. Each vesicle contains specific membrane 
proteins, known as v-SNARE proteins, which interact with t-SNAREs in the target membrane. 
The interaction of cognate SNAREs brings the two membranes into close apposition, allowing 
the two bilayers to fuse. After the fusion of vesicle and target membrane, the SNARE 
complexes must dissociate to make the individual SNARE proteins available for additional 
fusion events. The highly stable SNARE complexes are disassembled in an ATP-dependent 
reaction mediated by additional cytosolic proteins (reviewed by Lodish et al., 2007). 
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The endocytic pathway describes the movement of materials from the plasma membrane into 
the cell interior. All eukaryotic cells continuously engage endocytosis, a process in which a 
small region of the plasma membrane invaginates to form a membrane-limited vesicle. One 
type of endocytosis is called pinocytosis, which describes the non-specific uptake of small 
droplets of extracellular fluids and any material dissolved in it. Receptor-mediated endocytosis 
brings about the uptake of specific extracellular molecular ligands following their binding to 
receptors on the external surface of the plasma membrane. The plasma membrane region that 
contains the receptor-ligand complex then buds inward and pinches off, becoming a transport 
vesicle (clathrin coated). Following internalization, vesicle-bound materials are transported to 
endosomes which represent distribution centers along the endocytic pathway. Endosomes are 
divided into two classes: early endosomes, which are located near the peripheral region of 
the cell, and late endosomes, which are located closer to the nucleus. Most receptor-ligand 
complexes dissociate in the late endosome. The receptors are recycled to the plasma membrane, 
while the ligands are delivered to the lysosomes (reviewed by: Karp, 2005; Lodish et al., 2007). 
 
The major function of lysosomes is to degrade extracellular materials taken up by the cell 
and certain intracellular components. Materials to be degraded must be delivered to the 
lumen of the lysosome, where the various degradative enzymes reside. The cell has two 
specialized pathways for delivery of membrane proteins and cytosolic materials to the 
lysosomal lumen. The first pathway is used to degrade endocytosed membrane proteins. 
These endocytosed membrane proteins are incorporated into specialized vesicles that bud 
into the lumen of the endosome, producing a multivesicular endosome. The surface 
membrane of a multivesicular endosome will eventually fuse with the membrane of a 
lysosome, delivering its internal vesicles and the membrane proteins they contain into the 
lysosomal lumen for degradation. The second pathway, known as autophagy, is employed 
by cells when they are placed under stress. Cells will recycle macromolecules for use as 
nutrients by a process of lysosomal degradation. Autophagy involves the formation of 
double-membraned structures that envelop regions of the cytosol or entire organelles, 
creating autophagosomes. The outer membrane of an autophagosome can fuse with the 
membrane of a lysosome, delivering a large vesicle to the interior of the lysosome. Lipases 
and proteases within the lysosome will degrade the autophagic vesicle and its contents into 
their molecular components (reviewed by Lodish et al., 2007). 
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1.3.7. Protein 2C and its effect on membrane trafficking 
Poliovirus 2C is a 329aa (~37 kDa) polypeptide and it is the most conserved polypeptide 
among picornaviruses with respect to amino acid sequence and antigenicity (Argos et al., 
1984, Emini et al., 1985, reviewed by Carrasco et al., 2002). 2C-like proteins have been 
identified in a number of other animal and plant viruses (Gorbalenya & Koonin, 1989). A 
tentative model of domain organization has been proposed for this protein based on sequence 
alignments. According to this model, 2C would have three differentiated regions: the central 
region includes an NTP-binding domain, while the N- and C-terminal parts have a α-helix 
configuration and might contain amphipathic helices (figure 1.14; Teterina et al., 1997). Near 
the C-terminus, a cysteine-rich region is located, which displays a zinc finger motif that is 
conserved in enteroviruses and rhinoviruses and is essential for viral replication (Pfister et al., 
2000). The precursor 2BC remains largely uncleaved in picornavirus-infected cells and exerts 
some of the activities described for the mature proteins 2B and 2C (figure 1.11; reviewed by 
Carrasco et al., 2002). 
 
 
 
Figure 1.14: Linear map of poliovirus 2BC motifs. Protein 2B contains 2 hydrophobic 
regions; one amphipathic α-helix and a potential transmembrane domain with a β-sheet 
configuration. Protein 2C contains functional domains for RNA and NTP binding. 
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1.3.7.1 Membrane proliferation, rearrangement and binding 
Several lines of evidence suggest that 2C is involved in membrane proliferation. Bienz and 
colleagues (1987) were able to follow the location of the proteins of the P2 genomic region in 
respect to the virus-induced vesicle formation and the viral RNA synthesis during the viral 
replication cycle. P2 proteins become rER associated soon after their synthesis. At the site of 
this interaction electron-dense patches appeared which represent the PV replication complex. 
Simultaneously, vesicles are formed which finally bud off, carrying the patches on their outer 
surface. Protein 2C is most likely involved in the attachment of the replication complex to the 
vesicular membranes (Bienz et al., 1987). They were able to confirm these results by 
isolation of transcriptionally active replication complexes bound to smooth membrane 
vesicles from PV-infected cells. They demonstrated that the PV replication complex contains 
the P2 proteins in a membrane-associated form. Their findings allowed them to conclude that 
2C or its precursor is responsible for the attachment of the viral RNA to the vesicular 
membrane and for the spatial organization of the replication complex necessary for its proper 
functioning in viral transcription (Bienz et al., 1990). 
 
Cho and colleagues (1994) described a system to examine the effects of expression of 
poliovirus 2C and 2BC in human cells in the absence of other PV proteins. Using a 
recombinant vaccinia virus system, they expressed 2C and 2BC, as well as the proteins with 
single point mutations in the NTP-binding motifs which were shown to inactivate viral RNA 
replication (Teterina et al., 1992, Cho et al., 1994). Both 2C and 2BC were able to induce the 
reorganization of intracellular membranes and the formation of vesicles, which resembled 
those found in PV-infected cells. They were both associated with these vesicles. Golgi stacks 
were absent in cells expressing 2C or 2BC as in PV-infected cells. Mutations in the NTP-
binding motifs did not affect vesicle induction by 2C or 2BC (Cho et al., 1994; Aldabe & 
Carrasco, 1995). Expression of 2BC in yeast cells also induces a number of morphological 
modifications, one of the most striking being the proliferation of small membranous vesicles 
(Barco & Carrasco, 1995). 
 
To map the determinants of membrane binding and rearrangement in the 2C protein a 
computer-assisted analysis of the protein sequence was performed. This led to the prediction 
that the protein folds into a structure composed of three domains. Expression plasmids that 
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encode each or combinations of these predicted domains were constructed and the abilities of 
the expressed partial protein sequences to associate with intracellular membranes and to induce 
reorganization of these membranes were examined. Sequences from both the N-terminal and 
the C-terminal portions of the protein, but not the middle region, interact with intracellular 
membranes. The N-terminal portion of 2C is composed of a number of α-helices. One of these 
helices is a conserved amphipatic helix (Paul et al., 1994) and is essential for association of the 
protein with membranes in an in vitro membrane binding assay (Echeverri & Dasgupta, 1995). 
Mutations in the N-terminal sequence, predicted to disrupt the amphipatic helix, were lethal, 
suggesting that membrane interaction of this region is important for 2C function (Paul et al., 
1994). The C-terminal portion of 2C is predicted to include two helices, with one of them also 
being a conserved amphipatic helix (Teterina et al., 1997). 
 
1.3.7.2 Nucleoside triphosphatase (NTPase) activity 
An NTP-motif was identified in nonstructural proteins of several groups of positive-strand 
RNA-viruses, including picornaviruses. All the NTP-motif-containing proteins comprise 
several highly conserved sequence stretches. The two most prominent are the A 
(GXXXXGKS/T) and B (DD/E) motifs. In positive-strand RNA viruses, these proteins are 
homologous and the A and B sites are highly conserved. Therefore they should play the 
principal role in the functioning of the proteins (Gorbalenya et al., 1989). Protein 2C is thought 
to be a member of the AAATPase super-family of proteins. Members of the AAA+ super-
family are characterized by the presence of a Conserved ATPase Domain (CAD), containing 
well-conserved Walker A and B motifs for ATP binding (Walker et al., 1982; Swaffield & 
Purugganan, 1997). A third conserved C-terminal motif C has been described. Motif C consists 
of an invariant asparagine (Asn) residue preceded by a stretch of moderately hydrophobic 
residues. This C motif is common to a large family of NTP-binding pattern containing proteins 
(helicase superfamily III) encoded by the genomes of small DNA and RNA viruses. A helicase 
function has therefore been suggested for protein 2C but was not yet confirmed (Gorbalenya et 
al., 1990, Rodriguez & Carrasco, 1993). All three motifs are required for the functional role of 
the NTP-binding motif of 2C in RNA replication (Mirzayan & Wimmer, 1992, Pfister & 
Wimmer, 1999). Analysis of the amino acid sequence of PV protein 2C shows homology to 
this family of NTP-binding proteins. Point mutations were engineered into the most conserved 
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residues in the A and B sites. Viral RNA synthesis is greatly reduced in cells transfected with 
these mutants. This strongly suggests a functional role for the proposed NTP-binding motif of 
2C in RNA replication (Mirzayan & Wimmer, 1992). 
 
The first direct evidence for this functional significance of the NTP-binding pattern in PV 
2C was given by Teterina and colleagues (1992). They used genetic manipulation of PV 
cDNA clones, which produce infectious virus upon transfection cells. When conserved aa 
within the A or B motif of the NTP-binding pattern were replaced, even by similar residues, 
virus replication could not be detected. In contrast, similar mutations in non-conserved aa 
within the A motif did not prevent virus replication. These findings suggest that the 
conservation of the A and B motif within protein 2C may be functionally significant 
(Teterina et al., 1992). A Baculovirus expression system has also been used to investigate 
potential enzymatic activities associated with protein 2C. A mutant carrying a lesion in the 
NTP-binding motif A has been expressed. This mutant is lethal, which suggest an NTPase 
activity for protein 2C (Mirzayan & Wimmer, 1994). Pfister and Wimmer (1999) 
demonstrated that the ATPase activity of protein 2C requires all three motifs A, B, and C. 
Mutations of conserved residues in motif A and B abolished ATPase activity, as did a 
mutation of the conserved Asn residue in motif C, an observation indicating the 
involvement of this motif in ATP hydrolysis (Pfister & Wimmer, 1999). 
 
1.3.7.3 Guanidine sensitivity 
The growth of many picornaviruses is selectively inhibited by guanidine hydrochloride. 
Although guanidine inhibits several virus-induced processes, the primary effect appears to be 
blockage of viral RNA synthesis. Several lines of evidence suggest that protein 2C may be 
the target for the antiviral action of guanidine. Guanidine-resistant FMDV mutants and 
poliovirus mutants have been described containing modifications in protein 2C. Pincus and 
Wimmer (1986) described the cloning of cDNA segments containing either the mutation for 
guanidine resistance or the mutations responsible for guanidine dependence into the PV wild-
type background of an infectious clone. The viruses isolated from the transfected cells were 
found to express the resistance or dependence phenotypes, demonstrating that mutations in 
protein 2C are directly responsible for the altered guanidine sensitivity (Pincus & Wimmer, 
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1986, Baltera & Tershak, 1989). A variety of guanidine-resistant and guanidine-dependent 
PV strains were selected, and mutations responsible for the phenotypic alterations were 
mapped to the viral NTP-binding pattern (Tolskaya et al., 1994, Pfister & Wimmer, 1999). 
 
1.3.7.4 RNA binding activity 
There is some evidence that protein 2C is an RNA binding protein. Gel retardation experiments 
indicate that protein 2C interacts with a partial double-stranded RNA molecule. Deletion 
mutants, which lack different portions of the 2C carboxyl terminus, were constructed and none 
of these mutants were able to interact with RNA. This indicates that the RNA binding domain 
lies at the C-terminal end of 2C (Rodriguez & Carrasco, 1993). These preliminary results were 
confirmed by Rodriguez and Carrasco (1995) by generating 20 variants of 2C and analyzing 
their RNA binding activities. They were able to indicate two regions in 2C involved in RNA 
binding: a N-terminal region and a C-terminal region containing an Arg-rich region, a well 
established RNA-binding motif that is found in several RNA-binding proteins. Deletion of 
either the N- or C-terminal RNA binding region of protein 2C abolished RNA binding 
(Rodriguez & Carrasco, 1995). Synthesis of positive-strand RNA is likely to start at the 3’ end 
of the template RNA. Binding of bacterially expressed PV 2C to the 3’ end of the negative-
strand RNA was examined. It was demonstrated that 2C specifically binds to the 3’ cloverleaf 
structure of the negative-strand RNA. The binding of 2C to the 3’ cloverleaf of the negative-
strand RNA is, however, greatly affected when the conserved sequence UGUUUU in “stem a” 
of the cloverleaf is altered. The 2C binding was greatly facilitated when this sequence was 
present in the context of a double stranded structure (Banerjee et al., 1997). These results were 
confirmed by Banerjee and Dasgupta (2001) for different picornaviruses, such as HAV and 
HRV (Banerjee & Dasgupta, 2001). It has also been demonstrated that the 2C precursor, 2BC, 
also interacts with the 3’-terminal cloverleaf of the negative-strand RNA. Furthermore, it has 
been shown that the interaction of 2C/2BC with the negative strand 3’-terminal sequence does 
not only depend on an intact “stem a”, but is equally influenced by the presence of an intact 
“stem b” within the negative-strand cloverleaf structure (Banerjee et al., 2001) 
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1.4. Aims 
* Poliovirus protein 2C has been investigated extensively, including its association with 
host cell membranes. Therefore, we wish to localize TMEV protein 2C in transfected 
and TMEV-infected cells. 
 
* Protein 2C has been related to the changes in membrane trafficking in poliovirus 
infected cells. We therefore wish to identify interactions of TMEV protein 2C with 
host cell proteins. 
 
* We wish to visualize the effect of TMEV infection on intracellular membranes and 
membrane trafficking by using cellular markers and live-cell imaging. 
 
* We wish to express and purify TMEV protein 2C in order to produce an anti-TMEV-
2C antibody to localize protein 2C in TMEV-infected cells. 
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2. Materials and methods 
2.1. Cloning 
2.1.1 Preparative restriction enzyme digests 
Typically 2 µg of DNA was digested with 2 units of enzyme, in a final volume of 20 µl 
containing 2 µl of 10x restriction buffer. The reactions were incubated as per manufacturer’s 
instructions. 
 
2.1.2 Analytical restriction enzyme digests 
In general 0.2 µg of DNA was digested with 1 unit of enzyme, in a total volume of 10 µl, 
including 1 µl of 10x restriction buffer. The reactions were incubated as per manufacturer’s 
instructions. 
 
2.1.3 Polymerase chain reaction 
Specific DNA fragments were amplified by Polymerase Chain Reaction (PCR) using BIO-
X-ACTTM DNA polymerase (Bioline Ltd, London, UK). BIO-X-ACTTM is a mixture of 
polymerases that possesses a 5’-3’ DNA polymerase activity and 3’-5’ proofreading 
activity which prevents misincorporations during primer extension. BIO-X-ACTTM also 
leaves an “A” overhang such that the primer extension products are suitable for effective 
integration in TA cloning vectors. Primers were designed to maintain a single open reading 
frame (table 2.1). 
 
Primer name Primer sequence 5' to 3' 
TMEV-2BC-V5-FW GGATCCATGCCTGTGCAGTCGGTTTTTCAG 
TMEV-2C-V5-FW GGATCCATGGGGCCTCTACGCGAGGCCAATGAG 
TMEV-2C-V5-RV TCTAGAGACTGGGCAACCAAGCTGTTCATTTTC 
TMEV-2Cmut1-FW GCTGGGCAAGGCCTATCTGTGACC 
TMEV-2Cmut1-RV GGTCACAGAGTTGCCTTGCCCAGC 
TMEV-2Cmut2-FW GTGATTATGAATAATCTACTAGGACAAAATCCC 
TMEV-2Cmut2-RV GGGATTTTGTCCTAGATTATTCATAATCAC 
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Lenti-TMEV-2BC-FW GAAATGACTAGTATGCCTGTGCAGTCGGTTTTTCAG 
Lenti-TMEV-2C-FW GTCATGACTAGTATGGGGCCTCTACGCCAGGCCAATGAG 
Lenti-TMEV-2C-RV GTCTGGGGATCCCTGGGCAACCAAGCTGTTCAT 
Lenti-FMDV-2B-FW GACCTCACTAGTATGCCAAATGGAGCGCCCGAAAAGGCG 
Lenti-FMDV-2C-FW GAACTTACTAGTATGGGTGGAAACCATCAACCAGATGC 
Lenti-FMDV-2C-RV CCTGTGGGATCCACCATTTGGGCAAAGTATTTG 
TMEV-2C-Pk-FW GGAAAGCCGATCCCAAACCCTCTATTAGGTCTGGACTCCACCA
  TGCAACCTCAGGGGCCTCTACGC 
TMEV-2C-Pk-RV GGTGGAGTCCAGACCTAATAGAGGGTTTGGGATCGGCTTTCCA
  GGTTGCATGACATTGGGGCAAGC 
TMEV-3D-RV GTGGGGACAACTATTCCAACATTGG 
TMEV-2B-FW-NheI GAAATGAACGCTAGCCCTGTGCAGTCGGTT 
TMEV-2C-RV-ApaI GTCTGGTGGGGGCCCGGCAACCAAGCTGTTCATTTTCTT 
TMEV-3A-FW-KpnI AAGAAAGGTACCAGCTTGGTTGCCCAGTCC 
TMEV-3D-RV-PmeI GAATCATAGGTTTAAACAACTATTCCAACATTCCA 
2C-Pk-FW-InFusion CTGTCTACAACCTTCAACAGG 
2C-Pk-RV-InFusion ATAACGGGACAGAACTGCAG 
2BC-FW-N-TAP CATGATGGATCCGATATCATGGGGCCTGTGCAGTCG 
2C-FW-N-TAP CCCAATGGATCCGATATCATGGGGCCTCTACGCGAG 
2BC-RV-N-TAP ATTCTCTCTAGATCACGGGCCCAGCGCTGACTGGGC 
C-TAP-FW GCATCTGGTACCATGGAAAAGAGAAGATGG 
C-TAP-RV GCATCTCTTAAGGGATCCCCGGGAATTCCCCGG 
2BC-FW-C-TAP GATGTAGCGGCCGCTATGGGGCCTGTGCAGTCGGTT 
2C-FW-C-TAP AATGTCGCGGCCGCTATGGGGCCTCTACGCGAGGCC 
2BC-RV-C-TAP CAGTCTGATATCGACTGGCAACCAAGCTGTTCATT 
TMEV-2BC-His-FW GGATCCCCTGTGCAGTCGGTTTTTCAG 
TMEV-2C-His-FW GGATCCGGGCCTCTACGCGAGGCCAAT 
TMEV-2C-His-RV AAGCTTTGACTGGGCAACCAAGCTGTT 
TMEV-2BC-bact-FW GAAATGGGGATCCGACCTGTGCAGTCGGTTTTTCAG 
TMEV-2C-bact-FW GTCATGGGGATCCGAGGGCCTCTACGCGAGGCCAAT 
TMEV-2C-bact-RV CCAGTCGTCGACTCACTGGGCAACCAAGCTGTTCAT 
T7 TAATACGACTCACTATAGGG 
Tub-RV GATATCTCTAGAGTATTCCTCTCCTTCTTCCTCACC 
Lenti-Cherry-Tub-FW GGATCCATGGTGAGCAAGGGCGAGGAGG 
Lenti-Cherry-Tub-RV ACTAGTTCATTAGTATTCCTCTCCTTCTTCC 
 
Table 2.1: List of primers used for PCR. Primers are designed to maintain a single open 
reading frame. Primer names and sequences are shown. Sequences are presented from 5’ 
to 3’ end. 
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The PCR was undertaken in a 50 µl reaction mix containing 20ng of template DNA, 5 µl of 
10x OptibufferTM (Bioline Ltd, London, UK), 1 µl PCR nucleotide mix (10 mM of each 
dNTP, Promega, Southampton, UK), 4 units of BIO-X-ACTTM DNA polymerase (Bioline 
Ltd, London, UK), 40 pmol of both forward and reverse primer, 2 µl of 50 mM MgCl2, and 
nuclease-free water up to a final volume of 50 µl. The PCR consists of a series of 35 cycles 
of amplification. Prior to the first cycle, an initial PCR activation step is carried out at 94°C 
for 3 min. Following this hold, the three-step cycles begin with a denaturation step at 94°C 
for 1 min. Denaturation is followed by an annealing step. In this step the reaction 
temperature is lowered so that the primers can attach to the single-stranded template DNA. 
The annealing temperature depends on the melting temperature (Tm) of the primers, and is 
usually between 50°C-64°C for 30 sec. The annealing step is followed by an 
extension/elongation step at 68°C for 1 min, and a final extension step at 68°C for 10 min. 
PCRs were performed in a GeneAmp® PCR system 9700 thermal cycler (Applied 
Biosystems, Foster City, CA, USA). 
 
2.1.4 Agarose gel electrophoresis 
Flat bed agarose gels of 1% [w/v] agarose (Biogene, Kimbolton, UK) were prepared with 
TAE buffer (40 mM tris-acetate, 1 mM EDTA), which contained ethidium bromide at a 
final concentration of 0.5 µg/ml. DNA samples were loaded onto the gel in agarose loading 
buffer (50% [v/v] glycerol, 0.005% [w/v] bromophenol blue). Electrophoresis was carried 
out at 100 to 120 V in TAE buffer and the DNA bands were subsequently visualized by 
illumination from an UV transilluminator. 
 
2.1.5 Purification of DNA fragments from agarose gels 
PCR-products or preparative restriction digests were loaded into preparation wells of flat 
bed agarose gels (described in section 2.1.4). The band of interest was excised and purified 
using the QIAquick Gel Extraction Kit (Qiagen, West Sussex, UK), as directed by the 
manufacturer’s instructions. 
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2.1.6 TOPO® cloning 
To facilitate the preparative restriction enzyme digests necessary for further cloning steps, 
PCR-products were inserted into pcDNA3.1/V5-His-TOPO® (figure 2.1; Invitrogen, Paisley, 
UK). The TOPO vector is linearized with single 3’ thymidine (T) overhangs for TA cloning. 
The BIO-X-ACTTM DNA polymerase (Bioline Ltd, London, UK) used for the PCRs has a 
nontemplate-dependent terminal transferase activity that adds a single deoxyadenosine (A) to 
the 3’ ends of PCR products. This allows PCR inserts to ligate efficiently with the TOPO 
vector. The TOPO cloning reaction was undertaken in a final volume of 6 µl containing 3 µl 
PCR-product, 1 µl salt solution, 1 µl sterile water, and 1 µl TOPO® vector. After 30 to 60 min 
incubation at room temperature (RT, 22-23°C), a transformation was carried out using E. coli 
compentent cells (JM109; described in section 2.1.9). 
 
 
 
Figure 2.1: pcDNA3.1/V5-His-TOPO vector map: the map summarizes the features of 
the pcDNA3.1/V5-His-TOPO© vector (Invitrogen, Paisley, UK). 
 
2.1.7 Dephosphorylation of linearized plasmid DNA 
Calf intestinal alkaline phosphatase (CIAP, Promega, Southampton, UK), catalyzes the 
hydrolysis of 5’-phosphate groups of DNA. It is used to prevent recircularization and 
religation of linearized plasmid DNA by removing phosphate groups from both 5’-termini. 
CIAP is active on 5’ overhangs, 5’ recessed and blunt ends. Briefly, a reaction containing 
40 µl purified DNA (up to 10 pmol of 5’-ends), 5 µl CIAP 10x reaction buffer and up to 5 
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µl diluted CIAP (0.01 u/µl), was incubated at 37°C for 30 min. The reaction was stopped by 
adding 0.8 µl of EDTA (0.5 M) and the DNA was subsequently purified using the Wizard® 
SV gel and PCR clean up kit (Promega, Southampton, UK). 
 
2.1.8 Ligation of DNA 
Ligation reactions were set up in 10x T4 DNA ligase buffer (660 mM Tris-HCl, 50 mM 
MgCl2, 50 mM DTT, 10 mM ATP, pH 7.5) at a final volume of 10 µl. In general the 
reaction consisted of 1 µl of T4 DNA ligase (Roche Diagnostics Ltd., Burgess Hill, UK), 
0.5 µg of plasmid DNA and an equal to 2-fold concentration of insert. The reactions were 
incubated overnight at 4°C. 
 
2.1.9 In-Fusion PCR cloning 
The In-FusionTM 2.0 Dry-Down PCR Cloning kit (Clontech Laboratories, Inc., Mountain 
View, USA) was used as an alternative strategy for cloning. The In-Fusion mechanism is 
ligation-independent and uses the unique properties of the 3’-5’ exonuclease activity of the 
poxvirus DNA polymerase. PCR primers are designed that have at least 15 bases of 
homology with sequences flanking the desired site of insertion in the cloning vector. The 
DNA insert is amplified by PCR, as described in section 2.1.3, and subsequently cloned 
into the cloning vector, as per manufacturer’s instructions (figure 2.2). The 3’-5’ proofreading 
activity of the poxvirus DNA polymerase removes nucleotides from the 3’ end when incubated 
with linear duplex DNAs with homologous ends. Complementary regions on the substrate 
DNAs are therefore exposed that can spontaneously anneal through base pairing. Introduction 
into E. coli repairs the single stranded gaps (Zhu et al., 2007). 
 
In brief, 2 µl of Cloning Enhancer is added to 5 µl of PCR reaction. The mixture is incubated at 
37°C for 15 min, and subsequently incubated at 80°C for 15 min. The treated PCR fragment is 
then mixed with the cloning vector at a 2:1 molar ratio in 10 µl of deionized H2O, and this 
mixture is subsequently added to the dried-down In-Fusion enzyme. The In-Fusion reaction 
mixture is incubated at 37°C for 15 min, followed by 15 min incubation at 50°C. The In-Fusion 
reaction mixture is subsequently diluted with 40µl TE buffer (10mM Tris pH 7.4, 1 mM EDTA 
pH 8) and used to transform competent E. coli cells (as described below). 
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Figure 2.2: The In-Fusion cloning method. The In-Fusion enzyme produces single-
stranded PCR-fragment and vector ends that are fused due to the 15 bp homology. 
 
2.1.10 Transformation of E. coli competent cells 
Competent E. coli cells (JM109) were purchased from Promega (Southampton, UK) and 
transformed using the heat-shock method. In a chilled 1.5 ml microcentrifuge tube, 2 µl of a 
ligation reaction were added to 50 µl of competent cells. The tubes were flicked gently to mix 
the contents and placed on ice for 10 minutes. Heat-shock was performed in a water bath at 
42°C for 45 seconds. The tubes were immediately returned to ice for 2 minutes. Prior to 
incubating the transformation reaction for 1 hour at 37°C, 800 µl of Luria Broth (LB; 1% 
[w/v] bacto-tryptone, 0.5% [w/v] bacto-yeast extract, 1% [w/v] NaCl pH 7.0) was added. The 
cells were subsequently plate on agar supplemented with 100 µg/ml ampicillin (Amp). 
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2.1.11 Mini-preparation of plasmid DNA 
A single colony was used to inoculate 5 ml of LB medium containing 100 µg/ml Amp and 
grown overnight at 37°C with moderate shaking. Plasmid DNA was prepared using the 
QIAprep Miniprep kit (Qiagen, West Sussex, UK), as directed by the manufacturer’s protocol. 
 
2.1.12 Maxi-preparation of plasmid DNA 
In general, a single colony was used to inoculate an eight hour 5 ml starter culture (5 ml of 
LB containing 100 µg/ml Amp). An overnight 100 ml culture (100 ml of LB containing 
100 µg/ml Amp) was then inoculated with 200 µl starter culture. The plasmid DNA was 
purified using the Qiafilter Plasmid Maxi kit (Qiagen, West Sussex, UK), following the 
manufacturer’s protocol, and resuspended in water. 
 
2.1.13 DNA sequencing 
Double stranded plasmid DNA (300 ng) or PCR product (40 ng), supplemented with 3.2 pmol 
of sequencing primer was submitted to The Sequencing Service, University of Dundee. 
 
2.2. Analysis of translation profiles 
2.2.1 Coupled transcription/translation (TNT) reaction 
Proteins were expressed in vitro using the TNT® Wheat Germ Extract System (Promega, 
Southampton, UK), following the manufacturer’s protocol. In summary, proteins were 
radiolabelled with [35S]-methionine. TNT reactions were incubated at 30°C for 60 to 120 
min. The reactions were stopped by adding an equal volume of 2x SDS-PAGE sample 
loading buffer (2% [w/v] SDS, 20% [v/v] glycerol, 2% [v/v] β-mercaptoethanol, 0.2% 
bromophenol blue, 100 mM Tris, pH 6.8), and analyzed on sodium dodecyl sulfate (SDS) 
denaturing polyacrylamide gel electrophoresis (PAGE) gels (10% polyacrylamide, 
described in section 2.2.3). 
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2.2.2 Immunoprecipitation with TNT samples 
Prior to addition to the TNT samples, the antibody was bound to the affinity media. Protein 
G Sepharose 4 Fast Flow (GE Healthcare, Chalfont St Giles, UK) was used as affinity 
media. Prior to the binding of the antibody, the beads were prepared in phosphate-buffered 
saline (PBS). Three wash steps were carried out with PBS to remove the ethanol in which 
they were supplied. Between washes the beads were recovered by centrifugation at 
10 000 xg for 1 min. A 50% slurry was prepared by adding an equal volume of PBS and the 
beads were stored at 4°C. To 100 µl of 50% bead solution, 20 µl of antibody was added. 
The antibody was bound to the beads by rotating for 2 hours at 4°C. After rotation, the 
bead/antibody complex was washed 4 to 5 times with PBS containing 0.1% [v/v] Nonidet-
P40 (N-P40). The complex was recovered between washes by centrifugation at 10 000 xg 
for 1 min. After the final wash step, the pellet was resuspended in an equal volume of PBS 
containing 10 mg/ml bovine serum albumin (BSA, Sigma-Aldrich Company Ltd., Dorset, 
UK) and rotated for 30 min at 4°C. The complex was recovered by centrifugation at 
10 000 xg for 1 min, and again resuspended in an equal volume of PBS containing BSA. 
 
For the immunoprecipitation reaction, 1 ml of binding buffer (50 mM Magnesium acetate, 
20 mM Tris-HCl pH 7.4, 1mM DTT, 0.05% N-P40, 10 mg/ml BSA) and 10 µl of TNT 
sample were added to 50 µl of the 50% solution of antibody/bead complex and rotated for a 
minimum of 1 hour at 4°C. The precipitated antigen complexes were washed 5 times with 
wash buffer (50 mM Magnesium acetate, 20 mM Tris-HCl pH 7.4, 1 mM DTT, 0.05% N-
P40). The complex was recovered between washes by centrifugation at 10 000 xg for 
1 min. After the final wash step, the pellet was resuspended in 10 µl of 2x SDS-PAGE 
sample loading buffer and the complexes were dissociated at 100°C for 2 min. The beads 
were pelleted by centrifugation (10 000 xg) for 1 min and the supernatant was analyzed on 
SDS-PAGE gel (10% polyacrylamide, described in section 2.2.3). 
 
2.2.3 Denaturing SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
The gels were constructed with a 4% polyacrylamide stacking gel and a 10% polyacrylamide 
resolving gel. The gel was run using a Hoefer® apparatus (Amersham Biosciences, 
Buckinghamshire, UK). Electrophoresis was carried out in 1x Tris-Glycine buffer (0.1% 
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[w/v] SDS, 25 mM Tris, 250 mM Glycine) at a constant current of 40 mA, until the 
Bromphenol blue dye reached the bottom of the gel. Proteins were stained with Coomassie 
brilliant blue staining solution (0.2% [w/v] Coomassie brilliant blue (R-250), 20% [v/v] 
methanol, 20% [v/v] acetic acid). Gels were subsequently destained (20% [v/v] methanol, 
10% [v/v] acetic acid) and dried as appropriate. 
 
2.2.4 Visualization of radiolabelled translation products 
The distribution of radiolabel between the translation products was visualized by 
autoradiography on Kodak Biomax MR film (Sigma, Southampton, UK) for preparation of 
figures. 
 
2.3. Cell culture 
2.3.1 Growing cells from liquid nitrogen stock 
Aliquots removed from liquid nitrogen storage were defrosted quickly in a water bath. The 
samples were centrifuged (300 xg) for 3 min and the supernatant was discarded. The cells were 
resuspended in 1 ml Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich Company 
Ltd., Dorset, UK) containing 10% foetal calf serum (FCS, Invitrogen, Paisley, UK), and added 
to a 75 cm² tissue culture flask (Greiner Bio-One Ltd., Stonehouse, UK) containing DMEM 
supplemented with 10% FCS. The cells were incubated overnight at 37°C in a 5% CO2 
humidified incubator. The following day the medium was removed, the cells were washed 
twice with PBS, fresh medium was added and the flasks were returned to the incubator. 
 
2.3.2 Splitting cells 
To split cells, the medium was poured off and residual medium was removed by washing 
quickly with PBS. Trypsin/EDTA (Becton Dickinson, Plymouth, UK), a buffered salt 
solution containing 0.5% (w/v) trypsin and 0.2% (w/v) EDTA, was added to dissociate the 
adherent cells. After a short period of time, 10 ml of medium (DMEM containing 10% 
FCS) was added to the flask to inactivate the trypsin and the cells were subsequently 
dispersed by agitation. The cell suspension was transferred to a 15 ml tube and a 3 min 
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centrifugation at 750 xg was carried out, followed by the removal of the supernatant. The 
cell pellet was resuspended in 10 ml of medium (DMEM containing 10% FCS). To a fresh 
flask (75 cm²) containing 10 ml of DMEM supplemented with FCS at 10%, 2 ml of cell 
solution was added. Cells were maintained in 75 cm² flasks at 37°C in a 5% CO2 
humidified incubator. 
 
2.3.3 Freezing cells 
Once cells in a 75 cm² flask were 100% confluent (± 8-10x106 cells), a cell splitting 
procedure was carried out as described above until the stage where a pellet is formed. The 
supernatant was removed and the pellet was resuspended in 1 ml of medium (DMEM 
containing 10% FCS). Subsequently, 9 ml of medium consisting of 40% DMEM, 40% 
FCS, and 20% dimethyl sulfoxide (DMSO) was gradually added. The cell suspension was 
divided into 1 ml aliquots, resulting in ± 500 000 to 1 million cells/ ml. Cells were frozen 
down slowly overnight in an insulated cell rack at -70°C. After 1 to 2 days cells can be 
transferred to liquid nitrogen for extended storage. 
 
2.4. TMEV virus stock 
2.4.1 Preparation of TMEV virus stock 
Monolayers of BHK-21 cells (baby hamster kidney cells) were grown in a 75 cm² tissue 
culture flask (DMEM supplemented with 10% FCS) until 80% confluence. The medium 
was removed and the cells were washed twice with serum-free DMEM. Virus stock (0.5 ml; 
5x108 PFU/ml stock) was added to 2 ml of serum-free DMEM before adding the mixture to 
the flask containing the cells. The cells were incubated in the presence of the virus for 20 
min, at 37°C, with rocking. The medium was removed, replaced with 10 ml DMEM 
supplemented with 1% FCS and 0.2 ml of 1M HEPES, and the cells were incubated 
overnight, at 37°C, with rocking. The cells in medium were transferred by pipette into a 50 
ml centrifuge tube. Centrifugation (3500 xg) for 5 min pelleted cellular material and the 
supernatant, containing released virus, was recovered. The cell pellet was resuspended in 
5 ml DMEM and any intact cells were lysed by vortexing and freeze/thawing at -80°C. 
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Aliquots were transferred to microcentrifuge tubes, the cell debris pelleted (14 000 xg, 
5 min) and the supernatant recovered. The two supernatants were combined and stored in 
aliquots at -70°C. Typical virus titres achieved by this method were 5x108 PFU/ml. 
 
2.4.2 Titration of TMEV virus preparation 
Monolayers of BHK-21 cells were grown in 6-well plates (Greiner Bio-One Ltd., 
Stonehouse, UK) until 80 to 90% confluence. The virus preparation was diluted in a series 
of 10-fold dilutions in DMEM supplemented with 1% FCS. Duplicate wells of cells were 
set up for each dilution, and cells were inoculated with each virus stock dilution (1ml/well). 
The cells were incubated with the virus inoculum for 1h (37°C, 5% CO2) on a rocking 
platform to allow adsorption of the virus. The virus inoculum was aspirated and 2ml of 
overlay, consisting of 4% agar (SeaPlaque® agarose, Lonza Ltd., Nottingham, UK) mixed 
with DMEM (1% FCS) were added to each well. The agar was allowed to set, and an 
overlay of 2ml DMEM containing 1% FCS was added. The cells were incubated for 2 days 
(at 37°C, 5% CO2) without any mechanical action. When plaques were distinctly formed, 
the medium was aspirated and the monolayers were fixed overnight in 5% formaldehyde. 
After aspirating the fixative solution, the agar overlay was removed and the fixed cells were 
washed with PBS. Areas of cell lysis and therefore sites of virus infection or plaques were 
visualized by Coomassie blue staining (1h). After gently washing the monolayers with 
water, plaques were observed as unstained areas of the monolayer. Plaques were counted 
and the titer was estimated (plaque-forming-units per ml of virus preparation, pfu/ml), 
taking into account the dilutions made. 
 
2.4.3 TMEV production from cDNA clone 
2.4.3.1 Plasmid linearization 
The plasmid carrying the viral cDNA was linearized using a restriction enzyme cleaving at a 
unique restriction site after the 3’ end of the viral genome. The linearized DNA was purified 
using the Wizard® PCR preps DNA purification system (Promega, Southampton, UK), 
following the manufactures guidelines. The DNA was resuspended in RNase free H2O. 
 
 58
2.4.3.2 In vitro transcription 
The linearized plasmid DNA was transcribed in vitro using a T7 RNA polymerase (Roche 
Diagnostics Ltd., Burgess Hill, UK). In summary, the in vitro transcription reaction was 
undertaken in a 25 µl reaction mix containing 400 to 500 ng of linearized plasmid DNA, 10x 
transcription buffer (supplied with T7 RNA polymerase), ribonucleotides triphosphate (2.5 
mM of A, C, G and U; Ribonucleoside triphosphate set, Roche Diagnostics Ltd., Burgess 
Hill, UK), Protector RNase inhibitor (optional, Roche Diagnostics Ltd., Burgess Hill, UK) 
and T7 RNA polymerase (Roche Diagnostics Ltd., Burgess Hill, UK). The reaction is 
incubated for 1 hour at 37°C. The in vitro transcribed RNA can be stored at -80°C until 
needed for cell electroporation. A 5 µl sample was run on a 1% agarose gel to evaluate the 
quality of the in vitro transcribed RNA. 
 
2.4.3.3 Electroporation of BHK-21 cells 
For one in vitro transcribed viral RNA reaction, two 75 cm² flasks of confluent BHK-21 
cells were trypsinized and resuspended in complete medium (DMEM containing 10% 
FCS). Cells were centrifuged for 5 min at 200 xg. The cell pellet was washed twice with 
ice-cold sterile PBS and subsequently resuspended in ice-cold sterile PBS (750 µl per 
electroporation). Electroporation cuvettes and sterile eppendorf tubes containing 10 to 20 µl 
of in vitro transcribed RNA (2-20 µg) were prepared on ice. Subsequently, 750 µl of cell 
suspension was transferred to the RNA containing eppendorf tube. The cell and RNA 
mixture was rapidly transferred to the electroporation cuvette. Electroporation was carried 
out using the Gene pulser XcellTM system (Bio-Rad Laboratories Ltd., Hertfordshire, UK, 
described in section 2.5.3.2). The cells were resuspended in 10 ml DMEM, supplemented 
with 10% FCS, and transferred to a 75 cm² flask. After 6 to 7 hours, the medium was 
replaced by 10 ml serum-free medium. 
 
2.4.3.4 Virus harvest 
In general, the cells attach and grow normally for 24 hours after electroporation, at which 
point they nearly reach 100% confluency. The cytopathic effect (CPE) progressively takes 
place from 24 to 48 hours and becomes complete between 48 and 72 hours after 
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electroporation. When CPE was complete, the cells were collected with supernatant in a 15 
ml Falcon tube, and were frozen at -80°C for at least 8 hours. The tubes were thawed at RT 
or in a 37°C water bath, mixed vigorously, and centrifuged at 1200 xg for 15 min at 4°C. 
The supernatant was transferred to a new tube and subsequently aliquoted in cryotubes for 
storage at -80°C. In general, yields are between 5x107 and 5x108 PFU/ml. 
 
2.4.3.5 RNA extraction and detection of viral RNA 
RNA was extracted from the viral preparations by using the QIAamp® Viral RNA mini kit 
(Qiagen, West Sussex, UK) as per manufacturer’s instructions. The extracted RNA was 
subsequently used as template for one-step PCR assays (QIAGEN® OneStep RNA-PCR kit, 
Qiagen, West Sussex, UK). The one-step RT-PCRs were undertaken in a 50 µl reaction 
volume containing 10 µl RNA-extract, 10 µl 5x QIAGEN OneStep RT-PCR Buffer, 2 µl 
dNTP mix (final concentration of 400 µM of each dNTP), 2 µl QIAGEN OneStep RT-PCR 
Enzyme Mix (a combination of Omniscript and Sensiscript reverse transcriptase and 
HotStarTaq DNA polymerase), 1.5 µM of each primer, and RNase-free water to 50 µl. The 
reaction was carried out with an initial reverse transcription step at 50°C for 30 min, followed 
by PCR activation at 95°C for 15 min, 35 cycles of amplification (30 sec at 94°C; 30 sec at 
56°C; 1 min at 72°C), and a final extension step at 72°C for 10 min. 
 
2.5. Mammalian protein expression 
The process of introducing nucleic acids into eukaryotic cells by nonviral methods is 
defined as “transfection”. Using various chemical, lipid or physical methods, this gene 
transfer technology is a powerful tool for studying gene function in the context of a cell. 
Essentially, transfection is a method that facilitates the introduction of negatively charged 
molecules (phosphate backbone of DNA) into cells with negatively charged membranes. 
The use of viruses as vectors is an alternative method for delivery of genes into cells. 
lentiviruses (e.g. HIV-1) are of particular interest because they have been well studied and 
can integrate into the host cell genome to allow stable, long-term expression of the 
transgene (described in section 2.9; Anson, 2004). 
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2.5.1 Chemical reagents 
A cationic polymer is used to tightly associate with the negatively charged nucleic acids. 
An excess of positive charge, contributed by the polymer in the DNA/polymer complex, 
will allow the complex to come into closer association with the negatively charged cell 
membrane. Uptake of the complex is presumably established by endocytosis. 
 
2.5.1.1. ExGen 500 in vitro transfection reagent 
The ExGen 500 in vitro transfection reagent (Fermentas, York, UK) is a sterile solution of 
linear polyethylenimine (PEI, cationic polymer) molecules in water. It is a non-viral, non-
liposomal reagent that is capable of transfecting a wide variety of cell types. ExGen 500 has 
low toxicity and works efficiently in the presence or absence of serum. The efficient gene 
transfer is related to its capacity for condensing DNA, interacting with the cell membrane, 
protecting DNA and inducing endosomal swelling and rupture before DNA degradation can 
occur. ExGen 500 and DNA charge-interact and form small, stable, highly diffusible 
particles that settle on the cell surface. The ExGen 500/DNA complex is then absorbed into 
the cell by endocytosis, followed by the release of the complex into the cytoplasm via 
rupture of the vesicles and the translocation of the DNA to the nucleus. 
 
Prior to transfection, cells were plated to achieve a cell density of 50-70% at the time of 
transfection. The plasmid DNA was diluted in 150 mM NaCl (see manufacturer’s protocol for 
guidelines), vortexed gently and spun down briefly. ExGen 500 was added and the solution was 
vortexed immediately for 10 sec after which the ExGen 500/DNA mixture was incubated for 10 
min at RT. The ExGen 500/DNA mixture was subsequently added to the cells. The plate was 
gently rocked to achieve even distribution of the complexes, and centrifuged for 5 min at 
300 xg. The plates were then transferred to the incubator for 24 to 48 hours. 
 
2.5.1.2. GeneJuice® transfection reagent 
The GeneJuice® transfection reagent (Novagen, Nottingham, UK) is a proprietary formulation 
optimized for maximal transfection efficiency, ease of use, and minimal cytotoxicity. It is 
composed of a nontoxic cellular protein and a small amount of a novel polyamine. The 
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unique chemistry provides the advantage of compatibility with both serum-containing and 
serum-free media, and makes media changes unnecessary. 
 
Prior to transfection cells were seeded to achieve a cell density of 50-80% at the time of 
transfection. Initially a GeneJuice®:DNA ratio of 3:1 was used. Different ratios can be used 
for optimalization (see manufacturer’s protocol for guidelines). GeneJuice® transfection 
reagent was diluted with serum-free medium. GeneJuice® was added drop-wise to the serum-
free medium and mixed thoroughly by vortexing. The GeneJuice®/serum-free medium 
mixture was incubated at RT for 5 min. DNA was added to the GeneJuice®/serum-free 
medium mixture and mixed gently by pipetting. The GeneJuice®/DNA mixture was incubated 
at room temperature for 5-15 min. The entire GeneJuice®/DNA mixture was added in a drop-
wise manner to the cells in complete growth medium. The dish was gently rocked to ensure 
even distribution. The cells were incubated for 24 to 72 hours at 37°C (5% CO2). 
 
2.5.2 Cationic lipids 
Liposome-mediated transfection offers advantages such as relatively high efficiency of 
gene transfer, and ability to transfect certain resistant cell types. Synthetic cationic lipids 
are used to deliver DNA into cells. The cationic head group of the lipid compound 
associates with the negatively charged nucleic acids, resulting in an overall positively 
charged liposome/nucleic acid complex. Closer association of the complex with the 
negatively charged cell membrane will occur, producing a higher transfer efficiency. Entry 
of the liposome complex into the cell may occur by endocytosis or fusion with the plasma 
membrane (Gao & Huang, 1995). Following cellular internalization, the complexes appear 
in the endosomes, will be released from the endosomes by a so far unclear mechanism, and 
will later appear in the nucleus. 
 
2.5.2.1. FuGENE 6 transfection reagent 
The FuGENE 6 transfection reagent (Roche Diagnostics Ltd., Burgess Hill, UK) is a 
proprietary blend of lipids and other components that forms a complex with DNA, and then 
transports it into animal cells. Transfections can be carried out in serum-containing media. 
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One day before the transfection experiment, cells were plated so that overnight incubation 
achieved the desired density of 50 to 80% confluency. Initially a FuGENE 6:DNA ratio of 
3:1 was used. Different ratios can be used for optimalization (see manufacturer’s protocol 
for guidelines). FuGENE 6 reagent was diluted with serum-free medium. The order and 
manner of addition is critical. Serum-free medium must be pipetted first, followed by the 
addition of FuGENE 6 directly into the medium without allowing contact with the walls of 
the plastic tubes. The tube was flicked to mix and subsequently incubated for 5 minutes at 
room temperature. DNA was added to the diluted FuGENE 6, the tube was tapped to mix 
the contents and the transfection reagent/DNA complex was incubated for 15 to 45 min. 
The complex was then added to the cells in a drop-wise manner. The wells or flasks were 
swirled to ensure distribution over the entire plate surface, and finally returned to the 
incubator for 24 to 48 hours to allow gene-expression. 
 
2.5.2.2. Trans IT®-LT1 transfection reagent 
The Trans IT®-LT1 transfection reagent (Mirus, Cambridge BioScience, Cambridge, UK), 
a broad spectrum protein/polyamine based reagent that contains histone and a unique lipid, 
provides high efficiency and cell viability. Transfections do not require media changes and 
can be carried out in serum-containing media. 
 
Approximately 24 hours prior to transfection, cells were plated so that overnight incubation 
resulted in 50 to 70% confluency. In a sterile plastic tube, the Trans IT®-LT1 reagent (2-8 
µl per 1 µg DNA, see manufacturer’s protocol for guidelines) was added directly into 250 
µl of serum-free medium, and mixed by gentle pipetting. The mixture was incubated at 
room temperature for 5 to 20 min. The plasmid DNA was added to the diluted Trans IT®-
LT1 reagent, mixed by gentle pipetting, and incubated at room temperature for 15 to 30 
min. The Trans IT®-LT1 reagent/DNA complex was added to the cells in a drop-wise 
manner. The plate was gently rocked to distribute the complexes evenly and returned to the 
incubator for 24 to 48 hours. 
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2.5.3 Transfection by electroporation 
The mechanism for entry into the cell by electroporation is based upon perturbing the cell 
membrane by an electrical pulse, which forms pores that allow the passage of nucleic acids 
into the cell. The technique requires fine-tuning and optimization for duration and strength 
of the pulse for different cell types. Electroporation also requires more cells than chemical 
methods because of substantial cell death, and extensive optimization is often required to 
balance transfection efficiency against cell viability. 
 
2.5.3.1. Cell line nucleofector® kit L 
The Nucleofector technology (Amaxa GmbH, Koeln, Germany) is a highly efficient non-viral 
method for transfection. It is based on two components: the Nucleofector device that delivers 
unique electrical parameters, and Nucleofector Kits that contain cell-type-specific Nucleofector 
Solutions. The electrical parameters for particular cell types are pre-programmed into the 
Nucleofector so that optimization of the electrical parameters is not necessary. 
 
The cell line nucleofector® kit L (Amaxa GmbH, Koeln, Germany) provides a protocol 
optimized for BHK-21 cells. Monolayers of BHK-21 cells were cultured one day prior to 
nucleofection with a subcultivation ratio of 1:2. Cells were used at 90% confluency. The 
cells, 1x106 cells/100 µl of Nucleofector solution, were combined with the plasmid DNA 
(2µg) and then transferred to an Amaxa certified cuvette, following the manufacturer’s 
optimized protocol. The cell-specific program was chosen and the cuvette was inserted into 
the Nucleofector and the program was started. The cuvette was rinsed with culture medium 
and the cells were transferred into a culture dish (75 cm² flask), which was incubated for 24 
hours in a humidified 37°C/5% CO2 incubator. 
 
2.5.3.2. Gene pulser XcellTM system 
The Gene pulser XcellTM system (Bio-Rad Laboratories Ltd., Hertfordshire, UK) is a flexible, 
modular pulse delivery system that uses exponential or square-wave pulses to deliver the 
pulses optimal for different cell types. It presents specific pre-tested parameters for the most 
frequently used cell lines, including BHK-21 cells. Electroporation was carried out following 
the manufacturer’s protocol. Briefly, one day before electroporation, cells were cultured to 
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achieve 50 to 70% confluency at the time of the experiment. Cells were harvested and 
resuspended in electroporation buffer (Opti-MEM® I Reduced Serum Medium (1X), liquid-
with GlutaMAX™ I; Invitrogen, Paisley, UK). The required plasmid DNA (10-50 µg/ml) 
was added to Bio-Rad’s high-quality electroporation cuvettes, and the cells were added 
subsequently. The cuvette was placed in the ShockPod and the cells were pulsed using the 
pre-set protocol for BHK-21 cells. Immediately after the pulse, the cells were transferred to a 
75 cm² flask. The 75 cm² flasks were rocked to assure even distribution of the cells over the 
surface of the plate and then incubated for 24 to 48 hours at 37°C in a humidified atmosphere. 
 
2.6. Analyses of proteins expressed in mammalian cells 
2.6.1 Lysis of cells and purification of proteins 
Cells were harvested 24 to 48 hours after transfection. The medium was removed; the cells 
were washed with chilled PBS and harvested in 5ml PBS. The cells were transferred to a 15 
ml centrifugation tube and centrifuged at 400 xg for 5 to 10 min. The supernatant was 
removed and the pellet was resuspended in 750 µl chilled lysis buffer (20 mM Tris pH 7.8, 
650 mM NaCl, 5 mM EDTA, 0.5% N-P40, protease inhibitor cocktail tablet [Complete, 
Mini, EDTA-free; Roche Diagnostics Ltd., Burgess Hill, UK]). After sonication, the cell 
debris was pelleted by centrifugation at 10 000 xg for 40 min, and the supernatant was 
thereafter transferred to a fresh 1.5 ml tube. 
 
2.6.2 Western blotting 
Immediately after SDS-PAGE electrophoresis (as described in section 2.2.3), polypeptides 
were transferred to PVDF membranes (ImmobilonTM-P Transfer membranes, Millipore 
Corporation, UK). The membrane was methanol-activated during 10 to 15 min, rinsed with 
dH2O and washed in transfer buffer (2.9 g glycine, 5.8 g Tris base, 0.37 g SDS, 200 ml 
methanol in 1 liter dH2O). A blotting sandwich was prepared as follows: 1 fiber pad, 1 
Whatmann 3MM paper, membrane, protein gel (all air bubbles must be removed), 1 
Whatmann 3MM paper, 1 fiber pad. Both fiber pad and Whatmann 3MM paper were 
pretreated by soaking in transfer buffer. The blotting sandwich was placed in the blotting 
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apparatus and a constant current was applied (30 mA overnight or 400 mA for 1 hour). 
Following electroblotting, the membrane was incubated in blocking buffer (5% [w/v] 
skimmed milk powder, 0.1% [v/v] Tween 20 in PBS) for 1 hour. The proteins of interest were 
detected by incubating the membrane with an appropriately diluted primary antibody (in 
blocking buffer, 1:1000) for at least 1 hour. The membrane was washed three times with 
blocking buffer for 10 to 15 min. In order to detect bound primary antibodies, the membrane 
was incubated with the appropriate secondary HRP-conjugated antibody (in blocking buffer, 
1:3000). After 45 min the membrane was rinsed (briefly) with wash buffer (0.1% [v/v] 
Tween 20 in PBS), incubated for 15 min in wash buffer, and subsequently washed twice for 
10 min with wash buffer. The bound HRP-conjugated secondary antibodies were detected by 
enhanced chemiluminescence (ECL plus Western Blotting Detection System, Amersham 
Biosciences, Buckinghamshire, UK), following the manufacturer’s instructions, and 
visualized on Kodak Biomax MR film (Sigma, Southampton, UK). 
 
2.6.3 Fixing cells 
Cells grown in DMEM medium supplemented with 10% FCS on coverslips (10mm in 
diameter; General Scientific Co. Ltd., Redhill, UK) were washed with PBS, and 
subsequently fixed with 4% paraformaldehyde (PFA) for 30 min. The fixed cells were then 
washed twice with PBS before they were mounted using mowiol mounting solution (2.4 g 
Mowiol 4-88 [Calbiochem, San Diego, USA], 6 g glycerol, 6 ml H2O, 0.2 M Tris pH 8.5, 
12 ml 1,4-diazabicyclo[2.2.2]octane [DABCO, Sigma-Aldrich Company Ltd., Dorset, UK]) 
supplemented with diamino phenylindole (DAPI; 0.5µg/ml; Sigma-Aldrich Company Ltd., 
Dorset, UK) for nuclear staining. 
 
2.6.4 Immunofluorescence 
Cells were grown in DMEM medium supplemented with FCS at 10%. For imaging, cells 
were seeded onto glass coverslips in a 6 well plate and incubated overnight before being 
transfected, essentially as described above. After 36 to 48 hours, cells were fixed with 
4% PFA for 30 min. The fixed cells were washed with PBS before incubation with 
permeabilization buffer (500 ml PBS, 10% sucrose, 0.5% N-P40) for 20 min. The cells 
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were subsequently blocked with blocking buffer (permeabilization buffer containing 30% 
goat serum; Sigma-Aldrich Company Ltd., Dorset, UK) for 10 to 15 min. The proteins of 
interest were then detected by incubating the cells with an appropriately diluted primary 
antibody (in blocking buffer, 1:500) for at least 45 min. The cells were washed three times 
with wash buffer (0.1% [v/v] Tween 20 in PBS) for 5 min. In order to detect bound primary 
antibodies, the cells were incubated with the fluorochrome-conjugated secondary antibody 
(in blocking buffer, 1:500). Coverslips are kept in the dark to reduce photo-bleaching of the 
fluorescent probe. After 30 min the cells were washed three times (briefly) with wash 
buffer. The coverslips were subsequently mounted in mowiol mounting solution containing 
DAPI for nuclear staining. 
 
2.6.5 Imaging 
Images were acquired using a DeltaVision® microscope system (Applied Precision, 
Marlborough, UK), consisting of an inverted microscope (Olympus 1x70, Olympus, Tokyo, 
Japan) with a 1.40 NA 100x or 60x oil immersion objective and Photometric CH300 CCD 
camera. Images were processed with the softWoRx® Imaging software package (Applied 
Precision, Marlborough, UK). 
 
For live imaging cells were grown on WILLCO thin “glass bottomed” microwell dishes 
(dish 35 mm diameter, glass 12 mm diameter; Intracel Ltd., Royston, UK). 
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2.7 Bacterial protein expression and purification 
To purify a single protein for further study, affinity purification tags can be fused to any 
recombinant protein of interest, allowing fast and easy purification using the affinity 
properties of the tag. Fusion tags are polypeptides, small proteins or enzymes added to the 
N- or C-terminus of a recombinant protein. The biochemical features of different tags 
influence the stability, solubility and expression of the proteins to which they are attached 
(Nilsson et al., 1997). 
 
2.7.1 Polyhistidine tagging of proteins 
The most commonly used tag for purification and detection of recombinant proteins is the 
polyhistidine tag (His-tag). Protein purification using the His-tag relies on the affinity of 
histidine residues for immobilized metal such as nickel, which allows selective purification 
of proteins (Yip et al., 1989). The His-tag offers several advantages for protein purification. 
The tag usually does not need to be removed for downstream applications following 
purification as its small size renders it less immunogenic than other larger tags. It may be 
placed on either N- or C-terminus of the protein of interest. The interaction of the His-tag 
does not depend on the tertiary structure of the tag, making it possible to purify otherwise 
insoluble proteins using denaturing conditions. 
 
The protein of interest was inserted into the peHisTev vector (figure 2.3). A transformation 
was carried out (as described in section 2.1.9) using BL21(DE3)pLysS competent cells 
(Promega, Southampton, UK). A single colony of E. coli transformed with the peHis-Tev 
recombinant was used to inoculate 2 ml of LB medium containing the 30 µg/ml of 
kanamycin (Kan) and grown overnight at 37°C with moderate shaking. This starter culture 
was diluted 1:10 and grown at 37°C with moderate shaking to an A600 of 0.6. Protein 
expression was initially induced by adding isopronyl β-D thiogalactoside (IPTG) to a final 
concentration of 0.5 mM after which incubation was continued for a further 2 to 6 hours. 
Bacterial cells were pelleted by centrifugation at 4000 xg for 10 min. The bacterial cells 
were lysed by resuspending the pellet in 500 µl of sample buffer (PBS containing 0.3 M 
NaCl, 10 mM imidazol, protease inhibitor protease inhibitor cocktail tablet [Complete, 
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Mini, EDTA-free; Roche Diagnostics Ltd., Burgess Hill, UK]), followed by sonication. The 
lysate was centrifuged for 10 min at 12 000 xg at 4°C. The supernatant was transferred to a 
fresh tube and 100 µl of a 50% slurry of ProBondTM Nickel-Chelating Resin (PBS 
equilibrated; Invitrogen, Paisley, UK) was added. Samples were gently mixed and rotated 
for 1 hour at 4°C. After rotation, the bead/fusion protein complex was washed 3 times with 
0.5 ml of washing buffer (PBS containing 0.3 M NaCl, 30 mM imidazol and 1 mM PMSF). 
The complex was recovered between washes by centrifugation at 12 000 xg for 1 min. After 
the final wash step, 50 µl of elution buffer (PBS containing 0.3 M NaCl, 500 mM imidazol, 
1 mM PMSF) was added to the bead/fusion protein complex and incubated for 2 min. After 
centrifugation at 12 000 xg for 1 min, the pellet was resuspended in 2x SDS-PAGE sample 
loading buffer, the complexes were dissociated at 100°C for 2 min and analyzed on SDS-
PAGE gel (10% polyacrylamide, described in section 2.2.3). 
 
 
 
Figure 2.3: peHisTev vector map: the map summarizes the features of the peHis-Tev 
vector used for polyhistidine tagging of proteins. 
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2.7.2 Glutathione-S-Transferase tagging of proteins 
The glutathione-S-transferase (GST) tag has a strong affinity for immobilized glutathione-
covered matrices (Smith & Johnson, 1988). Glutathione-S-transferases are a family of 
cytosolic proteins with multiple functions that are present in eukaryotic organisms 
(Armstrong, 1997). GST isoforms are not produced in bacteria, thus endogenous proteins do 
not compete with the GST-fusion proteins for binding to the purification resin. The GST-tag 
(Mr 26 000) enhances the solubility of many eukaryotic proteins expressed in bacteria. 
 
The GST Gene Fusion System (Amersham Biosciences, Buckinghamshire, UK) was used 
to express, purify and detect fusion proteins produced in E. coli. The system is based on 
inducible, high-level expression of proteins as fusions with Schistosoma japonicum GST 
(pGEX plasmid; Smith & Johnson, 1988). Expression in E. coli generates fusion proteins 
with the GST moiety at the amino-terminus and the protein of interest at the carboxyl 
terminus. GST fusion proteins are purified from bacterial lysates by affinity 
chromatography using immobilized glutathione. GST fusion proteins are captured by the 
affinity medium, impurities are removed by washing, and the fusion proteins are eluted 
under mild, non-denaturing conditions using reduced glutathione. Cleavage of the protein 
from GST can be achieved using a site-specific protease whose recognition site is located 
immediately upstream from the multiple cloning site of the pGEX vector. 
 
The protein of interest was inserted into the multiple cloning site of vector pGEX-5X-3 
(figure 2.4). Expression is under the control of the tac promoter, which is induced by IPTG. 
Expression is prevented until IPTG induction by the lacIq gene product, a repressor protein 
that binds to the operator region of the tac promoter. A transformation was carried out (as 
described in section 2.1.9) using BL21(DE3)pLysS competent cells (Promega, 
Southampton, UK). A single colony of E. coli transformed with the pGEX recombinant was 
used to inoculate 2 ml of LB medium containing 100 µg/ml Amp and grown overnight at 
37°C with moderate shaking. This starter culture was diluted 1:10 and grown at 37°C with 
moderate shaking to an A600 of 0.6-0.8. Fusion protein expression was induced by adding 
IPTG to a final concentration of 0.5 mM, after which incubation was continued for a further 
2 to 6 hours. Bacterial cells were pelleted by centrifugation at maximum speed for 4 min. 
The bacterial cells were lysed by resuspending the pellet in 500 µl PBS containing 0.1% N-
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P40, 2 mM Benzamidine, 1 mM PMSF and 1 mM DTT, followed by sonication. The lysate 
was centrifuged for 10 min at maximum speed at 4°C. The supernatant was transferred to 
fresh tubes and 20 µl of a 50% slurry of Glutathione SepharoseTM 4B (PBS equilibrated; 
GE Healthcare, Chalfont St Giles, UK) was added. Samples were gently mixed and rotated 
for 30 min at 4°C. After rotation, the bead/fusion protein complex was washed 4 to 5 times 
with PBS containing 0.1% [v/v] N-P40. The complex was recovered between washes by 
centrifugation at 10 000 xg for 1 min. After the final wash step, the pellet was resuspended 
in 2x SDS-PAGE sample loading buffer, the complexes were dissociated at 100°C for 2 
min and analyzed on SDS-PAGE gel (10% polyacrylamide, described in section 2.2.3). 
 
 
 
Figure 2.4: pGEX-5x-3 vector map: the map summarizes the features of the pGEX-5x-3 
vector used for Glutathione-S-transferase tagging of proteins. 
 
2.7.3 Maltose binding protein tagging of proteins 
The pMALTM Protein Fusion and Purification System (pMALTM-2 vectors; New England 
BioLabs Ltd., Herts, UK) provides a method for expressing and purifying proteins. The protein 
of interest is inserted downstream of the malE gene of E. coli, which encodes maltose binding 
protein (MBP), resulting in the expression of an MBP fusion protein. High-level expression of 
the fusion protein is achieved by using the strong “tac”-promotor and the malE translation 
initiation signals. The pMALTM-2 vectors carry the laclq gene, which codes for the Lac 
repressor. This will keep expression of the fusion protein low in the absence of IPTG induction. 
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The protein of interest was inserted in pMAL-C2E (figure 2.5) and subsequently a 
transformation was carried out (as described in section 2.1.9) using E. coli K12 TB1 
competent cells (New England BioLabs Ltd., Herts, UK). Rich broth (80 ml; 1% [w/v] 
tryptone, 0.5% [w/v] yeast extract, 0.5% [w/v] NaCl pH 7.0, 0.2 % [w/v] glucose) 
containing 100 µg/ml Amp, was inoculated with 0.8 ml of an overnight culture of cells 
containing the fusion plasmid. This culture was grown at 37°C with moderate shaking to an 
A600 of 0.5, after which IPTG was added to the culture to a final concentration of 0.3 mM to 
induce expression of the fusion protein. Incubation was continued at 37°C for 2 hours. The 
cells were harvested by centrifugation at 4000 xg for 10 min. The supernatant was 
discarded and the pellet was resuspended in 5 ml of column buffer (20 mM Tris HCl pH 
7.4, 200 mM NaCl, 1 mM EDTA). The cells, resuspended in column buffer, were stored 
overnight at -20°C and thawed in cold water. The cells were lysed by sonication and the 
lysate was centrifuged for 20 min at 9000 xg at 4°C. The supernatant was transferred to 
fresh tubes and subsequently 50 µl of the supernatant was mixed with 50 µl amylose resin 
(New England BioLabs Ltd., Herts, UK) slurry. The amylose resin slurry was prepared by 
transferring 200 µl amylose resin to a microcentrifuge tube, after which a brief 
centrifugation was carried out. The supernatant was removed by aspiration and discarded. 
The resin was washed twice with 1.5 ml column buffer and finally resuspended in 200 µl 
column buffer resulting in a 50% amylose resin slurry. The resin/ fusion protein complex 
was incubated for 15 min on ice, followed by centrifugation for 1 min. The supernatant was 
removed and the pellet was washed with 1 ml column buffer. After centrifugation for 1 min 
and removal of the supernatant, the resin was resuspended in 2x SDS-PAGE sample 
loading buffer, the complexes were dissociated at 100°C for 2 min and analyzed on SDS-
PAGE gel (10% polyacrylamide, described in section 2.2.3). 
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Figure 2.5: pMAL-c2E vector map: the map summarizes the features of the pMAL-c2E 
vector used for maltose binding protein tagging of proteins. 
 
2.8. In vitro binding assay 
2.8.1 In vitro binding assay of cellular proteins 
The GST-tagged protein of interest was expressed and bound to Glutathione SepharoseTM 4B 
beads, essentially as described above. Furthermore, BHK-21 cells were grown to 100% 
confluency and then harvested. Cells were lysed by adding 1 ml of lysis buffer (650 mM NaCl, 
5 mM EDTA, 0.5% N-P40, protease inhibitor cocktail tablet [Complete, Mini, EDTA-free; 
Roche Diagnostics Ltd., Burgess Hill, UK]). The lysate was vortexed for 10 seconds and 
freeze/thawed. The lysate was then clarified by centrifugation (14 000 xg) at 4°C for 10 
minutes. The supernatant was recovered, added to the GST-fusion protein/bead complex and 
rotated for a minimum of 1 hour at 4°C. After rotation, the bead/fusion protein complex was 
washed 4 to 5 times with PBS. The complex was recovered between washes by centrifugation 
at 12 000 rpm for 1 min. After the final wash step, the pellet was resuspended in 2x SDS-PAGE 
sample loading buffer, the complexes were dissociated at 100°C for 2 min and analyzed on 
SDS-PAGE gel (10% polyacrylamide, described in section 2.2.3). 
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2.8.2 In vitro binding assay of TNT samples 
The GST-tagged protein of interest was expressed and bound to Protein Glutathione 
SepharoseTM 4B beads, essentially as described above. Furthermore, the relevant proteins 
were expressed in vitro using the TNT® Wheat Germ Extract System (Promega, 
Southampton, UK), following the manufacturer’s protocol. A typical binding reaction 
consisted of in vitro translation reaction (50 µl) added to the GST-fusion protein/bead 
complex and rotated for a minimum of 1 hour at 4°C in the presence of 1 ml binding buffer 
(50 mM Magnesium acetate, 20 mM Tris-HCl pH 7.4, 1 mM DTT, 0.05%-0.1% N-P40, 10 
mg/ml BSA). After rotation, the bead/fusion protein complex was washed 4 to 5 times with 
binding buffer without BSA. The complex was recovered between washes by centrifugation 
at 12 000 rpm for 1 min. After the final wash step, the pellet was resuspended in 2x SDS-
PAGE sample loading buffer, the complexes were dissociated at 100°C for 2 min and 
analyzed on SDS-PAGE gel (10% polyacrylamide, described above). 
 
2.9. Generating lentiviruses and establishing stable cell lines 
2.9.1 Generating lentiviruses 
A lentivirus is generated by cotransfecting HEK-293T cells (human embryonic kidney 
cells) with three plasmids: CMV, VSV/G and pdlNotI’MCS’F (figure 2.6; a kind gift from 
Prof. Rick Randall). The first plasmid CMV (pCMVR8.91) encodes most of the HIV-1 
viral proteins, including Gag, Pro-Poly, Rev and Tat which are driven by the CMV 
promoter. The second plasmid VSV/G (pMD-G) uses the CMV promoter to drive the 
expression of the viral envelope glycoprotein of vesicular stomatitis virus. The third 
plasmid pdlNotI carries the protein of interest and the puromycin gene, which are driven by 
the SFFV promoter. Only the pdlNotI plasmid contains the viral packaging signal sequence. 
lentiviral particles generated by cotransfection of these three plasmids will carry the gene of 
interest and the puromycin gene but none of the HIV-1 viral protein genes. The generated 
lentiviral particles can infect the target cell by using the VSV envelope glycoprotein, but no 
new viral particles will be produced after infection. 
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Figure 2.6: pdlNotI’MCS’F vector map: the map summarizes the features of the 
pdlNotI’MCS’F vector used for cotransfecting HEK-293 cells, combined with the CMV and 
VSV/G plasmids, to generate a Lentivirus that carries the gene of interest. 
 
To generate lentivirus, 70% confluent HEK-293T cells (75 cm² flask containing DMEM 
supplemented with 10% FCS) were transfected with 3 µg VSV/G, 3 µg CMV and 4.5 µg 
pdlNotI using the FuGENE 6 transfection reagent (Roche Diagnostics Ltd., Burgess Hill, 
UK), essentially as described above. Virus was harvested 48 hours and 72 hours after 
transfection, filtered through a 0.45 µm filter (Millipore, Billerica, USA), aliquoted (1 
ml/vial) and stored at -70°C. Following this procedure, generally, the titre of virus will be 
10 000 pfu/ml. 
 
2.9.2 Establishing stable cell lines 
To establish a stable cell line expressing the protein of interest using the recombinant lentivirus, 
the cell line of interest was grown in a 25 cm² flask to 50% confluency. The cells were infected 
with lentivirus (1 ml of virus stock [10 000 pfu/ml]) combined with serum-free DMEM (1 ml) 
and polybrene (4 mg/ml stock; 1:500 final dilution) and subsequently centrifuged at 300 xg for 
30 min. After infection, the inoculum was topped up to 5 ml with DMEM supplemented with 
10% FCS, and cells were incubated for 48 hours. After incubation, infected cells were selected 
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with puromycin. The toxicity of the selection agent on the cell line determines the appropriate 
concentration (described in section 2.9.3). Cell death should occur within 24 hours. If massive 
cell death occurs, it is advisable to change the medium immediately; otherwise the selection 
medium should be replaced every 3 to 4 days. After replacing the medium twice or more, 
expression of the protein of interest can be examined. 
 
2.9.3 Puromycin titration 
Cell types of interest were plated (2 x 104 cells) into each well of a 24-well plate containing 
1 ml of DMEM supplemented with 10% FCS. After 24 hours, the culture medium was 
discarded and 1 ml of fresh DMEM (containing 10% FCS) was added. Puromycin was also 
added in concentrations varying from 1-24 µg/ml. The cells were cultured for 3 to 5 days, 
replacing the puromycin containing medium every three days. The dishes were examined 
every day for viable cells. The lowest concentration of puromycin that causes massive cell 
death within 3 to 5 days was identified. 
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3. Results 
3.1. Localization of TMEV protein 2C in cells 
Poliovirus protein 2C and its precursor 2BC have been associated with the membranous 
vesicles comprising the PV replication complex. The P2 proteins are rER associated soon 
after synthesis. At the site of protein-ER interaction, the PV replication complexes appear. 
Replication occurs on the cystosolic surface of membranous vesicles. These vesicles, 
containing the replication complexes, move away from the rER to form a growing 
vesiculated area in the center of infected cells. Protein 2C and its precursor 2BC seem to be 
responsible for the attachment of viral RNA to the vesicular membranes and for the spatial 
organization of the replication complexes (Dales et al., 1965, Bienz et al., 1987, 1990, Egger 
& Bienz, 2005). 
 
To elucidate the localization of TMEV protein 2C and its precursor 2BC in the cell, 
constructs were made containing protein-complex 2BC and protein 2C tagged with the V5 
epitope. Mutations were introduced within the Walker A and B motifs. It was intended to 
express the V5-tagged proteins in mammalian cells and to determine the localization of the 
proteins by means of the anti-V5 antibody. The anti-V5 antibody is a high affinity 
monoclonal antibody raised against a linear 14aa epitope (GKPIPNPLLGLDST) found on 
the paramyxovirus SV5 P/V common N-terminal domain (produced from a mouse 
hybridoma cell-line). Moreover, it was intended to construct a full length infectious copy of 
TMEV containing the V5-epitope at the C-terminal end of protein 2C, in order to determine 
the localization of TMEV protein 2C in the cell in the context of other viral proteins. 
Furthermore, we wished to observe the localization of TMEV-protein 2C in TMEV-
infected cells by use of anti-FMDV-2C and anti-TMEV-2C antibodies. The anti-TMEV-2C 
antibody will also be used for co-localization of TMEV protein 2C with the Golgi complex 
in TMEV-infected cells. 
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3.1.1 Preparation of TMEV-2BC and TMEV-2C constructs tagged with the 
V5 epitope 
3.1.1.1 Construction of V5-tagged TMEV-2BC and TMEV-2C using the TOPO vector 
Sequences encoding protein-complex 2BC and protein 2C of the wt TMEV strain GDVII 
were amplified by PCR using primers TMEV-2BC-V5-FW/TMEV-2C-V5-FW and TMEV-
2C-V5-RV. Primers used for PCR amplification are outlined in table 2.1, section 2.1.3. PCR 
fragments of the correct length (2BC: 1386 bp; 2C: 978 bp) were purified by agarose gel 
electrophoresis. The PCR fragments were cleaved with BamHI and XbaI and the restriction 
fragments were subsequently gel purified. The purified restriction fragments were ligated 
into pcDNA3.1/V5-His-TOPO®, similarly restricted, to form TMEV-2BC-V5 and TMEV-2C-
V5. Furthermore, the constructs were checked by sequencing. 
 
3.1.1.2 Overlap PCR introducing mutations in highly conserved regions of TMEV-2C 
Mutations in the highly conserved Walker A and B motifs have been introduced using site-
directed mutagenesis by overlap extension PCR (figure 3.1). Three rounds of PCR reactions 
have been carried out to produce protein-complex 2BC and protein 2C with the two desired 
mutations. The highly conserved lysine (K) in the A motif (GSPGTGKS) has been changed to 
asparagine (N). Additionally, the conserved pair of aspartic acids in the B motif (DD) has been 
altered to asparagines (NN). The first two PCR assays were performed essentially as described 
in section 2.1.3. The first PCR was performed using the following primers: TMEV-2BC-V5-
FW/TMEV-2C-V5-FW and TMEV-2Cmut1-RV/TMEV-2Cmut2-RV. The second PCR was 
carried out using TMEV-2Cmut1-FW/TMEV-2Cmut2-FW and TMEV-2BC-V5-RV as 
primers. The gel-purified PCR products from round I were used as template for the final PCR 
amplification, with TMEV-2BC-V5-FW/TMEV-2C-V5-FW and TMEV-2BC-V5-RV as 
primers (figure 3.1). The final PCR products were purified by agarose gel electrophoresis. The 
PCR fragments were cleaved with BamHI and XbaI and the restriction fragments were 
subsequently gel purified. The purified restriction fragments were ligated into pcDNA3.1/V5-
His-TOPO®, similarly restricted, to form TMEV-2BC/2Cmut1-V5 and TMEV-2BC/2Cmut2-
V5. The presence of the desired mutations was confirmed by sequencing. 
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Figure 3.1: Overview of an overlap extension PCR utilized for site-directed 
mutagenesis. Three rounds of PCR reactions are carried out to produce protein-complex 
2BC and protein 2C with the two desired mutations. PCR I is carried out using a reverse 
primer containing the desired mutation. PCR II is performed using a forward primer 
containing the same mutation. The final PCR is carried out using PCR-product I and II, 
which overlap in the region (boxed area) containing the desired mutation, as templates. 
 
3.1.1.3 Construction of V5-tagged TMEV-2BC, TMEV-2C, FMDV-2BC, and FMDV-2C 
using a lentiviral vector 
Sequences encoding protein-complex 2BC and protein 2C of the wt TMEV strain GDVII 
were amplified by PCR using Lenti-TMEV-2BC-FW/Lenti-TMEV-2C-FW and Lenti-2C-
RV. Additionally, the FMDV-2BC-V5 plasmid, previously constructed, was used as 
template to generate FMDV-2BC and FMDV-2C PCR fragments. The primers used for 
these PCRs were Lenti-FMDV-2BC-FW/Lenti-FMDV-2C-FW and Lenti-FMDV-2C-RV. 
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PCR fragments were purified by agarose gel electrophoresis. The PCR fragments were 
cleaved with SpeI and BamHI and the restriction fragments were subsequently gel purified. 
The purified restriction fragments were ligated into pdlNotI’MCS’R’Pk, similarly 
restricted, to form Lenti-TMEV-2BC, Lenti-TMEV-2C, Lenti-FMDV-2BC, and Lenti-
FMDV-2C. The pdlNotI’MCS’R’Pk plasmid is a lentiviral vector containing the V5 (Pk) 
epitope (figure 3.2, a kind gift from Prof. Rick Randall). 
 
 
 
Figure 3.2: pdlNotI’MCS’R’Pk vector map: the map summarizes the features of the 
lentiviral vector pdlNotI’MCS’R’Pk vector used for V5 tagging of TMEV-2BC, TMEV-2C, 
FMDV-2BC, and FMDV-2C. The vector contains the SFFV promoter for mammalian 
expression of the V5-tagged proteins. 
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3.1.2 In vitro expression of V5-tagged proteins and detection of expressed 
proteins using the anti-V5 antibody 
The TOPO vector system contains a T7 promotor which can be used for in vitro expression 
of proteins. Proteins can be expressed as a fusion with the V5 epitope, and the fusion 
proteins can be subsequently detected by using an antibody to the V5 epitope. The V5-
tagged TMEV constructs were used for in vitro expression, as well as the V5-tagged 
FMDV constructs that already existed in our laboratory. 
 
3.1.2.1 In vitro expression of TMEV-2BC-V5, TMEV-2C-V5, and TMEV-2C-V5 mutants 
and detection of the expressed proteins using the anti-V5 antibody 
The TMEV-2BC-V5, TMEV-2C-V5, TMEV-2Cmut1-V5, and TMEV-2Cmut2-V5 plasmids 
were expressed in vitro using a wheat germ extract coupled transcription/translation system. 
The radiolabelled translation products were separated by 10% SDS-PAGE. The distribution 
of radiolabel was visualized by autoradiography. The gel profiles of the V5-tagged TMEV 
proteins are shown in figure 3.3. Furthermore, an immunoprecipitation experiment was 
performed. The in vitro translated radiolabelled proteins were incubated with protein G 
Sepharose beads containing the anti-V5 antibody. The proteins associated with the anti-V5 
antibody were eluted from the beads by boiling in SDS gel-loading buffer and analyzed by 
SDS-PAGE (figure 3.3). The anti-V5 antibody binds TMEV-2BC-V5, TMEV-2C-V5 and 
both mutants of TMEV-2C. It is generally accepted that the extra bands seen on the gel are 
a result from internal initiation. Several internal in-frame methionines (Met; M) have been 
identified in the TMEV protein 2B and 2C amino acid sequences that could result in the 
protein size of the extra bands. The extra band observed for TMEV-2BC (figure 3.3, *) may 
result from internal initiation at an in-frame Met identified in protein 2B at position 99. The 
extra band observed for TMEV-2C and mutants (figure 3.3, **) may also result from 
internal initiation from in-frame Met. Three possible in-frame Met have been identified in 
protein 2C at position 50, 60, and 62. 
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Figure 3.3: Gel profiles of in vitro coupled transcription/translation reactions and 
subsequent immunoprecipitation reactions. The lanes are labelled with the constructs 
used for the transcription/translation reactions and the antibody used for the 
immunoprecipitation reactions. The positions of the protein size markers are indicated. 
 
3.1.2.2 In vitro expression of FMDV-2BC-V5, FMDV-2B-V5, and FMDV-2C-V5 and 
detection of the expressed proteins using the anti-V5 antibody 
Previously in our laboratory constructs were made containing V5-tagged FMDV-2BC, 
FMDV-2B, and FMDV-2C. These plasmids were expressed in vitro using a wheat germ 
extract coupled transcription/translation system. The in vitro translated radiolabelled 
proteins were subjected to immunoprecipitation with the anti-V5 antibody. The 
radiolabelled translation products, together with the proteins associated with the anti-V5 
antibody were separated by 10% SDS-PAGE. The distribution of radiolabel was visualized 
by autoradiography. The gel profiles of the in vitro expressed proteins and the result of the 
subsequent immunoprecipitation reactions are shown in figure 3.4. The anti-V5 antibody 
binds FMDV-2BC-V5, FMDV-2B-V5, and FMDV-2C-V5. The extra bands observed on 
the gel profile are the result of initiation at internal Met identified in the FMDV protein 2B 
and 2C amino acid sequences. The extra band observed for FMDV protein 2C has been 
identified to be the result of internal initiation at an in-frame Met in FMDV protein 2C at 
position 43 (figure 3.4, *). 
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Figure 3.4: Gel profiles of in vitro coupled transcription/translation reactions and 
subsequent immunoprecipitation reactions. The lanes are labelled with the constructs 
used for the transcription/translation reactions and the antibody used for the 
immunoprecipitation reactions. The positions of the protein size markers are indicated. 
 
3.1.3 Intracellular localization of V5-tagged TMEV-2BC and TMEV-2C 
It was intended to localize V5-tagged TMEV protein-complex 2BC and protein 2C in the cell. 
BHK-21 cells were transfected with the constructs encoding the V5-tagged proteins, 
described above. Different transfection methods were employed (section 2.5). To localize the 
V5-tagged proteins, immunofluorescence was carried out as described in section 2.6.4. For 
detection of the V5-tagged proteins, the anti-V5 antibody was used and, for visualization, a 
rabbit anti-mouse antibody coupled to TexasRed (Abcam, Cambridge, UK) was used. It was 
not possible to detect an immunofluorescent signal for neither TMEV-2BC nor TMEV-2C. 
Furthermore, both mutants of TMEV-2C (section 3.1.1.2) were used for transfection. It was, 
however, not possible to detect a higher immunofluorescent signal. However, when the 
constructs encoding V5-tagged FMDV-2BC and FMDV-2C were used for transfection, we 
were able to detect an immunofluorescent signal (data not shown). The distribution of V5-
tagged FMDV-2BC and FMDV-2C observed upon transfection resembled the distribution 
previously seen by Moffat and colleagues (2005). It has to be noted, however, that both 
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TMEV and FMDV constructs encoding the V5-tagged 2BC and 2C could be detected after in 
vitro expression using the anti-V5-antibody (section 3.1.2.1; section 3.1.2.2). 
 
3.1.4 Construction of an infectious TMEV clone expressing protein 2C 
tagged with the V5 epitope 
To localize TMEV protein 2C in cells in the presence of all TMEV proteins, it was intended 
to construct a full-length infectious TMEV cDNA expressing protein 2C fused with the V5 
epitope. This construct would subsequently be used for in vitro transcription and the 
resulting RNA would be utilized for transfection of mammalian cells. To investigate the 
localization of protein 2C, HEK-293 cells would be transfected with RNA by 
electroporation using the Gene pulser XcellTM system. Furthermore it was intended to 
transfect BHK-21 cells in the same manner to see if virus particles containing a V5-tagged 
genome could be rescued. Several strategies were applied to prepare this construct (see 
below), but all were unsuccessful. This work was therefore not pursued any further. 
 
3.1.4.1 Construction of an infectious TMEV clone expressing protein 2C tagged with the V5 
epitope by overlap PCR 
Primers were designed to insert the V5 epitope (Pk) at the C-terminus of TMEV protein 2C 
by overlap PCR (figure 3.1). Both TMEV-2C-Pk-FW and TMEV-2C-Pk-RV contained the 
V5 epitope followed by a repeat of the last four amino acids of protein 2C (MQP-V5-
MQPQ) in order to keep the proteolytic cleavage site between proteins 2C and 3A intact. It 
was intended to amplify by PCR two fragments containing the V5 epitope, using TMEV-
2BC-V5-FW/TMEV-2C-Pk-RV and TMEV-2C-Pk-FW/TMEV-3D-RV as primer pairs. 
These two fragments, which share the V5 epitope, would then be used as template for a 
final PCR using primers TMEV-2BC-V5-FW and TMEV-3D-RV resulting in PCR 
fragment 2BC-V5-P3. The PCR fragment would subsequently be cleaved with EcoNI and 
PstI and ligated into a similarly cleaved TMEV cDNA to form a full-length infectious 
TMEV cDNA expressing protein 2C fused with the V5 epitope. The overlap PCR, 
however, was unsuccessful. The primers TMEV-2C-Pk-FW and TMEV-2C-Pk-RV were 
first acquired from Eurogentec (Eurogentec Ltd., Hampshire, UK). As the accuracy of the 
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primer sequence was questioned, a second set of overlap primers was obtained from MWG 
(MWG-Biotech, Ebersberg, Germany). Both primer sets, however, were found to be 
inadequate to amplify the desired PCR fragments. 
 
3.1.4.2 Construction of an infectious TMEV clone expressing protein 2C tagged with the V5 
epitope using construct pLH135 
The second strategy applied to construct a full-length infectious TMEV cDNA expressing 
protein 2C fused with the V5 epitope, makes use of the construct pLH135 previously made 
in our laboratory (figure 3.5). TMEV-2BC was amplified by PCR using TMEV-2B-FW-
NheI and TMEV-2C-RV-ApaI as primers. Furthermore, a PCR was carried out to amplify 
TMEV-P3 using TMEV-3A-FW-KpnI and TMEV-3D-RV-PmeI as primers. Both PCR 
fragments were purified by agarose gel electrophoresis. In order to construct plasmid 
p2BC-V5-P3, the V5CFP2A fragment in pLH135 was excised with NheI and ApaI, and 
replaced with a similarly restricted TMEV-2BC. The Pac fragment was subsequently 
removed with restriction enzymes KpnI and PmeI and substituted with a similarly restricted 
TMEV-P3 to form p2BC-V5-P3 (figure 3.5). It was intended to excise protein 2C-V5 with 
EcoNI and PstI, and subsequently ligate this fragment into a similarly cleaved TMEV 
cDNA to form a full-length infectious TMEV cDNA expressing protein 2C fused with the 
V5 epitope. However, restriction analysis revealed an EcoNI restriction site within the V5 
epitope, and no other single restriction sites within TMEV protein 2C were available. 
Therefore, a different strategy was applied to transfer the V5-tagged protein 2C into the 
full-length TMEV cDNA clone (explained in section 3.1.4.3). 
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Figure 3.5: Overview of the cloning strategy utilized for the formation of p2BC-V5-P3. 
The V5CFP2A fragment in pLH135 was excised with NheI and ApaI and replaced with a 
similarly restricted TMEV-2BC. The Pac fragment was subsequently excised with KpnI and 
PmeI and replaced with a similarly restricted TMEV-P3 to form p2BC-V5-P3. 
 
3.1.4.3 Construction of an infectious TMEV clone expressing protein 2C tagged with the V5 
epitope by In-Fusion PCR cloning 
The In-FusionTM PCR Cloning kit (section 2.1.9) was employed, unsuccessfully, to insert 
the V5-tagged protein 2C into the full-length TMEV cDNA clone. Primers with 15 bases of 
homology with sequences flanking the desired site of insertion in the TMEV cDNA clone 
were designed to amplify 2C-V5. The TMEV cDNA clone was cleaved with EcoNI and 
PstI to create the insertion site. The plasmid p2BC-V5-P3 (section 3.1.4.3) was used as 
template to amplify the 2C-V5 fragment with 2C-Pk-FW-InFusion and 2C-Pk-RV-InFusion 
as primers. The PCR fragment was purified by agarose gel electrophoresis and 
subsequently used for In-Fusion PCR cloning. It was not possible to construct the desired 
full-length infectious TMEV cDNA expressing a V5-tagged protein 2C. 
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3.1.5 Intracellular localization of TMEV-2C after TMEV infection detected 
with anti-2C antibody 
3.1.5.1 Localization of protein 2C in TMEV-infected BHK-21 cells detected by anti-FMDV-2C 
We wished to determine if the intracellular localization of protein 2C in TMEV-infected 
cells could be determined using anti-FMDV-2C antibodies, available in our laboratory. 
DM10 is a rabbit polyclonal antibody raised against the full length FMDV protein 2C. The 
4E3 antibody is a mouse monoclonal antibody raised against the full length FMDV protein 
2C. To demonstrate that these antibodies could be used to detect TMEV protein 2C, BHK-
21 cells were infected with TMEV-GDVII. Subsequently, western blot analysis, using both 
DM10 and 4E3, was carried on the cell extracts. Mock-infected BHK-21 cells were used as 
a negative control. Western blot analysis suggests that both DM10 and 4E3 can detect 
TMEV-2C; however, the results are not conclusive. The binding of the anti-FMDV-2C 
antibodies seems to be non-specific as demonstrated by the bands seen in the mock-infected 
cell extracts. Interestingly an extra band, not present in TMEV-infected cell extracts, can be 
observed in mock-infected cell extracts. The nature of this band has yet to be determined 
(figure 3.6). 
 
 
 
Figure 3.6: Western blot analysis of TMEV-infected and mock-infected BHK-21 cells 
using anti-FMDV-2C antibodies. DM10 (left panel) and 4E3 (right panel) antibodies were 
used to detect TMEV protein 2C in TMEV-infected BHK-21 cells. TMEV-infected (+) and 
mock-infected (-) cell extracts are indicated. The binding of the anti-FMDV-2C antibodies is 
non-specific as demonstrated by the bands identified in the mock-infected extracts. 
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The previously described constructs TMEV-2BC-V5, TMEV-2C-V5, FMDV-2BC, and 
FMDV-2C (section 3.1.1; section 3.1.2.2) were expressed in vitro using a wheat germ 
extract coupled transcription/translation system. The in vitro translated radiolabelled 
proteins were subjected to immunoprecipitation with the anti-FMDV-2C antibody DM10. 
The radiolabelled translation products, together with the proteins associated with DM10 
were separated by 10% SDS-PAGE. The distribution of radiolabel was visualized by 
autoradiography. The gel profiles of the in vitro expressed proteins and the result of the 
subsequent immunoprecipitation reactions are shown in figure 3.7. DM10 associates with 
both FMDV-2BC and FMDV-2C as expected. Moreover, a very weak association of DM10 
with TMEV-2BC-V5 and TMEV-2C-V5 can also be observed. 
 
 
 
Figure 3.7: Gel profiles of in vitro coupled transcription/translation reactions and 
subsequent immunoprecipitation reactions. The lanes are labelled with the constructs 
used for the transcription/translation reactions and the antibody used for the 
immunoprecipitation reactions. The positions of the protein size markers are indicated. 
 
DM10 was furthermore used to localize TMEV protein 2C in TMEV-infected BHK-21 
cells. TMEV GDVII virus stocks were prepared as described in section 2.4.1, and virus 
titers were determined by standard plaque assay on BHK-21 cells (section 2.4.2). The titer 
of the viral stock used was 5 x 108 plaque forming units (PFU). BHK-21 cells were grown 
to semi-confluence (1-4 x 104 cells/cm2) on 10 mm diameter coverslips. Cell cultures were 
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infected with TMEV GDVII at a multiplicity of infection (MOI) of 100. Cell cultures were 
washed twice to remove serum components and 0.2 ml of virus stock was added. After 
adsorption of the virus for 3 hours at 37°C, cells were fixed and immunofluorescence was 
carried out (section 2.6.4). TMEV protein 2C was detected with DM10 and visualized with 
a sheep anti-rabbit antibody coupled to TexasRed (Abcam, Cambridge, UK). At 3 hours post 
infection (p.i.), TMEV protein 2C seems to be spread out in the cytoplasm, showing a typical 
ER-like pattern (figure 3.8). 
 
 
 
Figure 3.8: Localization of TMEV protein 2C in TMEV-infected cells. TMEV protein 
2C was localized in TMEV-infected BHK-21 cells at 3 hours p.i. using DM10, an anti-
FMDV-2C antibody. TMEV protein 2C showed an ER-like pattern. DAPI (blue) was used 
for nuclear staining. Bar, 5 µm. 
 
3.1.5.2 Localization of protein 2C in TMEV-infected BHK-21 cells detected by anti-TMEV-2C 
The anti-TMEV-2C antibody, described in section 3.3.2, was used to localize TMEV 
protein 2C in TMEV-infected BHK-21 cells. Cell cultures were prepared and infected as 
described above (section 3.1.5.1). The virus was adsorbed at 37°C, cells were fixed at 
hourly time points (1-8 h p.i.), and immunofluorescence was carried out (section 2.6.4). 
TMEV protein 2C was detected with anti-TMEV-2C antibody and visualized with a sheep 
anti-rabbit antibody coupled to TexasRed. At 1 hour p.i., tiny dots spread out in the cytoplasm 
can be seen, which represent newly synthesized protein 2C. At 2 to 3 hours p.i., a typical ER-
like pattern can be observed; including small granules intermixed with the ER-like pattern. 
Protein 2C seems to accumulate in a peri- and juxtanuclear area from 4 to 6 hours p.i. This 
pattern can still be observed at 7 and 8 hours p.i., however, protein 2C seems to spread out in 
the cytoplasm as well (figure 3.9). 
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Figure 3.9: Localization of TMEV protein 2C in TMEV-infected BHK-21 cells. TMEV 
protein 2C was localized in TMEV-infected BHK-21 cells using the anti-TMEV-2C 
antibody. Newly synthesized protein 2C can be observed as tiny dots spread out in the 
cytoplasm at 1h p.i. (a). At 2h (b) and 3h p.i. (c), protein 2C seems to form an ER-like 
pattern. Accumulation of protein 2C in a peri- and juxtanuclear region can be observed 
after 4h (d), 5h (e), and 6h p.i. (f). At 7h (g) and 8h p.i. (h), protein 2C seems to start to 
spread out more in the cytoplasm. Bar, 5 µm. 
 90
3.1.5.3 Localization of protein 2C in TMEV-infected BHK-PDF18 cells detected by anti-
TMEV-2C 
BHK-PDF18 is a stable cell line which contains a yellow fluorescent Golgi complex and a 
cyan fluorescent ER. The PDF18 construct, previously made in our laboratory, was used to 
establish this stable cell line. The PDF18 construct contains the enhanced yellow fluorescent 
protein (EYFP) preceded by galactosyltransferase (GT), and followed by the self-cleaving 
FMDV-2A. It also contains the enhanced cyan fluorescent protein (ECFP) followed by 
FMDV-2A and the puromycin resistance gene (Pac). GT is a type II signal-anchor sequence 
that will target YFP to the Golgi complex. The PDF18 construct does not contain a signal 
sequence targeting ECFP to the ER, but it has been demonstrated that ECFP co-localizes with 
ER markers in transfected cells (Dr. Pablo de Felipe, personal communication). Pac will act 
as selection agent (figure 3.10). 
 
 
 
Figure 3.10: Diagram of the construct pPDF18 employed to establish the BHK-PDF18 
stable cell line. The construct contains yellow fluorescent protein (YFP), preceded by 
galactosyltransferase (GT), and followed by protein 2A, cyan fluorescent protein (CFP) 
and a second protein 2A. The construct also contains a puromycin resistance gene (Pac). 
 
The anti-TMEV-2C antibody, described in section 3.3.2, was used to localize TMEV 
protein 2C in TMEV-infected BHK-PDF18 cells. Cell cultures were prepared and infected 
as described in section 3.1.5.1. The virus was adsorbed at 37°C, cells were fixed at hourly 
time points (1-8 h p.i.), and immunofluorescence was carried out as described in section 
2.6.4. TMEV protein 2C was detected and visualized as described above (section 3.1.5.2). 
At 1 hour p.i. (figure 3.11-a), little newly synthesized protein 2C can be observed, and the 
Golgi complex is intact. At 5 hours p.i., protein 2C is accumulated in the perinuclear region. 
The Golgi complex has changed from a solid, crescent-shaped organelle into a series of 
punctuate fluorescent points forming a balloon-like structure. Some overlap between protein 
2C and Golgi complex can be observed (figure 3.11-b). After 8 hours of infection, the 
remnants of the Golgi complex are dispersed throughout the cytoplasm, overlapping with 
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protein 2C (figure 3.11-c). There is no co-localization between the Golgi complex and TMEV 
protein 2C, as both red and green signal can be observed separately in the merged image. 
 
 
 
Figure 3.11: Localization of TMEV protein 2C in TMEV-infected BHK-PDF18 cells. 
TMEV protein 2C was localized in TMEV-infected BHK-PDF18 cells using the anti-TMEV-
2C antibody. The merged image is shown, followed by the Golgi complex (green) and 
protein 2C (red). Newly synthesized protein 2C can be observed as tiny dots spread out in 
the cytoplasm at 1h p.i., and the Golgi complex is intact (a). At 5h p.i., the Golgi complex is 
changed into a balloon-like structure, overlapping with a perinuclear accumulated protein 
2C (b). At 8h p.i., protein 2C starts to spread out more in the cytoplasm, overlapping with 
the dispersed remnants of the Golgi complex (c). Bar, 5 µm. 
 92
3.2. Interaction of TMEV protein 2C with host cell proteins 
3.2.1 Transfection of mammalian cells with V5-tagged TMEV protein 2C 
The V5-tagged TMEV constructs (described in section 3.1.1) were used for transient 
transfection of mammalian cells. As discussed previously in section 3.1.3, very low 
transfection efficiencies were observed. Therefore, different cell lines were used, and 
furthermore different transfection methods were applied (section 2.5) in order to express the 
V5-tagged TMEV proteins. It was intended to express TMEV protein 2C in mammalian 
cells, and to identify cellular proteins that interact with TMEV protein 2C. A transient 
transfection was to be carried out, after which the cells were to be radiolabelled. X-linked 
anti-V5 beads were to be used to pull down any cellular proteins interacting with TMEV 
protein 2C. This work was, however, not pursued further due to low transfection efficiency. 
 
3.2.1.1 Transfection of different cell lines with TMEV-2BC-V5, TMEV-2C-V5, and TMEV-
2Cmut1-V5 
The TOPO vector system, used to construct plasmids TMEV-2BC-V5, TMEV-2C-V5, and 
TMEV-2Cmut1-V5, contains a CMV promotor for mammalian expression. Proteins can be 
expressed as a fusion with the V5 epitope in transiently transfected cells, and the fusion 
proteins can be subsequently analyzed by western blot using the anti-V5 antibody. Different 
cell lines were used for transient transfection: Balb/c cells (mouse fibroblast cell line), HeLa 
cells (immortal cell line derived from cervical cancer cells), HEK-293 cells (human 
embryonic kidney cell line), and BHK-21 cells (baby hamster kidney cell line). Furthermore, 
several transfection methods were applied (section 2.5). For the initial experiments, the 
transfection reagent FuGENE 6 was used. The low transfection efficiency of the V5-tagged 
TMEV proteins, as discussed previously in section 3.1.3, was confirmed by western blot 
analysis of the transfected cell extracts (figure 3.12). Western blot analysis demonstrated no 
expression of TMEV-2BC-V5, TMEV-2C-V5, or TMEV-2Cmut1-V5. However, the 
transient transfection of a V5-tagged Influenza NS1 protein was successful (figure 3.12). 
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Figure 3.12: Western blot analysis of transfected cell extracts. Several mammalian cell lines 
(Balb/c, HeLa, HEK-293, BHK-21) were transiently transfected with TMEV-2BC-V5, TMEV-
2C-V5, TMEV-2Cmut1-V5, and a V5-tagged Influenza NS1 protein. Transfected cell extracts 
were subsequently analyzed by western blot using the anti-V5 antibody. 
 
In section 3.1.2.1, it was demonstrated that TMEV-2BC-V5, TMEV-2C-V5, and TMEV-
2Cmut1-V5 can be expressed in vitro by using the T7 promoter provided within the TOPO 
vector system. Therefore, BSR-T7 cells were used for transient transfection. The BSR-T7 cell 
line is a BHK cell line constitutively expressing a T7 RNA polymerase (a kind gift from Prof. 
R. Elliot). Western blot analysis of the transfected cell extracts demonstrated no expression of 
TMEV-2BC-V5, TMEV-2C-V5, or TMEV-2Cmut1-V5. A negative control confirmed that 
the observed bands are non-specific (figure 3.13). 
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Figure 3.13: Western blot analysis of transfected cell extracts. BSR-T7 cells were transiently 
transfected with TMEV-2BC-V5, TMEV-2C-V5, and TMEV-2Cmut1-V5. Transfected cell 
extracts were subsequently analyzed by western blot using the anti-V5 antibody. 
 
3.2.1.2 Transfection of BHK-21 cells with Lenti-TMEV-2BC and Lenti-TMEV-2C 
The plasmids Lenti-TMEV-2BC and Lenti-TMEV-2C (section 3.1.1.3) were used to transiently 
transfect BHK-21 cells. The transfection was carried out using the GeneJuice® transfection 
reagent (section 2.5.1.2). Western blot analysis of the transfected cell extracts demonstrated no 
expression of Lenti-TMEV-2BC. Lenti-TMEV-2C was expressed. However, after repeating the 
experiment, expression of Lenti-TMEV-2C could not be confirmed (figure 3.14). 
 
 
 
Figure 3.14: Western blot analysis of transfected cell extracts. BHK-21 cells were 
transiently transfected with Lenti-TMEV-2BC, and Lenti-TMEV-2C. Transfected cell extracts 
were subsequently analyzed by western blot using the anti-V5 antibody. 
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3.2.2 Transfection of mammalian cells with TAP-tagged TMEV proteins 
It was intended to apply the TAP-tag system to identify cellular proteins interacting with 
TMEV protein 2C. Proteins can be fused with a TAP-tag at both N- and C-terminus. The TAP-
tag consists of two IgG binding domains of Staphylococcus Aureus protein A (prot A) and a 
calmodulin binding protein (CBP) separated by a Tobacco Etch virus (TEV) protease cleavage 
site. The N-terminal TAP-tag contains an additional cleavage site, an enterokinase (EK) (figure 
3.15). However, as for the V5-tagged TMEV proteins, the transfection efficiency of the TAP-
tagged TMEV proteins was very low, and could therefore not be used to identify cellular 
proteins interacting with TMEV-2C. 
 
 
 
Figure 3.15: The TAP-tag system. The TAP-tag can be fused to a protein at the N- or C-
terminus. Both N-terminal (A) and C-terminal (B) TAP-tag consists of two IgG binding 
domains of Staphylococcus Aureus protein A, and a CBP, separated by a TEV protease 
cleavage site. The N-terminal TAP tag also contains an EK cleavage site. 
 
3.2.2.1 Construction of N-TAP-tagged TMEV-2BC, TMEV-2C, TMEV-2C mut1/mut2 
Protein-complex 2BC, protein 2C, and both 2C mutants were amplified by PCR using 2BC-
FW-N-TAP/2C-FW-N-TAP and 2C-RV-N-TAP. PCR fragments were purified by agarose gel 
electrophoresis. The PCR fragments were cleaved with BamHI and XbaI and the restriction 
fragments were subsequently gel purified. The purified restriction fragments were ligated into a 
similarly restricted N-TAP-tag vector to form TMEV-2BC-N-TAP, TMEV-2C-N-TAP, 
TMEV-2Cmu1-N-TAP, and TMEV-2Cmut2-N-TAP (figure 3.16). The N-TAP-tag is provided 
in the pCMV5 vector which contains a CMV promotor for expression in mammalian cells. 
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Figure 3.16: Illustration of the cloning strategy utilized for the formation of N-TAP-
tagged TMEV proteins. PCR-amplified TMEV-2BC, TMEV-2C, TMEV-2Cmut1, and 
TMEV-2Cmut were cleaved with BamHI and XbaI and ligated into a similarly restricted N-
TAP-tag vector. 
 
3.2.2.2 Construction of C-TAP-tagged TMEV-2BC, TMEV-2C, TMEV-2C mut1/mut2 
The C-TAP-Tag is provided in the pIRESpuro2 vector. However, the remaining restriction sites 
in the multi cloning site (MCS) were not suitable for cloning. Therefore, the C-TAP-Tag was 
amplified by PCR using primer set: C-TAP-FW and C-TAP-RV. The PCR product was gel 
purified, and subsequently digested with restriction enzymes KpnI and AflII. The restriction 
fragment was gel purified and ligated into a similarly digested pcDNA3.1(-) vector to form 
pcDNA/C-TAP. Protein-complex 2BC, protein 2C, and both 2C mutants were amplified by 
PCR using 2BC-FW-C-TAP/2C-FW-C-TAP and 2C-RV-C-TAP. PCR fragments were 
purified by agarose gel electrophoresis. The PCR fragments were cleaved with NotI and 
EcoRV and the restriction fragments were subsequently gel purified. The purified restriction 
fragments were ligated into a similarly restricted pcDNA/C-TAP to form TMEV-2BC-C-
TAP, TMEV-2C-C-TAP, TMEV-2Cmu1-C-TAP, and TMEV-2Cmut2-C-TAP (figure 3.17). 
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Figure 3.17: Illustration of the cloning strategy utilized for the formation of C-TAP-
tagged TMEV proteins. The C-TAP-tag was amplified by PCR, cleaved by KpnI and AflIII, 
and finally ligated into a similarly restricted pcDNA3.1(-) vector. PCR-amplified TMEV-
2BC, TMEV-2C, TMEV-2Cmut1, and TMEV-2Cmut were cleaved with NotI and EcoRV and 
ligated into a similarly restricted pcDNA/C-TAP vector. 
 
3.2.2.3 Intracellular localization of TAP-tagged TMEV-2BC and TMEV-2C 
It was intended to localize TAP-tagged TMEV protein-complex 2BC and protein 2C in the 
cell. BHK-21 cells were transfected with the constructs containing the TAP-tagged 
proteins, described above. Different transfection methods were employed (section 2.5). To 
localize the TAP-tagged proteins, immunofluorescence was carried out essentially as 
described in section 2.6.4. Weser and colleagues (2006) have described that the highly 
specific interaction of the ZZ-domain of Protein A, which constitutes part of the TAP-tag, 
to rabbit IgGs can be used to detect TAP-tagged proteins in fixed cells by use of labelled 
secondary antibodies (Weser et al., 2006). For detection and visualization of the TAP-
tagged proteins, a sheep anti-rabbit antibody coupled to TexasRed was used. It was not 
possible to detect an immunofluorescent signal for TAP-tagged TMEV-2BC or TMEV-2C. 
 98
3.2.3 In vitro binding assay of cellular proteins using a total cell extract 
It was intended to identify cellular proteins that interact with TMEV protein 2C by using a 
total cell extract (section 2.8.1). Therefore a total cell extract of a BHK-21 monolayer was 
prepared. Furthermore, a GST-2C fusion protein was expressed in bacterial cells, and 
subsequently bound to glutathione sepharose beads (section 2.7.2, 3.3.1.2). The total cell 
extract was added to the GST-2C/bead complex to “pull down” cellular proteins associated 
with TMEV-2C. The gel profile obtained from SDS-PAGE shows the expression of GST-
2C, the vast pool of proteins present in the total cell extract, and the recovered protein/bead 
complex (figure 3.18). It was not possible to identify cellular proteins interacting with 
TMEV-2C. This work was not pursued further due to time constraints. 
 
 
 
Figure 3.18: Gel profile of an in vitro binding assay of total cell extract using GST-2C. 
Protein complex GST-2C was expressed in BL21 bacterial cells (A: uninduced; B: induced), 
and subsequently bound to glutathione sepharose beads (C). A total cell extract of BHK-21 
cells was prepared (D), and added to the GST-2C/bead complex. After rotation, the 
supernatant (E) was aspirated, the protein/bead complex was washed, and analyzed on SDS-
PAGE (F). The band corresponding to GST-2C is indicated. Furthermore, the positions of the 
size markers are shown. 
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3.2.4 Binding of in vitro translated reticulon 3 and AKAP10 to TMEV-2C 
It has been shown that the N-terminus of FMDV protein 2C binds to the C-terminal region of a 
protein kinase A (PKA) anchoring protein, AKAP10, and competes with the RII regulatory 
subunit of PKA (Knox et al., submitted). PKA activity is known to play a number of key roles 
in the regulation of cellular membrane traffic. The binding to AKAP10 was also observed for 
2C proteins derived from viruses of other genera within the Picornaviridae: the Entero-, 
Rhino-, Cardio-, Parecho-, and Hepatoviruses. In all cases specific binding, but with different 
affinities, was observed (Knox et al., submitted). It was intended to confirm the binding of 
TMEV protein 2C to AKAP10. Furthermore, it has been demonstrated that the host cell protein 
reticulon 3 (RTN3) associates with the viral replication complex through direct interaction with 
the N-terminus of the enterovirus 71-encoded protein 2C (Tang et al., 2007; section 4.2.1). The 
possible binding of TMEV protein 2C to RTN3 was investigated. 
 
To confirm the interaction between TMEV-2C and AKAP10, protein 2C was expressed as a 
GST-fusion protein (GST-2C), and as a MBP-fusion protein (MBP-2C). GST-2C and GST 
alone were purified on glutathione sepharose beads. MBP-2C and MBP alone were 
immobilized on amylose resin. Both GST-2C and MBP-2C were tested for their ability to 
interact with an in vitro translated AKAP10. A full length mouse AKAP10 clone was 
purchased from RZPD Deutches (clone: IRAKp961M07111Q; Ressourcenzentrum für 
Genomforschung GmbH, Berlin, Germany). Moreover, both GST-2C and MBP-2C were 
analyzed for their ability to bind an in vitro translated RTN3. A full length mouse RTN3 was 
also purchased from RZPD (clone: IRAVp968C0112D). The gel profiles demonstrate that 
RTN3 associates in vitro with GST-2C and MBP-2C (figure 3.19). They also show some 
non-specific binding to GST and MBP alone. However, it can be observed that the 
association to GST-2C and MBP-2C is stronger as suggested by the intensity of the bands. 
This in vitro binding assay did not show an interaction between TMEV-2C and AKAP10. 
The gel profiles show no association with GST-2C or MBP-2C (figure 3.19). This is in 
contrast to previously obtained results that demonstrated an interaction between protein 2C 
and GST-IAP3. IAP3 consists of the C-terminal 52 amino acids of AKAP10 (Knox et al., 
submitted). Several internal initiation sites have been identified within the RTN3 and 
AKAP10 amino acid sequences, which can explain the extra bands observed on the gel. 
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Figure 3.19: Binding of in vitro translated reticulon 3 and AKAP10 to TMEV protein 2C. 
In vitro translated RTN3 and AKAP10 were incubated with glutathione sepharose beads 
containing either GST or GST-2C (A), or MBP or MBP-2C (B). RTN3 associates with TMEV 
protein 2C. However, some non-specific binding to GST and MBP can be observed. AKAP10 
does not interact with TMEV-2C. 
 
3.2.5 Transfection and infection of cells with TMEV containing mutations 
within the N-terminal part of protein 2C 
It has been demonstrated that the N-terminal part of TMEV-2C binds to the C-terminal part of 
AKAP10 (Knox et al., submitted). Constructs encoding specific point mutations in the N-
terminal part of the coding region of the 2C protein in the TMEV cDNA have previously been 
made in our laboratory. The point mutations cause amino acid substitutions in the 2C coding 
sequence (table 3.1). 
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Construct Position of amino acid substitution Amino acid substitution 
  mutation in 2C coding sequence mutation 
pGDVII-wt none none 
pGDVII-mt4 4 Arginine → Alanine 
pGDVII-mt8 8 Glutamate → Alanine 
pGDVII-mt14 14 Lysine → Alanine 
pGDVII-mt18 18 Tryptophan → Alanine 
pGDVII-mt23 23 Isoleucine → Alanine 
 
Table 3.1: Constructs encoding specific point mutations in the coding region of the 2C 
protein in the cDNA of TMEV. The positions of the amino acid substitutions in the 2C coding 
region are shown. The amino acids have all been substituted by an alanine. 
 
It was intended to investigate the effect of the amino acid substitutions on virus replication. 
Therefore, wild type and mutant TMEV cDNAs were used to prepare virus stocks as described 
in section 2.4.3. The wild type and mutant TMEV cDNAs are provided in the pBluescript II SK 
(+) vector (Fermentas, York, UK). The cDNA was linearized using BamHI. The linearized 
plasmid DNA was subsequently purified and transcribed in vitro using a T7 RNA polymerase. 
The RNA was used for transfection of BHK-21 cells by electroporation. After 6 hours, growth 
medium was changed to serum-free medium and cells were examined for the appearance of 
CPE at different time points over a period of 120 hours. Cells were harvested when 100% CPE 
was displayed or at 120 hours post infection. CPE is characterized by the rounding up and 
detaching of the cells. Wild type and mutant 14 TMEV showed 100% CPE at 72 hours post 
infection, and mutant 18 TMEV displayed 100% CPE at 96 hours post infection. However, 
mutant 4, mutant 8, and mutant 23 TMEV showed some cell death that resembled the cell death 
observed in the negative control. BHK-21 cells were used for transfection by electroporation 
without adding RNA. These cells showed cell death, which is most likely due to serum-
starvation. The proportion of BHK-21 cells showing CPE at different time points after 
transfection, are displayed in table 3.2. 
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Transfected Approximate % CPE 
TMEV RNA 6 hours 24 hours 48 hours 72 hours 96 hours 120 hours
Wild type 10 50 90 100     
Mutant 4 10 20 40 60 70 80 
Mutant 8 10 40 40 60 70 80 
Mutant 14 10 50 80 100     
Mutant 18 10 50 70 80 100   
Mutant 23 10 20 60 80 90 80 
No RNA 10 20 40 60 70 80 
 
Table 3.2: The proportion of BHK-21 cells displaying CPE subsequent to transfection 
with RNA encoding wild type or mutant TMEV RNA. CPE was first observed in cells 
transfected with wild type and mutant 14 TMEV RNA, followed by mutant 18 TMEV. Cell death 
observed in cells transfected with mutant 4, mutant 8, and mutant 23 TMEV RNA resembled 
cell death seen in the negative control (no RNA). 
 
BHK-21 cells were infected with wild type and mutant TME viruses obtained from the growth 
medium covering BHK-21 cells previously transfected with wild type and mutant TMEV 
RNA. At 24 hours post infection, a characteristic CPE was seen for wild type (95%), mutant 14 
(90%) and mutant 18 TMEV (85%). Mutant 4, mutant 8 and mutant 23 displayed some cell 
death after 24 hours, which resembled cell death seen in the negative control (table 3.2; figure 
3.20), suggesting that no viral particles were rescued after transfection. This was confirmed by 
titration of the wild type and mutant TME virus preparations as described in section 2.4.2. The 
titration results are shown in table 3.3. No plaques could be observed for mutant 4, mutant 8, 
and mutant 23 TMEV mutants. Viral RNA was extracted from the virus preparations and 
detected by PCR (section 2.4.3.5). It was possible to rescue viral RNA from wild type and 
mutant TMEV virus preparations, suggesting that mutant 4, mutant 8, and mutant 23 are still 
able to replicate the viral RNA but are not capable of forming new virus particles. The presence 
of the expected mutations was checked by sequencing. The sequencing results confirmed the 
presence of mutant 4 and mutant 8. However, mutant 14, mutant 18, and mutant 23 TMEV 
seemed to have back-mutated to the original wild type sequence. After sequencing the original 
constructs, previously made in our laboratory, it was demonstrated that mutant 14 was not 
present in the original construct. Mutant 18 and mutant 23, however, were present in the 
original constructs. 
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Figure 3.20: CPE observed 24 hours after infection with wild type and mutant TME 
viruses. A typical CPE can be observed in cells infected with wild type, mutant 14 and mutant 
18 TME viruses. Most cells have rounded up and detached. Cells infected with mutant 4, 8, and 
23 resemble those of the negative control (naive). Some cell death can be observed. 
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TMEV  Approximate % CPE Titration of virus  
virus 24 hours preparation 
Wild type 95 8 x 106 pfu 
Mutant 4 20 no plaques 
Mutant 8 20 no plaques 
Mutant 14 90 4 x 105 pfu 
Mutant 18 85 3 x 105 pfu 
Mutant 23 20 no plaques 
naive 20 / 
 
Table 3.3: The proportion of BHK-21 cells showing CPE 24 hours after infection with 
wild type or mutant TME viruses and titer of the viral preparations. BHK-21-cells were 
infected with wild type and mutant TME viruses obtained from growth medium covering BHK-
21 cells previously transfected with wild type and mutant TMEV RNA. CPE was observed in 
cells 24 hours after infection with wild type (95%), mutant 14 (90%) and mutant 18 (85%) 
TMEV. Cell death observed in cells infected with mutant 4, mutant 8, and mutant 23 TMEV 
resembled cell death seen in the negative control (naive). Furthermore, the titer of the viral 
preparations is estimated. Mutant 4, mutant 8, and mutant 23 TMEV displayed no plaques. 
 
3.2.6 Expression of GFP-IAP3 
A discrepancy was observed concerning the binding of TMEV protein 2C to AKAP10. 
Therefore, we wished to locate AKAP10 in mammalian cells and explore the possible 
interaction with TMEV-2C. It has been demonstrated that the N-terminal part of protein 2C 
associates with the C-terminal part of AKAP10 (Knox et al., submitted). IAP3 consists of the 
C-terminal 52 amino acids of AKAP10. Therefore it was intended to construct a plasmid 
containing IAP3 fused to enhanced green fluorescent protein (EGFP), which can be used for in 
vitro expression and for expression in mammalian cells. 
 
3.2.6.1 Construction of pGFP-IAP3 
The IAP3 fragment was excised from a plasmid, pGST-IAP3, previously made in our 
laboratory, using BamHI and EcoRI restriction enzymes. The gel purified IAP3 fragment was 
subsequently ligated into pEGFP-C1, which was previously restricted with BglII and EcoRI, 
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to form pGFP-IAP3. This plasmid can be used for expression in mammalian cells. It was 
intended to construct a plasmid which could also be used for in vitro translation. Therefore, 
the GFP-IAP3 fragment was excised from pGFP-IAP3 with NheI and EcoRV restriction 
enzymes, and ligated into a similarly restricted pcDNA3.1(-) vector to form pcDNA-GFP-
IAP3 (figure 3.21). This construct can be used for in vitro translation, as well as expression in 
mammalian cells. 
 
 
 
Figure 3.21: Overview of the cloning strategy utilized for the formation of the GFP-
IAP3 construct. The IAP3 fragment was excised from a construct containing GST-IAP3 
with BamHI and EcoRI. IAP3 was subsequently ligated into pEGFP-C1, previously 
restricted with BglII and EcoRI to form pGFP-IAP3. The GFP-IAP3 fragment was 
subsequently excised from pGFP-IAP3 sing NheI and EcoRV and ligated into a similarly 
restricted pcDNA3.1(-) vector to form pcDNA-GFP-IAP3. 
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3.2.6.2 In vitro translation of pcDNA-GFP-IAP3 
The pcDNA-GFP-IAP3 construct was used to program a wheat germ extract coupled 
transcription/translation reaction. Furthermore, the GFP-2A-GUS and GUS-2A-GFP 
constructs, previously made in our laboratory, have been used as control reactions. The 
radiolabelled translation products were separated by 10% SDS-PAGE and visualized by 
autoradiography. The gel profiles of the in vitro coupled transcription/translation reactions 
show translation of GFP-IAP3, and moreover the expected translation products of GFP-2A-
GUS and GUS-2A-GFP can be observed (figure 3.22). 
 
 
 
Figure 3.22: Gel profiles of in vitro coupled transcription/translation reactions. The 
lanes are labelled with the constructs used for the transcription/translation reactions. In 
vitro translation of GFP-IAP3 can be observed. Furthermore, the full length and processed 
translation products of GFP-2A-GUS and GUS-2A-GFP are indicated. 
 
3.2.6.3 Intracellular localization of GFP-IAP3 
The pGFP-IAP3 construct, described in section 3.2.6.1, was used to transfect BHK-21 cells 
using the FuGENE 6 transfection reagent (section 2.5.2.1). Cells were fixed 24 hours after 
transfection, as detailed in section 2.6.3. Images were acquired using the DeltaVision® 
microscope system (section 2.6.5). IAP3 seems to form a granular pattern spread out in the 
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cytoplasm (figure 3.23). It was intended to co-transfect cells with pGFP-IAP3 and V5-
tagged TMEV-2C to investigate the possible co-localization of IAP3 and protein 2C. 
However, this was not possible due to very low transfection efficiencies observed for 
TMEV protein 2C. Furthermore, it was aspired to transfect BHK-21 cells with the pGFP-
IAP3, followed by an infection with TMEV GDVII, in order to investigate the co-
localization of IAP3 and protein 2C, visualized using anti-TMEV-2C antibody (section 
3.3.2). This work was not pursued due to time constraints. 
 
 
 
Figure 3.23: Intracellular localization of IAP3. The pGFP-IAP3 construct was used to 
transfect BHK-21 cells. A granular pattern, spread out in the cytoplasm, can be observed 
for IAP3. Bar (a), 15 µm; bar (b), 5 µm. 
 
3.3. TMEV protein 2C antibody production 
3.3.1 Bacterial expression of TMEV protein 2C 
3.3.1.1 Polyhistidine tagging of TMEV-2BC and TMEV-2C 
Protein-complex 2BC and protein 2C of the wt GDVII TMEV strain were amplified by PCR 
using TMEV-2BC-His-FW/TMEV-2C-His-FW and TMEV-2C-His-RV. PCR fragments were 
purified by agarose gel electrophoresis. The PCR fragments were cleaved with BamHI and 
HindIII and the restriction fragments were subsequently gel purified. The purified restriction 
fragments were ligated into a similarly restricted peHisTev vector to form TMEV-2BC-His and 
TMEV-2C-His (figure 3.24). 
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Figure 3.24: Illustration of the cloning strategy utilized for the formation of His-
tagged TMEV proteins. TMEV-2BC and TMEV-2C were amplified by PCR. The purified 
PCR-products were restricted with BamHI and HindIII and ligated into a similarly 
restricted peHisTev vector. 
 
TMEV-2BC-His and TMEV-2C-His were expressed essentially as described in section 2.7.1. 
BL21(DE3)pLysS competent cells were initially used for transformation. Expression of 
TMEV-2BC-His and TMEV-2C-His was induced at 37°C using 0.5 mM IPTG (final 
concentration), and the induced cell extract was subsequently used for binding to nickel beads. 
No expression could be observed. Therefore, different final IPTG concentrations were 
employed to induce expression of the His-tagged proteins. Figure 3.25 shows the gel profiles of 
TMEV-2BC-His and TMEV-2BC-His expressed at 37°C using 0.1 mM, 0.5 mM or 1 mM 
IPTG (final concentration). No expression could be observed under these conditions. Induction 
of expression of the His-tagged proteins was also carried out at RT using different IPTG 
concentrations. However, no expression could be detected at RT. Therefore, a different strain of 
bacterial cells, called Rosetta(DE3)pLysS competent cells, was used for transformation of the 
TMEV-2BC-His and TMEV-2C-His constructs. Rosetta(DE3)pLysS competent cells are a 
derivative of BL21(DE3)pLysS which supply the tRNAs for six codons that are used 
infrequently in E. coli. Expression was induced at 37°C and at RT using 0.1 mM, 0.5 mM, and 
1 mM IPTG (final concentration). However, expression could still not be observed. 
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Figure 3.25: Gel profiles of His-tagged TMEV-2BC and TMEV-2C. BL21(DE3)pLysS 
competent cells were used for transformation of TMEV-2BC-His (top) and TMEV-2C-His 
(bottom). Expression of the His-tagged proteins was induced at 37°C using different final 
IPTG concentrations as indicated. The uninduced cell extract, the induced cell extract, and 
the protein/nickel bead complex (eluted protein) are shown. The positions of the protein 
size markers are indicated. 
 
3.3.1.2 Glutathione-S-transferase tagging of TMEV-2BC and TMEV-2C 
Protein-complex 2BC and protein 2C of the wt GDVII TMEV strain were amplified by PCR 
using TMEV-2BC-bact-FW/TMEV-2C-bact-FW and TMEV-2C-bact-RV. The purified PCR 
fragments were cleaved with BamHI and SalI and the restriction fragments were 
subsequently gel purified. The purified restriction fragments were ligated into a similarly 
restricted pGEX-5V-3 vector to form TMEV-2BC-GST and TMEV-2C-GST (figure 3.26). 
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Figure 3.26: Overview of the cloning strategy utilized for the formation of GST-tagged 
TMEV proteins. TMEV-2BC and TMEV-2C were amplified by PCR. The purified PCR-
products were restricted with BamHI and SalI and ligated into a similarly restricted pGEX-
5X-3 vector. 
 
TMEV-2BC-GST and TMEV-2C-GST were expressed essentially as described in section 
2.7.2. BL21(DE3)pLysS competent cells were used for transformation. Expression of 
TMEV-2BC-GST and TMEV-2C-GST was induced at 37°C using 0.5 mM IPTG (final 
concentration), and the induced cell extract was subsequently used for binding to 
glutathione sepharose beads. It was not possible to detect expression of TMEV-2BC-GST. 
However, expression of TMEV-2C-GST was observed (figure 3.27). 
 
 
 
Figure 3.27: Gel profiles of GST-tagged TMEV-2BC and TMEV-2C. BL21(DE3)pLysS 
competent cells were used for transformation of TMEV-2BC-GST and TMEV-2C-GST. 
Expression of the GST-tagged proteins was induced at 37°C using a 0.5 mM final IPTG 
concentration. The expressed TMEV-2C-GST bound to glutathione sepharose beads is 
shown. The positions of the protein size markers are indicated. 
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3.3.1.3 Maltose binding protein tagging of TMEV-2BC and TMEV-2C 
Protein-complex 2BC and protein 2C of the wt GDVII TMEV strain were amplified by 
PCR using TMEV-2BC-bact-FW/TMEV-2C-bact-FW and TMEV-2C-bact-RV. The PCR 
fragments were purified by agarose electrophoresis. The purified PCR fragments were 
cleaved with BamHI and SalI and the restriction fragments were subsequently gel purified. 
The IAP3 fragment in the pMAL-IAP3 construct, previously made in our laboratory, was 
excised using BamHI and SalI, and replaced with the similarly restricted PCR-fragments to 
form TMEV-2BC-MBP and TMEV-2C-MBP (figure 3.28). 
 
 
 
Figure 3.28: Illustration of the cloning strategy employed for the formation of MBP-
tagged TMEV proteins. The IAP3 fragment was excised from pMAL-IAP3 with restriction 
enzymes BamHI and SalI, and replaced by similarly restricted TMEV-2BC and TMEV-2C 
PCR-fragments. 
 
TMEV-2BC-MBP and TMEV-2C-MBP were expressed essentially as described in section 
2.7.3. BL21(DE3)pLysS competent cells were used for transformation, and expression of 
TMEV-2BC-GST and TMEV-2C-GST was induced at 37°C using 0.3 mM IPTG (final 
concentration). The induced cell extract was subsequently used for binding to amylase 
resin. It was not possible to observe expression of TMEV-2BC-MBP. However, expression 
of TMEV-2C-MBP was detected (figure 3.29). 
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Figure 3.29: Gel profiles of MBP-tagged TMEV-2BC and TMEV-2C. BL21(DE3)pLysS 
competent cells were used for transformation of TMEV-2BC-MBP (top) and TMEV-2C-
MBP (bottom). Expression of the MBP-tagged proteins was induced at 37°C using a 0.3 
mM final IPTG concentration. The expressed TMEV-2C-MBP bound to amylose resin is 
shown. The positions of the protein size markers are indicated. 
 
3.3.2 Development of an anti-TMEV-2C antibody 
The bacterial expression of TMEV-2C allowed us to have an anti-TMEV-2C antibody 
developed. TMEV-2C-MBP was purified by John Nicholson. In brief, a 100 ml overnight 
culture was prepared, as described in section 2.7.3, and incubated at 37°C. After incubation, 
50 ml of overnight culture was transferred into 2x1 L culture and incubated at 37°C until an 
OD (600 nm) of 0.6 was reached. IPTG was added to a final concentration of 0.5 mM, and 
incubation was continued for 3 hours. Cells are centrifuged at 6000 rpm for 20 min, and 
subsequently resuspended in column buffer and sonicated. The lysed cells are centrifuged 
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for 15 min at 10 000 rpm to remove the cell debris. An amylase resin column (New 
England BioLabs Ltd., Herts, UK ) was used to purify TMEV-2C-MBP. The polyclonal 
anti-TMEV-2C antibody was developed by Diagnostics Scotland (Edinburgh, Scotland). 
The purified TMEV-2C-MBP was used for immunization of rabbits. Serum was collected 
at 1, 2, and 3 months after immunization. It was intended to purify the anti-TMEV-2C-
antibody using TMEV-2C-GST. However, due to time constraints, the purification was not 
carried out. Therefore, the whole antiserum was used for preliminary experiments. 
 
The TMEV-2BC-V5 and TMEV-2C-V5 constructs, discussed in section 3.1.1.1, were 
expressed in vitro using a wheat germ extract coupled transcription/translation system. 
Furthermore, an immunoprecipitation experiment was performed. The in vitro translated 
radiolabelled proteins were incubated with protein G Sepharose beads containing the anti-
TMEV-2C antibody. The proteins associated with the anti-TMEV-2C antibody were eluted 
from the beads by boiling in SDS gel-loading buffer and analyzed by 10 % SDS-PAGE. 
The distribution of radiolabel was visualized by autoradiography (figure 3.30). The anti-
TMEV-2C antibody binds TMEV-2BC-V5 and TMEV-2C-V5. 
 
 
 
Figure 3.30: Gel profiles of in vitro coupled transcription/translation reactions and 
subsequent immunoprecipitation reactions. The lanes are labelled with the constructs 
used for the transcription/translation reactions and the antibody used for the 
immunoprecipitation reactions. The positions of the protein size markers are indicated. 
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TMEV-2C-GST and GST alone were expressed essentially as described in section 2.7.2. 
The cell extracts were analyzed by western blot using the anti-TMEV-2C antibody. TMEV-
2C-GST was detected by the anti-TMEV-2C antibody, as shown in figure 3.31. However, 
some non-specific bands can be observed for both TMEV-2C-GST and GST alone. 
Purification of the anti-TMEV-2C antibody might result in a more specific binding. 
 
 
 
Figure 3.31: Western blot analysis of TMEV-2C-GST using anti-TMEV-2C. TMEV-
2C-GST and GST alone were expressed, and cell extracts were subsequently analyzed by 
western blot using the anti-TMEV-2C antibody. TMEV-2C-GST is indicated. 
 
The anti-TMEV-2C antibody was also used for immunofluorescence experiments described 
in section 3.1.5. Protein 2C can be localized in TMEV-infected cells by using the anti-
TMEV-2C antibody. Furthermore, protein 2C was localized in TMEV-infected BHK-
PDF18 cells, showing overlap with the dispersed remnants of the Golgi complex at late 
stages of infection. 
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3.4. TMEV infection 
3.4.1 Creation of a stable cell line constitutively expressing fluorescent 
microtubules 
A computer-based analysis has demonstrated that TMEV protein 2C is highly similar to three 
members of the AAA ATPase superfamily: (1) lipotransin: a hormone-sensitive lipase 
(HSL)-interacting protein that appears to translocate HSL to the lipid droplet; (2) VPS4: a 
protein required for endosomal transport; and (3) p60 katanin: the katanin subunit 
responsible for microtubule severing (figure 3.32). It was intended to investigate the 
similarity between TMEV protein 2C and the p60 subunit of katanin. 
 
Katanin is a heterodimeric, ATP-dependent, microtubule-severing protein first purified from 
sea urchin eggs (Strongylocentrotus purpuratus). It has a microtubule-stimulated ATPase 
activity and hydrolysis of ATP is required for the microtubule-severing reaction. Katanin is also 
known to disassemble stable microtubules (MTs) to form polymerisation-competent tubulin 
subunits (McNally & Vale, 1993). It is a heterodimer of 60 and 80 kDa subunits, which is 
highly concentrated at centrosomes throughout the cell cycle (McNally et al., 1996). 
 
TMEV protein 2C might exhibit a similar function to the p60 subunit of katanin in infected 
cells. Therefore, it was aspired to produce a stable cell line constitutively expressing 
fluorescent MTs. The stable cell line would then be infected with TMEV and the effect of 
TMEV on MTs would be investigated. The anti-TMEV-2C antibody would be used to link 
TMEV protein 2C to the possible effect of TMEV on MTs. 
 
MTs and the Golgi complex are closely related in the cytoplasm of the cell. The Golgi complex 
is composed of cisternal stacks, usually arranged around the centrosome, which is the major 
organizing center for MTs. Golgi stacks are broken up and dispersed in the cytoplasm upon 
drug-induced disruption of MTs. Furthermore, MT-dependent motor proteins dynein and 
kinesin bind to the Golgi membrane and seem to play a role in transport to and from the Golgi 
complex. The Golgi complex undergoes fragmentation during mitosis. MTs depolymerize 
during prophase resulting in the extensive reorganization of the Golgi stacks (reviewed by 
Thyberg & Moskalewski, 1999). 
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 Figure 3.32: Alignment showing similarity with TMEV protein 2C. A computer based 
analysis showed that TMEV protein 2C is highly similar to lipotransin, VPS4, and p60-katanin. 
The conserved Walker A, B and C motifs are indicated in red. The additional conserved 
residues (*) are indicated in blue. 
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3.4.1.1 Creation of a stable cell line constitutively expressing YFP-tubulin 
It was intended to produce a stable cell line constitutively expressing YFP-tubulin. 
Poliovirus protein 2C and its precursor 2BC have been associated with the membrane 
rearrangements, the disappearance of the Golgi complex, and the vesicle formation 
observed in infected cells. Therefore, it was intended to also induce CFP-Golgi or CFP-ER 
in the stable cell line expressing YFP-tubulin. 
 
A construct was generated containing α-tubulin preceded by EYFP and followed by the 
self-cleaving FMDV 2A protein. Moreover, the construct contained ECFP preceded by GT 
or calreticulin (CR), and followed by a second FMDV 2A protein and Pac. GT is a type II 
signal-anchor sequence that will target CFP to the Golgi complex. CR, however, is a type I 
signal sequence that will transport CFP to the ER. Pac will act as selection agent. 
 
EYFP-α-tubulin was amplified by PCR using T7 and Tub-RV. The pIRES-EYFP-tubulin 
plasmid, available in our laboratory, was used as template. It contains a fusion protein of 
EYFP and human α-tubulin. The purified PCR product was cleaved with NheI and XbaI, and 
subsequently purified by agarose gel electrophoresis. Furthermore, the constructs pEYFP-2A-
GT-ECFP-2A-Pac and pEYFP-2A-CR-ECFP-2A-Pac, previously made in our laboratory, 
were cleaved with NheI and XbaI, creating three fragments: (1) pcDNA3.1(-)-2A-Pac; (2) 
2A-GT/CR-CFP; and (3) EYFP. EYFP-α-tubulin was ligated into pcDNA3.1(-)-2A-Pac, 
forming pEYFP-α-tubulin-2A-Pac. The 2A-GT/CR-ECFP fragment was subsequently ligated 
into pEYFP-α-tubulin-2A-Pac, previously cleaved with XbaI, to form pEYFP-α-tubulin-2A-
GT-ECFP-2A-Pac and pEYFP-α-tubulin-2A-CR-ECFP-2A-Pac (figure 3.33). 
 
The constructs were used to transfect BHK-21 cells using the FuGENE 6 transfection 
reagent, as described in section 2.5.2.1. Puromycin was used as a dominant selectable 
marker to permit isolation of stable transfectants. Therefore, the overlaying growth medium 
was replaced 24 hours post transfection with growth medium supplemented with 10µg/ml 
puromycin. Cells were grown for 14 days with a change of medium supplemented with 
puromycin after 7 days. After 14 days, the plates were inspected for the presence of colonies. 
It was, however, not possible to isolate healthy colonies. 
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Figure 3.33: Overview of the cloning strategy used for the creation of a stable cell line 
constitutively expressing YFP-tubulin. EYFP-α-tubulin was amplified by PCR and 
cleaved with NheI and XbaI. The pEYFP-2A-GT/CR-ECFP-2A-Pac construct was similarly 
restricted, creating the following fragments: pcDNA3.1(-)-2A-Pac, 2A-GT/CR-ECFP, and 
EYFP. EYFP-α-tubulin ligated into pcDNA3.1(-)-2A-Pac. Subsequently, 2A-GT/CR-ECFP 
was ligated into pEYFP-2A-Pac, previously restricted with XbaI. 
 
3.4.1.2 Creation of a stable cell line constitutively expressing cherry-tubulin using the 
lentivirus system 
Cherry-tubulin was amplified by PCR using Lenti-cherry-Tub-FW and Lenti-cherry-Tub-
RV. A vector containing cherry-tubulin, available in our laboratory, was used as template. 
The purified PCR product was cleaved with BamHI and SpeI and subsequently gel purified. 
cherry-tubulin was then ligated into the similarly restricted pdlNotl’MCS’F vector (figure 2.5, 
section 2.9.1), to form Lenti-cherry-Tubulin (figure 3.34). 
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Figure 3.34: Overview of the cloning strategy employed for the creation of a stable cell 
line constitutively expressing cherry-tubulin. Cherry-tubulin was amplified by PCR. The 
purified PCR-product was cleaved with BamHI and SpeI, and subsequently ligated into a 
similarly restricted pdlNotl’MCS’F vector. 
 
The Lenti-cherry-tubulin construct was used to generate lentivirus particles that carry the 
cherry-tubulin fusion protein (as described in section 2.9.1). These lentivirus particles were 
subsequently used to infect BHK-21 cells, as described in section 2.9.2; and infected cells 
were selected with puromycin. The lowest concentration of puromycin that causes massive 
cell death of BHK-21 cells was identified as 10µg/ml (section 2.9.3). It was intended to use 
the lentiviral particles containing cherry-tubulin to establish a stable cell constitutively 
expressing cherry-tubulin. However, it was not possible to create this stable cell line. 
Colleagues have encountered extensive problems with creating a stable cell line constitutively 
expressing fluorescent microtubules (Tony Vaughn, personal communication). 
 
3.4.2 Observation of intracellular changes during TMEV infection by 
means of various cellular markers 
Various cellular markers were used to observe intracellular changes in TMEV-infected 
BHK-21 cells. Different compartments and proteins that serve a function in membrane 
trafficking were targeted. Most cellular markers showed similar changes in the infected 
cells as a result of infection. Infection causes a decentralization of the monitored organelles 
and proteins, which results in an accumulation of the organelles and proteins at the 
periphery of the cell. The different organelles and proteins seem to surround the expanding 
site of virus replication. One exception was identified; BIGI is localized at the Golgi 
complex in mock-infected cells, and is spread out in the cytoplasm during TMEV infection 
(section 3.4.2.6). 
 120
3.4.2.1 Changes in the intracellular structure of actin caused by TMEV infection 
Actin is a highly conserved globular, structural protein (G-actin). The individual G-actin 
subunits assemble into long filamentous polymers called F-actin. Two parallel F-actin 
strands interact in a helical formation, giving rise to microfilaments, a major component of 
the cytoskeleton. Actin participates in many important cellular functions, including vesicle 
and organelle movement and the maintenance of cell shape. Furthermore, actin is the 
monomeric subunit of thin filaments, which are part of the contractile apparatus in muscle 
cells. It was intended to investigate the changes in the intracellular structure of actin caused 
by TMEV infection. 
 
BHK-21 cell cultures were prepared and infected as described in section 3.1.5.1. The virus 
was adsorbed at 37°C, cells were fixed at hourly time points (1-8 h p.i.), and 
immunofluorescence was carried out (section 2.6.4). Actin was detected with a monoclonal 
anti-actin antibody using a 1:200 dilution (Sigma-Aldrich Company Ltd., Dorset, UK), and 
visualized with a rabbit anti-mouse antibody coupled to TexasRed. Figure 3.35 shows a 
mock infection of BHK-21 cells (a), and BHK-cells at 5 hours and 7 hours post infection. 
Preliminary results suggest that the filamentous structure of actin disappears during 
infection. Actin appears to accumulate at the cellular membrane, creating an area devoid of 
actin, which is thought to be the viral replication site. These results have to be confirmed by 
further experiments. 
 
 
 
Figure 3.35: Immunofluorescent staining of BHK-21 cells using anti-actin. Mock-infected 
cells show an actin organization (a). Actin appears to accumulate at the periphery of the cell 
during infection as shown at 5 hours (b) and 7 hours p.i. (c). Nuclear staining is due to the 
secondary antibody. Bar (a-b), 15 µm; bar (c), 5 µm. 
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3.4.2.2 Changes in the intracellular organization of tubulin caused by TMEV infection 
As it was not possible to establish a stable cell line constitutively expressing fluorescent 
microtubules (section 3.4.1), it was intended to determine the effect of TMEV-infection on 
microtubules by means of a cellular marker for tubulin. 
 
Cultures of BHK-21 cells were prepared and infected as described previously (section 
3.1.5.1). The virus was adsorbed at 37°C, cells were fixed at hourly time points (1-8 h p.i.), 
and immunofluorescence was carried out (section 2.6.4). Tubulin was detected with an anti-
tubulin antibody using a 1:80 dilution (Sigma-Aldrich Company Ltd., Dorset, UK), and 
visualized with a sheep anti-rabbit antibody coupled to TexasRed. Preliminary results suggest 
that TMEV-infection causes a redistribution of tubulin. At 7 hours post infection, tubulin 
seems to cluster at the periphery of the cell, surrounding the viral replication complexes 
(figure 3.36). Further experiments are required to confirm these results. 
 
 
 
Figure 3.36: Immunofluorescent staining of BHK-21 cells using anti-tubulin. The normal 
intracellular tubulin organization can be seen in image (a). At 7h p.i. (b), it can be observed 
that tubulin is concentrated near the cellular membrane, surrounding the site of viral 
replication. Nuclear staining is due to the secondary antibody. Bar a, 15 µm; bar b, 5 µm. 
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3.4.2.3 Disassembly of the Golgi complex caused by TMEV infection 
It has been demonstrated that membranous vesicles arise in the perinuclear region of PV-
infected cells. These vesicles proliferate extensively, and spread out in the cytoplasm. The 
Golgi complex is involved in the generation of these membranous vesicles. Furthermore, 
PV infection results in the disassembly and disappearance of the Golgi complex. It was, 
therefore, aspired to observe the changes in the Golgi complex, occurring during TMEV-
infection. The observations made, are confirmed by live imaging of TMEV-infected BHK-
PDF18 cells as described in section 3.4.3. 
 
BHK-21 cell cultures were prepared and infected as described in section 3.1.5.1. TMEV GDVII 
was adsorbed, cells were fixed at hourly time points (1-8 h p.i.), and immunofluorescence was 
carried out (section 2.6.4). Two antibodies were used to localize the Golgi complex in the 
TMEV-infected cells: (i) anti-GM130 antibody (Sigma-Aldrich), an antibody raised against the 
130 kDa Golgi matrix protein (1:500 dilution); and (ii) a monoclonal anti-Golgi 58K protein 
antibody (anti-Golgi; Sigma-Aldrich), which recognizes an epitope on the microtubule-binding 
peripheral 58 kDa Golgi membrane protein (1:100 dilution). Anti-GM130 was visualized with a 
sheep anti-rabbit antibody coupled to TexasRed, whilst anti-Golgi was visualized using a rabbit 
anti-mouse antibody coupled to TexasRed. A mock infection of BHK-21 cells shows the 
typical crescent-shaped Golgi complex. This shape remains at 1 hour and 2 hours post 
infection. At 3 hours p.i., the solid, crescent-shaped organelle has changed into a series of 
punctuate fluorescent points spread out in the cytoplasm. At 5 and 7 hours p.i., the Golgi 
complex has disassembled and the remnants form a balloon-like structure, surrounding the viral 
replication site (Figure 3.37). 
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Figure 3.37: Immunofluorescent staining of BHK-21 cells using anti-GM130/Golgi. A 
mock infection (a; anti-GM130) shows a crescent-shaped Golgi-complex, which remains at 
1h (b, anti-GM130) and 2h p.i. (c; anti-Golgi). At 3h p.i. (d; anti-Golgi), the Golgi complex 
is dispersed over the cytoplasm. At 5h and 7h p.i. (e-f; anti-Golgi), the remnants are 
accumulated at the cellular membrane. Bar (a), 30 µm; bar (b-f), 15 µm. 
 
3.4.2.4 Relocalization of PKA caused by TMEV infection 
Protein kinase A (PKA) activity is known to play a number of key roles in the regulation of 
cellular membrane traffic. It has been shown that the N-terminus of TMEV protein 2C binds to 
the C-terminal region of a PKA anchoring protein, AKAP10 and competes with the RII 
regulatory subunit of PKA (Knox et al., submitted). This may serve to displace PKA from the 
Golgi complex. It has been shown that PKA is involved in various aspects of vesicle-mediated 
protein transport processes: (1) protein transport from the ER to the Golgi complex (Muniz et 
al., 1997); (2) budding of constitutive transport vesicles from the trans-Golgi network (Muniz et 
al., 1997); (3) endosome-to-Golgi and Golgi-to-ER transport (Lee & Linstedt, 2000); (4) 
endosome fusion, exo-, endo-, and transcytosis (Hansen & Casanova, 1994, Takuma & Ichida, 
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1994a, Muniz et al., 1996;, Rapacciuolo et al., 2003, Kim et al., 2005); and (5) stimulation of 
the binding of ADP-ribosylation factor 1 (Arf1) to the Golgi membranes. PKA seems to play an 
important role in membrane trafficking (Martin et al., 2000). 
 
It was intended to localize PKA in TMEV-infected BHK-21 cells. Cell cultures were 
prepared and infected as described previously (section 3.1.5.1). The virus was adsorbed at 
37°C, cells were fixed at hourly time points (1-8 h p.i.), and immunofluorescence was carried 
out (section 2.6.4). Three antibodies were used to localize PKA: (i) polyclonal to protein 
kinase A regulatory subunit I alpha (anti-PKAI; Abcam); (ii) polyclonal to cAMP-dependent 
protein kinase type II-alpha regulatory subunit (anti-PKAII; Abcam); and (iii) PKA antibody, 
which is raised against the catalytic subunit (anti-PKA-CAT; Abcam). The three primary 
antibodies were used at a 1:500 dilution. Anti-PKAI and anti-PKAII were visualized with a 
sheep anti-rabbit antibody coupled to TexasRed, whilst anti-PKA-CAT was visualized using 
a rabbit anti-mouse antibody coupled to TexasRed. Preliminary results suggest that TMEV 
infection alters the intracellular distribution of PKA. At 7 hours post infection, PKA appears 
to cluster near the cellular membrane, creating a region devoid of PKA within the cell were 
viral replication takes place (figure 3.38). Confirmation of these results by further 
experiments is required. 
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Figure 3.38: Relocalization of PKA in BHK-21 cells upon TMEV infection. Mock-infected 
cells stained with anti-PKAI/PKAII/PKA-CAT, show the intracellular localization of PKA. At 
7h p.i., PKA appears to have accumulated at the periphery of the cell. Nuclear staining is due 
to the secondary antibody. Bar (a,c,e,f), 15 µm; bar (b,d), 5 µm. 
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3.4.2.5 Changes in the localization of endosomes caused by TMEV infection 
Endosomes are membrane-bound compartments within the cell. They are part of both the 
secretory and the endocytic pathway of membrane trafficking. The secretory pathway allows 
soluble and membrane proteins to be transported from the ER through the Golgi complex and 
out to various locations including endosomes. The endocytic pathway is used to take up 
substances from the cell surface into the interior of the cell by way of endosomes. It was aspired 
to investigate the effect of TMEV-infection on the localization of early endosomes (EE). 
 
BHK-21 cell cultures were prepared and infected as described in section 3.1.5.1. TMEV GDVII 
was adsorbed, cells were fixed at hourly time points (1-8 h p.i.), and immunofluorescence was 
carried out (section 2.6.4). Early endosomes were detected with a polyclonal anti-EEA1 
antibody, an early endosome marker, using a 1:500 dilution (anti-EE; Abcam), and visualized 
with a sheep anti-rabbit antibody coupled to TexasRed. A mock infection shows an even 
distribution of the EE in the cytoplasm. At 6 hours post infection, early endosomes have 
accumulated at the periphery of the cell, surrounding the viral replication site (figure 3.39). 
 
 
 
Figure 3.39: Immunofluorescent staining of BHK-21 cells using anti-EE. A mock 
infection (a) shows EE spread out in the cytoplasm. At 6h p.i. (b), early endosomes are 
concentrated at the cell membrane. Bar (a), 15 µm, bar (b) 5 µm. 
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3.4.2.6 Redistribution of BIGI caused by TMEV infection 
BIGI, also called ADP-ribosylation factor guanine nucleotide-exchange factor I (Arf-
GEFI), activates ADP-ribosylation factor I (ArfI) by catalyzing the replacement of Arf-
bound GDP with GTP to regulate Golgi vesicular transport. It has recently been observed 
that some members of the Arf family of small GTPases (ArfI), which control secretory 
trafficking, associate with newly formed membranous RNA replication complexes in PV-
infected cells (Belov et al., 2005). Two PV proteins 3A and 3CD, recruit different Arf-
GEFs, including BIGI, to the membranous vesicles that arise during PV infection. These are 
responsible for Arf activation and translocation to these membranes (Belov et al., 2007). 
 
It was intended to localize BIGI in TMEV-infected BHK-21 cells. Cell cultures were prepared 
and infected as described previously (section 3.1.5.1). The virus was adsorbed, cells were fixed 
at hourly time points (1-8 h p.i.), and immunofluorescence was carried out (section 2.6.4). BIGI 
was localized using a polyclonal anti-BIGI/ARFGEFI antibody at a 1:500 dilution (anti-BIGI; 
Bethyl Laboratories Inc., Cambridge BioScience, Cambridge, UK), and visualized with a sheep 
anti-rabbit antibody coupled to TexasRed. Mock-infected cells show a typical localization to 
the Golgi area. At 3 hours post infection, BIGI has been redistributed to the perinuclear region, 
where the replication vesicles are located. At 5 and 7 hours post infection, BIGI can be 
observed spread out in the cytoplasm at the viral replication site (figure 3.40). 
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Figure 3.40: Relocalization of BIGI in BHK-21 cells upon TMEV infection. Mock-infected 
cells stained with anti-BIGI localize BIGI to the Golgi area (a). TMEV-infected cells stained 
with anti-BIGI at 3h p.i. (b), show redistribution to the perinuclear area. At 5h and 7h p.i. (c,d), 
BIGI is localized in the cytoplasm. Bar, 15 µm. 
 
3.4.3 Live imaging of TMEV-infected BHK-PDF18 cells 
BHK-PDF18 cells (section 3.1.5.3) were infected with TMEV GDVII and monitored every 
10 minutes for 24 hours. It can be observed that the Golgi complex turns from a solid, 
crescent-shaped organelle at the start of infection, into a series of punctuate fluorescent 
points (4h p.i.) forming an expanding balloon-like structure, surrounding the concomitantly 
expanding site of virus replication. The remnants of the Golgi complex are finally dispersed 
throughout the cytoplasm (6-8h p.i.). No rapid collapse of the Golgi complex back onto the 
ER can be observed (figure 3.41, supplementary material). The movie, provided on CD-
ROM, shows the complete sequence of the images. 
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Figure 3.41: Disassembly of the Golgi complex upon TMEV infection. BHK-PDF18 
cells were infected with TMEV and images were taken every 10 minutes for 24 hours. The 
figure shows selected images taken at the start of infection (a), 4h p.i. (b), 6 h p.i. (c), and 8 
h p.i. (d). For the complete sequence, see the movie. Bar, 15µm. 
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4. Discussion 
“The very essence of the virus is its fundamental entanglement with 
the genetic and metabolic machinery of the host.” 
American Nobel laureate Joshua Lederberg, 1993 
In the introduction, several examples of how positive stranded RNA viruses replicate in 
association with cytoplasmic membranes of infected cells were presented. Poliovirus 
protein 2C and its precursor 2BC seem to play an important role in the formation of 
membranous vesicles and therefore have a considerable effect on membrane trafficking in 
infected cells. I will describe the intracellular localization of TMEV protein 2C and the 
intracellular changes seen in TMEV infected cells. Furthermore, I suggest that the observed 
interactions of TMEV protein 2C with cellular proteins may cause some of the effects on 
membrane trafficking seen in infected cells. 
 
4.1. Intracellular localization of TMEV protein 2C 
4.1.1 Expression of TMEV protein 2C 
Localization of transiently expressed protein 2C tagged with the V5 epitope was not possible. 
The lack of detection of protein 2C is likely to result from either low levels of protein 
expression, suggesting expression of protein 2C may have a detrimental effect on cells, or rapid 
degradation of protein 2C after expression. It was demonstrated that the expression level of 
protein 2C was not altered by introducing mutations in the highly conserved Walker A and B 
motifs. Use of the lentivector, containing a different promoter for mammalian expression, also 
did not change transfection efficiency. Transient expression analysis of FMDV protein 2B and 
2C also resulted in very low expression levels. FMDV-2B could not be detected due to low 
levels of expression, probably due to cell toxicity (Garciá-Briones et al., 2006). Transfection 
efficiency improved when a modified FMDV protein 2B, including a tag was used (Moffat et 
al., 2005). FMDV-2C could be detected by western blotting and a typical 2C fluorescence 
signal could be observed in cells. However, the rate of expressing cells was very low, and the 
intensity of the fluorescence signal in positive cells was faint. Cells also showed an elongated 
morphology, suggesting that expression of 2C has a toxic effect on cell viability and cell 
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morphology (Garciá-Briones et al., 2006). An additional explanation for our results could be 
that the epitopes recognized by the anti-V5 antibody are masked. It is possible that TMEV 
protein 2C expresses, but that the conformation of the V5-tagged protein prevents the anti-V5 
antibody from binding to the V5 epitope. It was, however, demonstrated that in vitro coupled 
transcription/translation of the V5-tagged TMEV protein 2C results in expression of TMEV-2C 
detectable by using the anti-V5 antibody. 
 
The transfection efficiency of protein 2C is greatly improved when only the N-terminal 
60aa of protein 2C tagged with the V5 epitope, are used for transfection (Dr. Caroline 
Knox, personal communication). It has been shown that the N-terminal region of PV 
protein 2C (residues 1 to 122) is required for membrane association. It was predicted that 
the N-terminal region is composed of a number of α-helices, of which one is a conserved 
amphipathic helix essential for membrane association. The C-terminal region of PV protein 
2C (residues 252-329) also seems to include a conserved amphipathic helix, which is 
possible responsible for the membrane related activities of that part of protein 2C. The 
central region of PV protein 2C (residues 88 to 274) includes well-conserved NTP-binding 
motifs (Walker A and B motifs), and does not display any determinants for membrane 
association. Analysis of the different regions of PV protein 2C showed that the N- and C-
terminal region, but not the central region, interact with intracellular membranes and induce 
major changes in their morphology. However, when the central region was fused to the N-
terminal region, the membrane rearrangements induced were most similar to the smooth 
vesicles that proliferate in PV-infected cells. Mutation analysis has demonstrated that the 
NTP-binding activity is not required for vesicle induction (Teterina et al., 1997). The higher 
expression levels of TMEV protein 2C observed when only the N-terminal 60 residues of 
2C are used may be explained by the membrane rearrangements caused by the central 
region of protein 2C. The N-terminal region of protein 2C is required for membrane 
association; however, the membrane rearrangements induced by only this region may not 
be as detrimental as the ones induced by the full length protein. 
 
It was not possible to construct a full length infectious copy of TMEV containing the V5 
epitope at the C-terminus of protein 2C. Overlap PCR was used to try to introduce the V5-
epitope in the full length TMEV cDNA. Primers used for the overlap PCRs were found to 
be inadequate, possible due to inaccurate primer sequences. It was possible to construct a 
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2BC-V5-P3 fragment by using the pLH135 construct, previously made in our laboratory. 
The In-FusionTM PCR Cloning kit was then used, unsuccessfully, to insert the V5-tagged 
protein 2C into the full-length TMEV cDNA clone, possible due to using less than optimal 
conditions. A full length infectious TMEV copy containing the V5 epitope would be a 
useful tool to localize the V5-tagged protein 2C in the context of the other viral proteins. It 
would be possible to localize protein 2C and its precursor 2BC in infected cells, in 
association with the replication complex. The localization of TMEV protein 2C may differ 
in the context of other viral proteins compared to the localization of transiently expressed 
protein 2C. The effect of introducing the V5 epitope in the genomic cDNA on viral viability 
could also be ascertained. 
 
4.1.2 Localization of protein 2C upon TMEV infection 
4.1.2.1 Highly conserved protein 2C 
Protein 2C is the most conserved protein in the Picornavirus family and it was postulated that 
TMEV protein 2C may exhibit similar antigenic determinants to FMDV protein 2C. 
Therefore, anti-FMDV-2C antibodies were employed for detection and localization of TMEV 
protein 2C. The results demonstrated that TMEV-2C can be detected by anti-FMDV-2C 
antibodies; however, the interaction is highly non-specific. Furthermore, our results showed 
that the extra band observed in the gel profile of FMDV-2C, which is a result of internal 
initiation, is not detected by the DM10 antibody (figure 3.7, section 3.1.5.1). This suggests 
that the N-terminal region may contain an immuno-dominant epitope. It has been 
demonstrated that protein 2C is highly conserved across the Picornavirus family (Mirzayan 
& Wimmer, 1992). Protein 2C is completely conserved among the 3 serotypes of PV (Toyoda 
et al., 1984). Comparison of the amino acid sequence also demonstrated a high degree of 
homology over a region of 115 residues between other Picornaviruses, such as EMCV, PV, 
FMDV, RV-14 and RV-12 (Argos et al., 1984, Franssen et al., 1984, Pincus et al., 1986). 
Furthermore, it was observed that protein 2C contains an NTP-binding pattern, which is 
evolutionary conserved and can be found in several viral proteins (Gorbalenya & Koonin, 
1989, Klein et al., 1999). Comparative sequence analysis has identified 2C-like proteins in 
several virus families (figure 4.1). Analysis of the amino acid sequence of several animal 
Picornaviruses and Cowpea Mosaic virus (CPMV), a member of the Comoviruses, shows a 
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strong homology in the 2C region. CPMV contains a two-part genome consisting of an M-
RNA (middle component) and a larger B-RNA (bottom component), which are separately 
encapsidated. The B-RNA part encodes the viral non-structural proteins, including the 2C-
like protein p58 (Argos et al., 1984, Franssen et al., 1984). Potyviruses contain a 2C-like 
protein, the CI protein, which contains the conserved NTP-binding pattern (Lain et al., 1991). 
Furthermore, Caliciviruses contain a 2C-like protein with NTPase activity (Koonin & Dolja, 
1993, Kaiser et al., 2006). Several insect viruses, including Drosophila C virus, contain 2C-
like regions (Johnson & Christian, 1998, Sasaki et al., 1998, Nakashima et al., 1999). 
 
 
 
Figure 4.1: The 2C-like proteins. Protein 2C is highly conserved across the Picornavirus 
superfamily. The structural and non-structural protein regions of picornavirus-like viruses 
are shown. The 2C-like protein is indicated. 
 
4.1.2.2 Localization of TMEV protein 2C 
TMEV infection of BHK-21 cells resulted in a typical distribution of protein 2C detected 
with the anti-TMEV-2C antibody. At 1 hour post infection, newly synthesized protein 2C 
can be observed as tiny dots spread out in the cytoplasm. After 2 to 3 hours, a typical ER-
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like pattern can be seen, suggesting that viral protein synthesis occurs at the ER. Protein 2C 
then redistributes to accumulate in a juxtanuclear site, possible the Golgi complex area, 
suggesting that this may be the viral replication site. After 7 to 8 hours, this pattern can still 
be observed, but protein 2C also seems to spread out in the cytoplasm, suggesting a rapidly 
expanding viral replication site. During PV infection, no newly synthesized proteins could 
be observed 1 hour upon infection. After 1.5 hours, protein 2B could be observed spread 
out in the cytoplasm and 3 hours upon infection a feathery ER-like pattern could be seen, 
possible indicating viral translation at the ER. After 4 hours, vesicles containing viral 
proteins and negative stranded RNA arose that moved rapidly towards the nucleus to 
accumulate in a perinuclear area. These vesicles represent viral replication complexes, and 
migrate eventually to the microtubule organizing centre (MTOC), which contains the Golgi 
complex (Egger & Bienz, 2005). Furthermore, FMDV infection in BHK-21 cells resulted in 
a similar distribution for protein 2C. At 2 to 2.5 hours upon infection, protein 2C exhibited 
a punctuated, scattered pattern. After 3 hours, protein 2C appeared to concentrate at one 
side of the nucleus, which has been associated with the viral replication site (Moffat et al., 
2005, Garciá-Briones et al., 2006). Transfection with FMDV-2C resulted in a perinuclear 
distribution close to the Golgi complex, similar to that observed at early times upon 
infection (Knox et al., 2005, Garciá-Briones et al., 2006). Moreover, Human Parechovirus-
1 (HPEV-1) infection also showed a comparable localization of protein 2C. Early upon 
infection (4h p.i.), protein 2C was found in numerous small granules in the cytoplasm. After 
6 hours, the pattern of protein 2C was changed drastically into dot- and stick-like 
formations concentrating in a perinuclear area or accumulating on one side of the cell. At 8 
hours p.i., protein 2C was still presented in long stick-like structures, and after 10 hours as 
irregular bodies (Krogerus et al., 2003). 
 
TMEV infection of the BHK-PDF18 stable cell line resulted in a typical disassembly of the 
Golgi complex and localization of protein 2C showed an overlap with the Golgi complex. 
At 1 hour upon infection, little newly synthesized protein 2C was observed scattered 
throughout the cytoplasm and an intact Golgi complex is seen. After 5 hours, protein 2C is 
accumulated at one side of the nucleus, near a dispersed Golgi complex, which has changed 
from a solid crescent shape into a series of punctuate dots forming a balloon-like structure. 
At 8 hours p.i., the remnants of the Golgi complex are dispersed throughout the cytoplasm. 
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Some overlap between protein 2C and the Golgi complex can be observed, however the 
superimposed images show two separate signals for protein 2C and the Golgi complex. This 
suggests that protein 2C may play a role in the viral replication complexes that form near 
the Golgi complex. However, the source of the membranous vesicles, which contain the 
replication complexes, may not be the Golgi complex. Similar observations were made for 
FMDV protein 2C. FMDV protein 2C is membrane-associated but does not fractionate with 
Golgi markers on density gradients, suggesting that the Golgi complex is not a source for 
the structures containing protein 2C, or, that the used Golgi markers are excluded. 
Furthermore, FMDV protein 2C did not co-localize with marker proteins for the Golgi 
complex, the ER, the ERGIC, endo- and lysosomes. Golgi markers and protein 2C largely 
overlap but merged immunofluorescence images show no co-localization. This suggests 
that the juxtanuclear distribution of protein 2C is not maintained by association with the 
Golgi complex (Knox et al., 2005, Garciá-Briones et al., 2006). Poliovirus replication 
complexes contain all viral structural and non-structural proteins, including protein 2C 
(Girard et al., 1967, Takegami et al., 1983, Takeda et al., 1986, Bienz et al., 1992, Pfister et 
al., 1992, Egger et al., 1996, 2000). PV induced membranous vesicles are initially formed 
from ER membranes (Bienz et al., 1987). At later times in infection, PV proteins co-
localize with Golgi markers (Bolten et al., 1998). Furthermore, virus induced membranes 
isolated from PV-infected cells contained marker proteins for the ER, Golgi, and lysosomes 
(Schlegel et al., 1996). 
 
4.2. Interaction of TMEV protein 2C with host cell proteins 
It was not possible to identify interactions of transiently expressed protein 2C with host cell 
proteins due to very low transfection efficiency, as measured by expression. Transfection of 
different mammalian cell lines did not result in expression levels of protein 2C detectable by 
western blotting. As it was possible to express TMEV protein 2C in vitro by using the T7 
promoter, BSR-T7 cells, a cell line that constitutively expresses the T7 polymerase, were used 
to transiently express protein 2C. No expression of protein 2C was detected. Furthermore, 
introduction of a TAP-tag at the N- or C-terminus of protein 2C does not alter the level of 
expression, suggesting that protein 2C may be degraded as discussed previously (section 4.1.1). 
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4.2.1 Interaction of protein 2C with reticulon 3 
It was shown that reticulon 3 (RTN3) binds TMEV protein 2C (figure 3.19, section 3.2.4), 
which suggest a function for RTN3 in viral replication. RTN3 is a member of a widely 
distributed family of highly conserved ER-associated proteins with a reticular distribution (van 
de Velde et al., 1994, Oertle et al., 2003a). Reticulon/Nogo was first described as a 
neuroendocrine-specific protein (Roebroek et al., 1993). Four genes have been identified in 
mammals: RTN1, 2, 3, and RTN4/Nogo, and each of them can produce multiple N-terminal 
isoforms as a result of differential promoter usage or alternative splicing (Oertle et al., 2003b). 
The N-terminal region is highly variable and different in size, whereas the C-terminal region is 
well conserved among family members. RTN1-4 share an 188aa domain localized in the C-
terminal region, called the RTN homology domain (RHD). The RHD contains two potential 
transmembrane domains and a 66aa hydrophilic loop, which was called Nogo66 for 
RTN4/Nogo (Oertle et al., 2003a). The functions of RTNs remain largely unknown. It has been 
demonstrated that RTN4/Nogo exhibits a potent inhibitory effect on neurite outgrowth and is 
involved in restricting neuronal regeneration in the central nervous system (Chen et al., 2000, 
GrandPré et al., 2000, Prinjha et al., 2000, reviewed by Oertle & Schwab, 2003). These 
functions are however not common to other RTNs. They have been linked to a variety of 
proteins. Nogo-A is expressed in association with α-tubulin and myelin basic protein in mature 
oligodendrocytes of rat spinal cord (Taketomi et al., 2002). Nogo has also been linked to 
mitochondrial proteins (Hu et al., 2002). Furthermore, it has been suggested that RTNs can 
modulate the anti-apoptotic activity of Bcl-XL and Bcl-2 through interaction and relocalization 
to the ER (Tagami et al., 2000), meaning that RTNs might be involved in the regulation of cell 
survival. Caenorhabditis elegans RTN interacts with RME-1, a protein functioning in the 
endocytic recycling, during embryogenesis, suggesting that RTN functions in the endocytic 
pathway (Iwahashi et al., 2002). RTN1-C interacts with SNARE proteins, suggesting that 
RTNs are involved in membrane trafficking including exocytosis (Steiner et al., 2004). The 
accumulation of RTNs in the ER suggests an intracellular function related to the ER. 
 
The role of RTN3 in membrane trafficking has been investigated. It has been demonstrated 
that RTN3 is involved in membrane trafficking in the early secretory pathway. Expression 
of full-length RTN3 displayed heterogenous patterns: a filamentous/reticular pattern, which 
substantially overlaps with microtubules, and a granular distribution, which reflects 
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aggregated ER. The N-terminal cytoplasmic region within the RHD is required for the 
formation of the filamentous/reticular pattern. However, both the N- and C-terminal 
cytoplasmic regions within the RHD are necessary for the formation of the granular pattern. 
Overexpression of full-length RTN3 caused dispersion of Golgi proteins and blockage of 
antero- and retrograde protein transport between ER and Golgi. ERGIC-53, a marker for the 
ER-Golgi intermediate compartment, showed a perinuclear accumulation with loss of 
peripheral ERGIC-53 localization, suggesting an inhibition of retrograde transport from the 
ER-Golgi intermediate compartment (ERGIC) and cis-Golgi to the ER. However, two other 
recycling proteins, the KDEL-receptor and gp27, were dispersed. Transport of VSVG-GFP 
from ER to Golgi was also blocked by overexpression of RTN3 (Wakana et al., 2005). 
 
It has recently been demonstrated that RTN3 binds the 2C protein of Enterovirus 71 (EV-
71), and is required for viral replication (Tang et al., 2007). The host-encoded RTN3 was 
found to be associated to the viral replication complex through direct interaction with the 
EV71 protein 2C. It was observed that the N-terminal region of protein 2C, featuring both 
RNA- and membrane-binding activity, interacts with RTN3. The region of interaction was 
mapped to the RHD region of RTN3. However, the N-terminal region of RTN3 might play 
a role in regulating the interaction. Decreased production of RTN3 reduced the synthesis of 
EV71-encoded viral proteins and replicative double-stranded RNA. RTN3 seems to play an 
important role in EV71 replication, through potential modulation of the interaction between 
viral RNA and replication complex (Tang et al., 2007). 
 
Interaction of RTN3 with the 2C proteins encoded by different Enteroviruses, such as EV71, 
PV, and coxsackievirus A16 (Tang et al., 2007), and TMEV (section 3.2.4), suggest it is a 
common factor in viral replication of Picornaviruses. PV infection involves complex 
membrane rearrangements and the formation of replication complex-associated vesicles. 
These vesicles are derived mainly from the ER, but also possibly from the Golgi-complex. 
Protein 2C can bind to cellular membranes and induce vesicle formation through the N-
terminal amphipatic region (Dales et al., 1965, Bienz et al., 1983, 1987, Cho et al., 1994, 
Suhy et al., 2000). A mutant (I25K) of PV 2C showed a reduction in negative RNA synthesis 
(Paul et al., 1994). When this mutation was introduced into EV71 2C, no interaction between 
2C and RTN3 was detected, suggesting that the decrease in viral RNA synthesis was caused 
by the loss of the RTN3-2C interaction (Tang et al., 2007). The interaction of protein 2C with 
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RTN3 is another indication that protein 2C interferes with the membrane trafficking in 
infected cells. It has been demonstrated that a member of the RTN family interacts with 
SNARE proteins (Steiner et al., 2004). RTN3 may exhibit similar interactions. SNARE 
proteins participate in COPII vesicle formation (Springer & Schekman, 1998). Furthermore, it 
has been shown that PV replication complex-associated vesicles are derived from the ER by 
the COPII budding mechanism and are similar to the vesicles of the secretory pathway (Rust 
et al., 2001). The interaction between 2C and RTN3 may be necessary for the formation of 
vesicles via a COPII-dependent pathway. 
 
4.2.2 Interaction of protein 2C with AKAP10? 
4.2.2.1 In vitro interaction of protein 2C and AKAP10? 
Knox and colleagues (submitted) demonstrated that the N-terminal part of FMDV protein 2C 
binds to the C-terminal region of AKAP10, also called D-AKAP2, and competes with the RII 
regulatory subunit of PKA (figure 4.2). The binding of AKAP10 was also observed for 2C 
proteins derived from other Picornaviridae, including TMEV (Knox et al., submitted). A 
yeast two-hybrid screen was employed to identify cellular proteins that possible interact with 
protein 2C. The C-terminal region of AKAP10 was identified by interaction with FMDV 
protein 2C. To confirm this interaction, the C-terminal 52aa of AKAP10 (IAP3) were 
expressed as a GST-fusion protein (GST-IAP3), purified onto glutathione sepharose beads 
and tested for its ability to bind in vitro translated FMDV protein 2C. The regulatory subunit 
type IIα which binds AKAP10, was also tested for binding to GST-IAP3. Both FMDV-2C 
and RIIα interact in vitro with GST-IAP3. Protein 2C and RIIα share an identical 28aa 
binding domain on GST-IAP3, suggesting that the two proteins compete for binding to 
AKAP10. This was confirmed using a competition binding assay (Knox et al., submitted). 
This suggests that protein 2C may exhibit a similar conformation to PKA to bind AKAP10. 
Figure 4.3 shows a model of the binding of the dimer of regulatory subunits of PKA to 
AKAP10. The binding site seems to be formed by α-helices within the regulatory subunits of 
PKA. It has been predicted that the N-terminal region of protein 2C, which has been 
identified to bind to AKAP10, is composed of a number of α-helices (Teterina et al., 1997), 
which may contribute to the interaction with AKAP10. As described in section 3.2.4, the 
interaction between TMEV protein 2C and AKAP10 could not be confirmed. TMEV protein 
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2C was expressed as a GST-fusion protein, purified on glutathione sepharose beads and tested 
for its ability to bind in vitro translated AKAP10. No in vitro interaction between AKAP10 
and GST-2C could be observed. 
 
 
 
Figure 4.2: Competition between PKA and picornavirus protein 2C for binding to 
AKAP10. PKA consists of two regulatory subunits and two catalytic subunits. AKAP10 is a 
PKA anchoring protein, targeting PKA to intracellular membranes. AKAP10 is known to 
interact with the RIIα subunit of PKA. Protein 2C competes with this interaction. 
 
The N-terminus of protein 2C was identified as the binding site of AKAP10 (Knox et al., 
submitted). The fusion of GST to protein 2C at the N-terminus of 2C might interfere with 
the interaction. “Unidirectional” interactions have previously been observed and are likely 
to reflect conformational constraints of the interactions. The polarity of the interaction may 
be explained by the possibility that the interacting fusion protein is misfolded. The fusion at 
the N-terminus, which harbors the binding site, may interfere with the overall structural 
integrity of protein 2C. This “unidirectionality” has been observed for protein interaction 
mapping of viruses. A unidirectional interaction was seen between calicivirus proteins p76 
and p32 (Kaiser et al., 2006). Furthermore, an in vitro binding assay using PV P2 
nonstructural proteins, identified a 2C/2C association not detected using a yeast two-hybrid 
system (Cuconati et al., 1998). Various two-hybrid studies demonstrated that the two-
hybrid system never detects all physiological interactions, and the failure of an in vitro 
binding assay does not necessarily indicate that the interactions are false, as structural 
constraints might play a role (reviewed by Uetz et al., 2007). Interestingly, the N-terminal 
region of protein 2C has also been identified as the binding region of RTN3 (Tang et al., 
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2007); however, the fusion of GST to the N-terminal part of TMEV protein 2C does not 
interfere with the interaction with RTN3. To resolve the discrepancy observed for the 
interaction between TMEV 2C and AKAP10, the binding assay with AKAP10 would have to 
be repeated in parallel with FMDV-2C expressed as a GST-fusion protein to determine if the 
polarity of the interaction also interferes with the interaction between FMDV-2C and 
AKAP10. Furthermore, it would be interesting to carry out competition binding assays with 
RTN3 and AKAP10 to determine if TMEV protein 2C is most likely to interact with RTN3 
or AKAP10 when both proteins are present. 
 
 
 
Figure 4.3: Illustration for the interaction between AKAP10 and PKA. The regulatory 
subunits of PKA (red and pink) form a dimer and interact with AKAP10 for membrane 
targeting. The possible interaction site for AKAP10 is indicated. 
 
A kinase anchoring proteins (AKAPs) are multifunctional proteins that function as targeting 
units and recruit PKA by binding to a specific docking domain at the N-terminus of the R 
subunit (Newlon et al., 1997). PKA consists of two regulatory (R) subunits and two 
catalytic subunits. Two types of R subunits have been identified; RI and RII (figure 4.2). 
Dual specific AKAPs (D-AKAPs) interact with both RI and RII. The members of the 
AKAP family have been localized to different subcellular sites such as the plasma 
membrane, the actin cytoskeleton, the nucleus, the mitochondria and the ER (Huang et al., 
1999, reviewed by Colledge & Scott, 1999). Huang and colleagues (1997) identified the 
mouse D-AKAP2 (AKAP10). It contains a C-terminal PKA binding region that binds RIα, 
RIIα, RIIβ but not RIβ in vitro, and a putative regulator of G protein signaling (RGS) 
domain (Huang et al., 1997). The human D-AKAP2 contains an additional putative RGS 
domain (Wang et al., 2001). 
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The subcellular localization of PKA through AKAPs is believed to be responsible for the 
specificity of the cAMP signaling pathway. PKA has been localized to ER and Golgi 
complex (Nigg et al., 1985, Rios et al., 1992, Keryer et al., 1999). Protein phosphorylation 
by PKA is important for regulating membrane trafficking. Protein transport from ER to 
Golgi complex is regulated by phosphorylation (Davidson et al., 1992). Furthermore, PKA 
plays a role in budding and transport of vesicles across the Golgi stacks and from the trans-
Golgi-network to the plasma membrane (Ohasi & Huttner, 1994, Muniz et al., 1996, 1997). 
PKA is moreover involved in exo-, endo-, and transcytosis, and endosome fusion 
(Woodman et al., 1992, Eker et al., 1994, Hansen & Casanova, 1994, Takuma & Ichida, 
1994b). The binding of Arf1, a GTP-binding protein required for the formation of COP-
coated vesicles, to Golgi membranes is enhanced by PKA (Martin et al., 2000). It has also 
been observed that COPII recruitment and export from the ER is initiated by PKA signaling 
(Aridor & Balch, 2000). Phosphorylation by PKA of specific SNARE proteins may play an 
important role in exocytosis (Foster et al., 1998, Marash & Gerst, 2001). 
 
PV protein 2C seems to be involved in the perturbation of the host-cell membrane traffic and 
the formation of virus-induced vesicles (Bienz et al., 1983, 1990, 1992, Cho et al., 1994, 
Aldabe & Carrasco, 1995, Teterina et al., 1997). Protein 2C binds to membranes and this 
interaction is mediated through its N-terminus (Echeverri & Dasgupta, 1995, Kusov et al., 
1998). The N-terminal part has also been found to be the binding site of the membrane 
protein AKAP10 (Knox et al., submitted). Protein 2C and PKA RIIα share an identical 
binding domain on AKAP10. The redistribution of PKA induced by the binding of AKAP10 
to protein 2C may explain the effect on membrane trafficking seen during infection. 
 
4.2.2.2 Mutations in the AKAP10 binding region 
Mutations have been introduced at several sites within the N-terminal region of TMEV 
protein 2C, which has been identified as the binding region for AKAP10. The amino acids at 
position 4, 8, 14, 18, and 23 were changed into alanines. After sequencing it was observed 
that the original pGDVII-mut14 construct did not contain the desired mutation. Transfection 
of the TMEV mutant RNAs resulted in dramatic differences in the onset of CPE compared to 
wild type TMEV. The cell culture supernatants were used for infection and were furthermore 
examined by plaque assay. TMEV mutant 4, mutant 8, and mutant 23 did not show a typical 
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CPE after transfection, and no plaques could be observed after titration. TMEV mutant 18 
showed typical CPE after transfection, and plaques were observed after titration. Infection of 
BHK-21 cells using the cell culture supernatants also resulted in CPE as seen in a wild type 
infection, albeit some retardation in the onset of CPE could be observed. 
 
TMEV mutant 4, 8, and 23 seem to have an important effect on virus replication. Viral RNA 
can be rescued from the cell culture supernatant after transfection. Sequencing results showed 
that TMEV mutant 4 and 8 still contained the desired mutation. The mutations introduced in 
position 4 and 8 of protein 2C might interfere with the binding of AKAP10. It has been 
shown that the first 20aa are sufficient for binding to IAP3 (Knox et al., submitted). The N-
terminal region of protein 2C has been identified to play an important role in membrane 
binding of protein 2C (Echeverri & Dasgupta, 1995, Kusov et al., 1998). The alanine 
substitutions may result in a less tightly membrane associated protein 2C, which may have 
major implications for virus replication. This was also observed for the alphavirus membrane 
associated protein nsP1. When the cystein residues (418-420), responsible for the very tight 
binding to membranes of Semliki Forest virus nsP1 protein, were mutated to alanines, nsP1 
was still membrane associated, but less tightly (Laakkonen et al., 1996). Furthermore, it has 
been observed that PV protein 2C may play a role in determining virion structure (Li & 
Baltimoree, 1990). It has been postulated that viral RNA replication and virion assembly are 
coupled processes which occur in association with membranes (Calguiri & Compans, 1973). 
Protein 2C is tightly associated with membranes, suggesting it could function during 
encapsidation of viral RNA (Vance et al., 1997). As it was possible to rescue viral RNA of 
TMEV mutant 4 and 8 but no viral particles, these mutants of protein 2C might also interfere 
with the encapsidation of viral RNA. 
 
TMEV mutant 23 however does not contain the desired mutation after transfection, as 
confirmed by sequencing. The dramatic effect on the onset of CPE might be caused by 
second-site mutations that occurred during viral replication. RNA viruses show high 
mutation rates partly caused by the lack of exonuclease proofreading activity of the virus-
encoded RNA polymerases. New viral genetic variants are constantly created to adapt to 
changing environmental conditions. Beneficial mutations needed for adaptation are quickly 
identified (reviewed by Holland et al., 1982, Elena & Sanjuán, 2005). This might also 
explain the disappearance of the introduced mutation in TMEV mutant 18, which acts as 
wild type TMEV. 
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4.2.2.3 Intracellular localization of IAP3 
Transfection of BHK-21 cells with the pGFP-IAP3 construct resulted in a granular pattern 
spread out in the cytoplasm, which seems to be similar to the mitochondrial localization 
previously observed for full length AKAP10 (Wang et al., 2001). IAP3 consists of the C-
terminal 52aa of AKAP10. The C-terminal 40 residues of AKAP10 were shown to be 
responsible for the interaction with the R subunits of PKA. AKAP10 binds to both RI and RII 
subunits (Huang et al., 1997). Wang and colleagues (2001) have observed that AKAP10 (D-
AKAP2) is enriched in mitochondria, together with cytochrome c, a mitochondrial marker. In 
addition to the mitochondrial staining, subcellular localization of AKAP10 also reveals a low 
level diffuse background signal and low levels of nuclear staining, suggesting the existence of 
multiple pools of AKAP10 (Wang et al., 2001). Furthermore, D-AKAP1 has also been 
localized to mitochondria (Huang et al., 1999). The primary function of AKAPs is to target 
PKA to specific subcellular locations. PKA protein or enzymatic activity has been associated 
with mitochondria (Kleitke et al., 1976, Dimino et al., 1981, Burgess & Yamada, 1987, 
Muller & Bandlow, 1987). Furthermore, it has been demonstrated that cAMP can be 
transported into mitochondria (Kulinskii et al., 1981, Kulinskii & Zobova, 1985). PKA has 
moreover been associated with mitochondrial respiration (Papa et al., 1999, Qu et al., 1999). 
Mitochondria are also involved in triggering the apoptotic pathway (Kroemer, 1999, reviewed 
by Waterhouse & Green, 1999). 
 
TMEV protein 2C binds AKAP10 and may therefore be localized to the mitochondria in 
infected cells. PKA, which has been associated with mitochondria, may be redistributed in 
the cell caused by the interaction of protein 2C and AKAP10. This may have important 
implications for the mitochondrial pathway of apoptosis. Interaction of protein 2C with 
AKAP10 may prevent the triggering of the apoptotic pathway. Furthermore, enterovirus 
protein 2B is involved in suppressing apoptosis of the infected cells. Protein 2B forms pores 
in ER and Golgi membranes, which results in a decrease of ER and Golgi Ca2+ content, which 
in turn reduces the Ca2+ accumulation in the neighboring mitochondria. The disturbance of 
the intracellular Ca2+ homeostasis is probably involved in this anti-apoptotic function, as it 
has been shown that Ca2+ fluxes between ER and mitochondria play an important role in ER-
dependent apoptosis (Campanella et al., 2004, reviewed by van Kuppeveld et al., 2005). 
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4.3. Expression of TMEV protein 2C in E. coli 
The results demonstrated that we were able to express TMEV protein 2C in E. coli as a fusion 
protein to the GST-tag, as well as the MBP-tag. This allowed us to purify TMEV protein 2C in 
order to have a polyclonal antibody made against protein 2C. The anti-TMEV-2C antibody has 
been proven to be adequate for immunoprecipitation and immunofluorescence experiments. 
However, the anti-TMEV-2C antibody showed some non-specificity when used for western 
blotting, suggesting that purification of the antibody might be desirable. It was observed that 
fusion to a His-tag did not result in expression of protein 2C. Furthermore, the precursor 2BC 
could not be expressed in E. coli. It has been demonstrated that TMEV proteins 2B and 2C 
contain hydrophobic domains and are tightly membrane bound, which can interfere with 
expression. Protein 2C can be expressed as a fusion to the GST-tag and the MBP-tag, which 
suggests protein 2C may be less toxic for the E. coli cells than protein 2B. However, when 
fused to the His-tag, protein 2C can not be expressed. This suggests that the size of the tag 
fused to protein 2C plays a role in the expression. A larger tag may change the structure of the 
fusion protein, and therefore the effect of expression of the protein on the E. coli cells. The lack 
of expression observed for the precursor 2BC, may be caused by the high toxicity of protein 
2B. Previous efforts to express PV protein 2B and 2C at high levels in E. coli cells have been 
proven difficult. It was observed that PV protein 2B is toxic for E. coli and lysed the cells upon 
production. Protein 2B contains two hydrophobic regions: an amphipathic α-helix and a 
potential transmembrane domain with a β-sheet configuration (Teterina et al., 1997). 
Expression of protein 2B can only be tolerated for a very limited period of time before drastic 
changes in membrane permeability eventually cause cell lysis. Protein 2C is also hydrophobic 
and associated to membranes and therefore toxic; however expression can be tolerated for 
longer. High levels of expression of protein 2C do not seem to modify membrane permeability 
and do therefore not cause lysis of E. coli cells (Lama & Carrasco, 1992, Lama et al., 1992). 
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4.4. TMEV infection and its effect on membrane trafficking 
4.4.1 Cytoskeleton 
The cytoskeleton, contained within the cytoplasm, is a dynamic structure that maintains cell 
shape, enables cellular motion, and plays important roles in both intracellular trafficking 
and cellular division. The cytoskeleton consists of three main components: actin filaments, 
intermediate filaments, and microtubules. The actin and microtubule cytoskeleton play a 
major role in the entry, replication and egress of viruses. Viruses induce rearrangements of 
the cytoskeleton by interfering with cellular signaling pathways to support infection. The 
actin and microtubule transport systems and their motor proteins are employed by viruses to 
move to different subcellular sites, which provide the optimal molecular environment for 
uncoating, replicating and packaging of the viral genome. Furthermore, it has been 
demonstrated that microtubule motors, kinesin and dynein, and the actin filament motor, 
myosin, cooperate and that their coordinated activity is essential for organelle motility 
(reviewed by Langford, 1995, Rogers & Gelfand, 1998). The effect of TMEV infection on 
actin filaments and microtubules was investigated by means of cellular markers for actin 
and tubulin. The preliminary results suggest that TMEV infection causes both cytoskeleton 
components to accumulate at the cellular membrane, creating a hollow area which is 
thought to represent the expanding viral replication site. This suggests that cytoskeletal 
integrity may not be necessary for TMEV infection, as was previously shown for poliovirus 
(Doedens et al., 1994). 
 
4.4.1.1 Actin filaments 
The actin cytoskeleton plays a critical role in cell migration, and mediates several 
intracellular transport processes, based on controlled actin polymerization or on myosins, 
which translocate along actin filaments upon ATP hydrolysis. The actin-myosin system has 
been implicated in membrane trafficking (reviewed by Goodson et al., 1997). Viruses have 
evolved the capacity to use the host actin cytoskeleton to promote their own motility during 
infection. Actin is an ATP-binding protein that exists in two forms, monomers (G-actin) 
and double helical polymers or filaments (F-actin). Actin filaments are built by head-to-tail 
assembly of polar monomeric actin. The resulting filaments are characterized by a fast 
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growing plus-end and a slow growing minus-end. The processes of actin poly- and 
depolymerization are regulated by numerous actin-binding proteins. They allow the cell to 
modulate actin assembly based on external and internal stimuli. Actin is present throughout 
the cytoplasm but the highest concentration of actin is directly underneath the plasma 
membrane, where it forms the actin cortex. Several viral proteins are known to interact with 
actin-binding proteins, and are therefore able to control actin poly- and depolymerization to 
support their own motility (reviewed by: Gouin et al., 2005, Radtke et al., 2006). 
 
The actin-cytoskeleton plays an important role in the life-cycle of a number of viruses. 
They interact with the actin filaments at various stages during infection, disrupting and 
rearranging the actin filaments to their own advantage. Furthermore, the infectious particles 
of several viruses, such as Retro-, Picorna-, and Herpesviruses, contain actin (Grigera et 
al., 1988, reviewed by Cudmore et al., 1997, Newman & Brown, 1997, Grünewald et al., 
2003, Johannsen et al., 2004). The actin cytoskeleton dramatically changes during vaccinia 
infection. The Vaccinia virus induces disassembly of actin stress fibers and formation of 
actin tails to allow efficient egress and intracellular spread. The polymerization of actin 
filaments is promoted by the virus, probably by recruiting host proteins that are associated 
with the actin cytoskeleton (reviewed by Cudmore et al., 1997, Higley & Way, 1997, 
Wolffe et al., 1997, Roper et al., 1998). The polymerization of actin filaments is probably 
used to propel viruses from cell to cell (reviewed by Smith & Enquist, 2002). Retrovirus 
infection results in a rapid loss of cytoskeletal integrity, and in addition they have been 
shown to depend on actin filaments for the completion of their infectious life cycle. The 
budding process may be dependent on actin (reviewed by Cudmore et al., 1997). The HIV 
Gag protein has been identified as necessary and sufficient for viral budding, and has been 
associated with the actin cytoskeleton (Rey et al., 1996). Furthermore, the HIV protein Nef 
has been shown to increase infectivity, probably by interacting with proteins involved in 
actin cytoskeleton rearrangements (Campbell et al., 2004). It has also been shown that HIV 
infection is less effective after inhibiting actin polymerization (Komano et al., 2004). 
Recently, it was observed that rotavirus infection and replication leads to rearrangements of 
the cytoskeleton with disorganization of cytoskeletal elements, such as actin, through a 
calcium-dependent process. The NSP4 protein may play a role in these calcium-dependent 
actin rearrangements (Berkova et al., 2007). 
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TMEV may use the actin cytoskeleton early in infection for intracellular transport. At later 
stages of infection actin appears to disappear from the cytoplasm and accumulate at the 
plasma membrane. This suggests that actin is no longer needed for viral replication. A 
hollow area is created within the cell, which we believe represents the expanding viral 
replication site. It is not known in which way TMEV could induce actin rearrangements. 
Actin reorganizations may be caused by interactions of viral proteins with actin-binding 
proteins. It has been previously observed that HPEV-1 protein 2C does not co-localize with 
actin (Krogerus et al., 2003). This suggests that protein 2C does not bind to actin, however 
it does not rule out a possible function of protein 2C in the actin rearrangements. Protein 2C 
may interact with actin-binding proteins that regulate the process of actin poly- and 
depolymerization. Furthermore, it is possible that the actin rearrangements are calcium-
dependent. Protein 2B forms pores in ER and Golgi membranes (reviewed by van Kuppeveld 
et al., 2005), which results in the disturbance of the intracellular Ca2+ homeostasis, which 
may be involved in the redistribution of actin in infected cells. 
 
4.4.1.2 Microtubules 
Microtubules are an important component of the cytoskeleton of the cell, and they play a vital 
role in the control of cell morphology and function. They help to organize membranous 
organelles during interphase and comprise the mitotic spindle of a dividing cell. They help to 
maintain the shape and the internal arrangements of the cell, and delineate tracks along which 
membrane organelles are transported during exo- and endocytosis. Intact microtubules are 
also required for preservation of the normal structure and function of the Golgi complex. 
Microtubules are composed of α/β-tubulin dimers and several microtubule-associated 
proteins (MAPs; reviewed by Thyberg & Moskalewski, 1999). Some of the dynamic 
properties of microtubules can be accounted for by the intrinsic properties of the α/β-tubulin 
heterodimer. Microtubules undergo periods of growth and shrinkage and can switch rapidly 
between these two states (Mitchison & Kirschner, 1984). This dynamic instability is a result 
of the GTP hydrolysis by tubulin (Caplow & Shanks, 1996, Desai & Mitchison, 1997). A 
variety of proteins have also been purified that modulate the dynamic behaviour of 
microtubules. Some of these microtubule-associated proteins stabilize the microtubules, while 
others promote destabilization. The destabilization and disassembly of microtubules are 
necessary for cell processes such as mitosis. Microtubules transport membrane bound 
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organelles and other structures by using motor proteins. Kinesin and dynein are the two main 
microtubule associated motors. Kinesin serves plus-end directed transport, towards the 
plasma membrane, while dynein serves minus-end transport, towards the centrosome, which 
regulates to a large extent the distribution of microtubules. Both motor proteins have been 
shown to bind to the Golgi complex (reviewed by Thyberg & Moskalewski, 1999). 
 
A computer-based analysis has demonstrated that TMEV protein 2C is highly similar to 
katanin, a member of the AAA ATPase superfamily (figure 3.32, section 3.4.1). Katanin is 
a heterodimeric, ATP-dependent, microtubule-severing protein first purified from sea 
urchin eggs (Strongylocentrotus purpuratus; figure 4.4). It has a microtubule-stimulated 
ATPase activity and hydrolysis of ATP is required for the microtubule-severing reaction. 
Katanin is also known to disassemble stable microtubules to form polymerisation-
competent tubulin subunits (McNally & Vale, 1993). It is a heterodimer of 60 and 80 kDa 
subunits, which is highly concentrated at centrosomes throughout the cell cycle (McNally et 
al., 1996). The p60 subunit is a novel member of the AAA ATPase superfamily. Sequence 
analysis of p60 revealed an ORF that encodes a 516aa polypeptide, which contains a C-
terminal domain that is highly conserved in the AAA ATPase superfamily. This region 
contains the “Walker A” and “Walker B” motifs found in many ATPases. Consistent with 
the finding of an AAA domain in its sequence, p60 displayed a microtubule-stimulated 
ATPase activity. Furthermore, p60 exhibits a microtubule-severing activity. Both p60 
activities are displayed even in the absence of the p80 subunit (Hartman et al., 1998). It has 
also been demonstrated that the p60 subunit of katanin oligomerizes in an ATP- and 
microtubule-dependent manner. Oligomerization increased the affinity of katanin for 
microtubules and stimulated its ATPase activity. After ATP hydrolysis, microtubule-bound 
katanin oligomers disassembled microtubules and then dissociated into free katanin 
monomers (Hartman & Vale, 1999). Sequence analysis of the p80 subunit revealed a 
predicted 690aa polypeptide that contains six “WD40” repeat motifs. The WD40 repeats in 
several proteins have been documented to participate in protein-protein binding interactions 
(Komachi et al., 1994; Wall et al., 1995). Two functional domains of p80 were postulated. 
It is thought that p80 may be involved in heterodimerization with p60. Furthermore, p80 
could contain a domain that interacts with a centrosomal protein. The six WD40 repeats in 
p80 represent a good candidate domain for participating in either dimerization or 
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centrosome targeting. Hartman and colleagues showed that the WD40 repeats are not 
required for dimerizing the two katanin subunits, but they have uncovered a role for the 
WD40 domain of p80 in targeting katanin to centrosomes in vivo (Hartman et al., 1998). 
 
 
 
Figure 4.4: Illustration of the microtubule-severing activity of katanin. The p60 and 
p80 subunit of katanin oligomerize to form a hexamer, which disassembles microtubules in 
an ATP-dependent manner. 
 
We aspired to establish a stable cell line constitutively expressing fluorescent microtubules to 
observe the effect of TMEV infection and in particular protein 2C on microtubules. We were 
not able to establish a stable cell line, possibly because polymerization of a tubulin fusion 
protein into microtubules is not feasible. Therefore we employed a cellular marker for tubulin 
to determine the effect of TMEV infection on microtubules. Our preliminary results suggest 
that microtubules, like actin filaments, cluster near the plasma membrane creating a hollow 
area representing the viral replication site. It is possible that protein 2C exhibits a similar 
function to katanin. Protein 2C may induce the disassembly of microtubules, resulting in 
monomeric tubulin, which is redistributed to the verge of the infected cell caused by the 
expansion of the viral replication site. The dissociation of the microtubules may play a role in 
the disassembly of the Golgi complex during infection, as discussed in section 4.4.2. 
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Furthermore, it is possible that other viral proteins interact with microtubules or MAPs, and 
therefore cause the microtubule rearrangement observed during infection. 
 
Many viruses require microtubules for efficient replication. Microtubules are required 
during cell entry, for efficient nuclear targeting, and for cytosolic transport of the viral 
genome-protein complex. Microtubule motors are known to catalyze the intracellular 
transport of many viral structures. Viruses make use of the cytoplasmic membrane traffic; 
endocytosis for entry, and exocytosis for egress. Furthermore, it has been demonstrated that 
depolymerization of microtubules results in reduction of the viral yield, probably because 
free diffusion in the cytoplasm is then used for viral distribution. Viral proteins also interact 
directly with the microtubule motors dynein or kinesin. Dynein transports viral particles to 
the MTOC during virus entry and assembly. Viral proteins interact with kinesin during 
assembly and egress, and kinesin may also catalyze transport from the MTOC to the 
nucleus during entry (reviewed by: Döhner et al., 2005, Greber & Way, 2006). Herpes 
Simplex virus (HSV) infection results in the loss of the radial organization of microtubules. 
Microtubules are redistributed to the cell periphery and the MTOC disappears. The 
reorganization of the microtubule network seems to facilitate the nuclear localization of 
VP22, a major virion phosphoprotein (Kotsakis et al., 2001). Furthermore, it has been 
demonstrated that axonal HSV progeny capsids colocalize with kinesin-1 (Diefenbach et 
al., 2002). The Gag polyprotein of many Retroviruses contains a matrix protein that has 
been shown to interact with kinesin-4. This interaction may play a role in the transport of 
subviral particles to the plasma membrane for virus budding (Tang et al., 1999). 
Adenoviruses deliver their genomes to the nucleus after entry into the cell. They travel 
along the microtubule cytoskeleton towards the nucleus, using the microtubule motor 
dynein (Bailey et al., 2003). The microtubule cytoskeleton also plays an important role 
during influenza infection. Drug-induced microtubule depolymerization results in a random 
distribution of the nucleoprotein in the cytoplasm, and interferes with the normal polarized 
delivery and segregation of hemagglutinin to the apical surface (Rindler et al., 1987, 
Momose et al., 2007). Vaccinia virus infection requires microtubules for efficient formation 
of intracellular mature virus particles and for the assembly of intracellular enveloped virus 
particles. Newly assembled virus particles accumulate near the MTOC in a microtubule and 
dynein-dependent manner. At later stages of the infection, the microtubule cytoskeleton 
becomes dramatically reorganized, probably caused by the loss of centrosome function. An 
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accumulation of viral encoded proteins exhibiting MAP-like properties can also be 
observed, which may play a vital function in the rearrangements of the microtubule 
cytoskeleton (Ploubidou et al., 2000). 
 
4.4.2 Golgi complex 
Picornavirus infection leads to profound alterations in the morphology and functioning of 
cellular membranes. Proliferation of cytoplasmic membrane vesicles is usually observed during 
the replication of Picornaviruses. Large numbers of membrane vesicles have been observed in 
the perinuclear region of poliovirus infected cells (Dales et al., 1965). It has been suggested that 
these vesicles originate from several intracellular membrane structures, such as ER, Golgi 
complex and lysosomes and it requires at least in part de novo synthesis of phospholipids 
(Bienz et al., 1987, Guinea & Carrasco, 1990, Schlegel et al., 1996). Concomitant with the 
synthesis of new vesicles, there is also an important rearrangement of the intracellular 
membranous organelles of the secretory pathway, the disappearance of the Golgi complex, and 
a swelling of the ER together with a reorganization of the cytoskeletal framework (Lenk & 
Penman, 1979, Joachims & Etchison, 1992). Poliovirus infection causes the disassembly of the 
Golgi complex. This effect has been attributed to the expression of protein 2B (Sandoval & 
Carrasco, 1997). Our results show a redistribution of the Golgi complex during TMEV 
infection. Cellular markers have been used to determine the effect of TMEV infection on the 
Golgi complex. We observed that the Golgi complex turns from a solid, crescent-shaped 
organelle at the start of infection, into a series of punctuate fluorescent points forming an 
expanding balloon-like structure, surrounding the concomitantly expanding site of virus 
replication. The remnants of the Golgi complex are finally dispersed throughout the cytoplasm. 
Live imaging confirmed these findings. The exact mechanism behind the disassembly of the 
Golgi complex upon TMEV-infection is not known. 
 
The Golgi complex is a membrane-bound organelle that consists of a stack of flattened 
cisternae connected by tubular bridges into a ribbon structure. It is localized to the 
perinuclear area, close to the centrosome, which is the major organizing center for 
microtubules. The Golgi apparatus serves an essential role in secretory trafficking, lipid 
biosynthesis, protein modifications and the sorting and transport of proteins. Many factors 
contribute to the formation and the maintenance of the Golgi structure: Golgi matrix 
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proteins, GTPases, specialized cytoskeleton motors, regulatory kinases, and a constant 
membrane input from the ER (reviewed by Colanzi & Corda, 2007). The Golgi complex 
undergoes extensive fragmentation during mitosis which allows its correct partitioning and 
inheritance by daughter cells. The Golgi ribbon is converted into clusters of vesicles and 
tubules dispersed throughout the cytoplasm. Membrane trafficking is inhibited during 
mitosis and occurs when Golgi fragmentation starts, suggesting that the inhibition of 
vesicular transport is partly responsible for Golgi fragmentation. Furthermore, it has been 
demonstrated that the Golgi complex is closely related to microtubules. Intact microtubules 
are required for the maintenance of the normal structure and function of the Golgi 
apparatus. The Golgi complex is disassembled and dispersed upon drug-induced disruption 
of microtubules. During prophase microtubules depolymerize resulting in a reorganization 
of the Golgi complex and eventually the Golgi fragmentation (reviewed by: Lowe et al., 
1998, Thyberg & Moskalewski, 1999, Colanzi & Corda, 2007). 
 
Our results showed that microtubules undergo dramatic reorganizations upon TMEV-infection. 
The microtubule cytoskeleton in the cytoplasm disappears and tubulin accumulates at the 
periphery of the infected cell. The disassembly of the Golgi complex in TMEV-infected cells 
may resemble the fragmentation of the Golgi complex during cell division. The reorganization 
of the microtubules observed in infected cells may in part cause the dispersion of the Golgi 
complex. Our results showed that TMEV protein 2C does not co-localize with the Golgi 
complex, however, its possible severing effect on microtubules may indirectly cause the 
dispersion of the Golgi complex in TMEV-infected cells. However, very recently, it was 
observed that Golgi fragmentation in PV-infected cells requires intact microtubules (Beske et 
al., 2007). PV infection induces a dramatic disruption of the Golgi complex. A loss of the 
cohesive Golgi structure can be observed, accompanied by a dispersion of the remnants 
throughout the cytoplasm. Similar observations can be made following expression of PV 
protein 2B in isolation (Sandoval & Carrasco, 1997). Fragmentation of the Golgi complex is 
prevented by pre-treatment with nocodazole, a drug that induces microtubule depolymerization. 
This suggests that Golgi fragmentation in PV-infected cells requires intact microtubules (Beske 
et al., 2007). Perhaps microtubules are also required for Golgi fragmentation in early stages of 
TMEV-infection. Furthermore, it was recently observed that Arf1 is active during mitosis and 
that this activity is required for mitotic Golgi fragmentation. Arf1 is a small GTPase required 
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for COPI vesicle formation from the Golgi membrane, suggesting that Golgi fragmentation 
during mitosis is mediated by vesicle budding (Xiang et al., 2007). BIG1 activates ArfI to 
regulate Golgi vesicular transport. It has recently been observed that some members of the Arf 
family of small GTPases (ArfI), which control secretory trafficking, associate with newly 
formed membranous RNA replication complexes in PV-infected cells (Belov et al., 2005). Two 
PV proteins 3A and 3CD, recruit different Arf-GEFs, including BIG1, to the membranous 
vesicles that arise during PV infection. These are responsible for Arf activation and 
translocation to these membranes (Belov et al., 2007). Our results showed that BIG1 is located 
at the viral replication site during TMEV-infection, as discussed in section 4.4.5, suggesting 
that Arf1 may also be redistributed from the Golgi complex to the viral replication site. This 
may in part contribute to the Golgi fragmentation seen in TMEV-infected cells. 
 
Recently it was shown that PKA plays a vital role in the assembly and the maintenance of 
the Golgi complex (Bejarano et al., 2006). PKA is associated with the cytosolic surface of 
the Golgi membrane through interactions of the RIIα subunits with an anchor protein (Nigg 
et al., 1985). It was shown that PKA is locked in the Golgi complex, not exchanging rapidly 
with the cytosolic pool. Down-regulation of RIIα by siRNA resulted in the depletion of the 
Golgi apparatus. Furthermore, the displacement of PKA from the Golgi complex resulted in 
the collapse of the organelle, and inhibition of PKA activity caused fragmentation of the 
Golgi complex (Bejarano et al., 2006). The possible interaction of TMEV protein 2C with 
AKAP10 may cause a redistribution of PKA, as observed in TMEV-infected cells 
(discussed in section 4.4.3). The displacement of PKA from the Golgi complex may in part 
explain the dispersion of the Golgi complex upon infection. 
 
4.4.3 Protein kinase A 
Protein kinase A, also known as cyclic-AMP-dependent protein kinase, is an enzyme that is 
regulated by the fluctuating levels of cyclic AMP within cells. PKA alters the 
phosphorylation state of cellular target proteins that act through the cAMP signaling 
pathway. The PKA holoenzyme is a heterotetramer that contains a regulatory (R) subunit 
dimer that maintains two catalytic (C) subunits in an inactive state. Binding of cAMP to 
sites in each R subunit results in the dissociation of PKA and the release of the active C 
subunits. Phosphorylation of substrates occurs at serine (Ser) or threonine (Thr) residues 
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and the target sequences are Arg-Arg-X-Ser/Thr or Lys-Arg-X-X-Ser/Thr. The intracellular 
concentration of cAMP controls PKA activity. Low levels of cAMP result in inactive C 
subunits bound to the R subunit dimer. Increase in cAMP results in binding of cAMP to the 
R subunits, followed by an allosteric conformational change which causes release of the C 
subunits. Furthermore, PKA activity is modulated by protein kinase inhibitors that act as 
pseudo-substrates for the C subunits. The existence of multiple C and R subunit isoforms 
specifies PKA signaling. Three isoforms of the C subunit have been identified (α, β, and γ). 
The kinetic characteristics and cAMP sensitivities of Cα- and Cβ-containing PKA show 
small differences, but substrate specificity and interaction with R subunits are 
indistinguishable. The R subunits exist in two major isoforms, RI and RII, with two 
subtypes each, α and β. The dimeric R subunits exhibit distinct cAMP binding affinities and 
differential localization within the cell. Type I enzymes are predominantly located in the 
cytoplasm, whereas type II enzymes tend to associate with cellular membranes. Spatial 
targeting of PKA results from interactions with anchoring proteins (AKAPs). The 
differences in subcellular targeting of type I and type II PKA contribute to the specificity in 
cellular responses (reviewed by Dell’Acqua & Scott, 1997). 
 
Protein kinase A (PKA) activity is known to play a number of key roles in the regulation of 
cellular membrane traffic. PKA has been implicated in protein transport from the ER to the 
Golgi complex, and in the budding of constitutive transport vesicles from the trans-Golgi 
network (Muniz et al., 1997). Furthermore, PKA seems to play a role in endosome-to-Golgi 
and Golgi-to-ER transport (Lee & Linstedt, 2000). In addition PKA activity has also been 
associated with endosome fusion, exo-, endo-, and transcytosis (Takuma & Ichida, 1994a, 
Muniz et al., 1996;, Rapacciuolo et al., 2003, Kim et al., 2005, Hansen & Casanova, 1994). 
Moreover, PKA functions in the stimulation of the binding of Arf1 to the Golgi membrane 
(Martin et al., 2000). 
 
Our preliminary results suggest that PKA undergoes redistribution upon TMEV infection, and 
accumulates at the periphery of the cell during late stages of infection. We determined the 
localization of PKA in infected cells by means of cellular markers for both RIα and RIIα 
subunits, and the catalytic subunit. Similar redistribution was observed for all cellular markers 
in TMEV-infected cells. Particular isoforms of PKA are localized to the Golgi complex and 
protein phosphorylation is an important feature in regulating steps along cellular transport 
 155
pathways. Sub-cellular compartmentalization of PKA through the use of AKAPs is now 
widely believed to be responsible for the specificity of the cAMP signaling pathway. It has 
been shown that the N-terminus of TMEV protein 2C binds to the C-terminal region of a PKA 
anchoring protein, AKAP10 and competes with the RII regulatory subunit of PKA (Knox et al., 
submitted). This may serve to displace PKA from the Golgi complex, resulting in the dispersion 
of the Golgi complex as observed in TMEV-infected cells (discussed in section 4.4.2). 
Furthermore, PKA is known to stimulate binding of Arf1 to the Golgi membranes. The changes 
in PKA localization during TMEV infection may cause a redistribution of Arf1, which may 
contribute to the Golgi fragmentation observed in TMEV-infected cells. 
 
4.4.4 Endosomes 
Internalization of proteins and lipids is mediated by clathrin-coated vesicles and other less 
characterized pathways. The endocytosed molecules are delivered to the early endosomes. 
Receptor-mediated endocytosis is an essential process in signal transduction whereby 
receptor-ligand complexes are internalized and processed. After receptor-ligand 
uncoupling, receptors are transported along the recycling pathway, whereas ligands follow 
the degradation route. Early endosomes are generally accepted as the single entry site for 
internalized molecules and the first sorting station on the endocytic pathway. They are a 
dynamic compartment with a high homotypic fusion capacity, and exhibit a highly complex 
organization consisting of cisternal regions of tubular elements and large vesicles. There are 
two extreme views on the relationship between early and late endosomes. The endosome 
maturation model states that early endosomes are formed de novo, presumably from 
clathrin-coated vesicles. Late endosomes are formed by fusion of residual components of 
the early endosomal compartment, once recycling to the plasma membrane has been 
exhausted. The second model states that early endosomes represent a stable compartment 
maintained by a balance of incoming and departing material. Endosomal carrier vesicles are 
formed from early endosomes and fuse with late endosomes in a microtubule-dependent 
manner. The clathrin-coated vesicle pathway is the best characterized internalization 
pathway and is cytosol- and ATP-dependent with a requirement for multiple GTP-binding 
proteins such as the GTPase dynamin. Dynamin is a ~100 kDa protein that facilitates 
budding of clathrin-coated pits, which leads to the formation of coated vesicles in a GTP-
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dependent manner. Other small GTPases, such as Rab4 and Rab5, have been associated 
with early endosomes. Rab5 plays a role in promoting early endosome fusion and regulates 
the rate of clathrin-dependent endocytosis at the plasma membrane. Rab4 has been 
implicated in recycling endosomal material to the plasma membrane. The endocytosis 
process also seems to require myosin and actin filaments. Furthermore, the dynamics of 
early endosomes and microtubules are in part coupled. The tubular elements of endsomes 
overlap with microtubules and transport from early to late endosomes is microtubule-
dependent. Moreover, coat proteins have been identified on early endosomes. The COPI 
coat complex is known to regulate retrograde transport from the Golgi complex to the ER, 
but there are some indications that an endosomal COPI complex functions in endosomal 
transport. The endosomal COPI interacts with membranes through interaction with small 
GTPases, such as Arf1 (reviewed by: Claque, 1998, Battey et al., 1999, Gruenberg, 2001). 
 
The clathrin-dependent endocytic pathway is employed by many viruses for entry into host 
cells. It is generally accepted that Semliki Forest virus (SFV), an enveloped alphavirus, 
requires the clathrin-dependent pathway for entry (DeTulleo & Kirchhausen, 1998). Entry 
of HIV is believed to occur by direct fusion at the plasma membrane; however clathrin-
dependent endocytosis has been shown to significantly contribute to productive entry into 
the host cells, suggesting that the clathrin-dependent pathway is used by some viruses as an 
alternative entry route (Daecke et al., 2005). Contradictions have been observed for other 
viruses, such as Sindbis virus and some Picornaviruses. Electron microscopy has not been 
able to resolve the viral entry route. Poliovirus has been found in association with clathrin-
coated pits and in completely invaginated coated vesicles (Zeichhardt et al., 1985, 
Willingmann et al., 1989). However, more recent studies demonstrated that PV does not 
appear to require the clathrin-dependent endocytic pathway (DeTulleo & Kirchhausen, 
1998). Cells expressing dominant-negative forms of dynamin that block clathrin-dependent 
endocytosis were used to examine the mode of entry of SFV, Sindbis virus, Human 
Rhinovirus 14 (HRV-14), and PV. It was shown that PV was not prevented from entering 
cells in which the clathrin-mediated endocytosis was blocked. However, SFK, Sindbis virus 
and HRV-14 were only able to infect cells were the clathrin-dependent endocytic pathway 
was active (DeTulleo & Kirchhausen, 1998). Clathrin-coated vesicles are not the sole route 
of endocytic transport from the plasma membrane to the endosomal compartments, 
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suggesting that PV employs an alternative non-clathrin-mediated pathway of endocytosis 
for entry into the cell (Hansen et al., 1993, Damke et al., 1995). 
 
We wanted to determine the effect of TMEV infection on the endocytic pathway using a 
cellular marker for early endosomes. Our results showed that early endosomes show a 
punctate staining pattern consistent with the cytoplasmic distribution of endosomes in mock 
infected cells and at early stages of infection. During late stages of infection, the early 
endosomes seem to accumulate at the periphery of the cell surrounding the expanding viral 
replication site. The TMEV-receptor for entry into the cell has not yet been identified. Entry 
into the cell differs amongst Picornaviruses; however it is possible that TMEV employs the 
clathrin-mediated endocytic pathway for entry into the cell. This may explain the 
characteristic endosomal staining early upon infection. Actin filaments and microtubules have 
been associated with early endosomes. The effects observed on these cytoskeleton 
components during TMEV-infection may partly explain the accumulation of early endosomes 
at the periphery of the cell at later stages of infection. Furthermore, the involvement of Arf1 
in endosomal COPI coated vesicles may also contribute to explaining our results. Arf1 may 
be displaced from endosomal vesicles by BIG1, as discussed in section 4.4.5, which may 
account for the redistribution of early endsomes. Our results also showed an interaction 
between TMEV protein 2C and RTN3. It was suggested that RTNs may play a role in the 
endocytic pathway (Iwahashi et al., 2002), and a possible interaction with SNARE proteins, 
which are involved in membrane trafficking including endocytosis, has been proposed 
(Steiner et al., 2002). The interaction of TMEV protein 2C with RTN3 may play a role in the 
effect of TMEV infection on endocytosis. Interestingly, a computer-based analysis has 
demonstrated that TMEV protein 2C is highly similar to vacuolar protein sorting protein 4 
(VPS4), an AAA ATPase required for endosomal transport (figure 3.32, section 3.4.1). VPS4 
catalyzes the release of an endosomal membrane associated class E protein complex required 
for normal morphology and sorting activity of the endosome (Babst et al., 1998). 
 
4.4.5 BIG1 
BIG1 or Brefeldin A-inhibited guanine nucleotide-exchange protein 1 is a ~200kDa protein 
that preferentially activates Arf1 and Arf3. BIG1 is mainly cytosolic and Golgi-associated, 
and is found in the cytosol in a multiprotein complex with a similar Arf-activating protein 
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BIG2, which also serves as an A-kinase anchoring protein. It has been demonstrated that 
the N-terminal part of BIG1 is required for Golgi association (Mansour et al., 1999). 
Recently, BIG1 was also localized to several nuclear sites in serum starved HepG2 cells, 
which suggests a previously unknown function for BIG1 in nuclear processes (Padilla et al., 
2004). BIG1 is a member of the guanidine-exchange protein family (GEPs). GEPs differ in 
molecular weight, domain structure and sensitivity to inhibition by Brefeldin A (BFA); 
however all GEPs contain an ~200aa Sec7 domain that is responsible for Arf activation 
(Franzusoff & Schekman, 1989, Chardin et al., 1996). Arfs are 20 kDa GTPases of the Ras 
superfamily that regulate vesicular transport. Arfs function in the formation of coated 
membranous vesicles originating from different intracellular departments. Furthermore, 
they participate in cytoskeleton remodeling and regulation of phospholipase D activity. 
Three classes of Arfs have been described. Class I consists of Arf1-3, and functions in ER-
Golgi trafficking. The not well-characterized class II contains Arf4 and Arf5, whereas class 
III contains Arf6 which plays a significant role in endocytic pathways and cytoskeletal 
remodeling (reviewed by Moss & Vaughan, 1998). They are activated by GEPs, which 
promote the replacement of bound GDP with GTP, and inactivated by GTPase-activating 
proteins, which are required to stimulate hydrolysis of bound GTP to generate Arf-GDP 
(Donaldson, 2000, Jackson & Casanova, 2000). The best characterized member of the Arf 
family is Arf1, which is vital for retrograde membrane transport from the Golgi complex to 
the ER and intra-Golgi. Arf1 has also been implicated in membrane transport from the 
trans-Golgi network, endosomal trafficking and exocytosis of secretory vesicles (reviewed 
by Nie et al., 2003). 
 
Recently, it was observed that some members of the Arf family of small GTPases (ArfI), 
which control secretory trafficking, associate with newly formed membranous RNA 
replication complexes in PV-infected cells. The accumulation of Arfs on membranes does 
not occur in the presence of BFA, a fungal metabolite that prevents normal function of Arfs 
and is known to inhibit poliovirus infection. It was also demonstrated that the Arf 
translocation can be induced independently by synthesis of PV protein 3A or protein-
complex 3CD. Arf1-GFP redistributes from the Golgi-complex to a perinuclear site in PV 
infected cells, which represents the PV replication site. This suggests that Arfs are involved 
in PV replication. Interestingly PV proteins 2B and 2C and their precursor 2BC, which are 
 159
known to bind and remodel membranes, do not seem to have an effect on Arf distribution 
(Belov et al., 2005). Moreover, it was demonstrated that Coxsackievirus B3 protein 3A 
inhibits the activation of Arf1, which regulates the recruitment of the COPI coat complex to 
membranes. Protein 3A is known to inhibit ER-to-Golgi transport, which may be important 
for viral suppression of immune responses. The underlying mechanism may be that protein 
3A specifically inhibits GBF1, a member of the GEP family, by interacting with its N-
terminus (Wessels et al., 2006a). It was confirmed that protein 3A of Coxsackievirus B3 
inhibits ER-to-Golgi transport by interfering with the Arf1-dependent COPI recruitment to 
membranes through binding GBF1 and inhibiting its function. It was also shown that PV 
protein 3A interferes with Arf1 function in the same manner; however no interference with 
protein transport or COPI-recruitment was observed for protein 3A of several other 
Picornaviruses, such as HRV, ECMV, FMDV and HAV (Wessels et al., 2006b, 2007). 
 
BIG1 activates Arf1 and therefore we aspired to determine the effect of TMEV-infection on 
BIG1. Our results showed that BIG1 concentrated in a juxtanuclear area, representing the 
Golgi-complex, in mock-infected cells. Upon infection, BIG1 undergoes redistribution to 
the perinuclear area, which is the site of viral RNA replication. During the late stages of 
infection, BIG1 is distributed in a punctate pattern in the cytoplasm, which represents the 
expanding viral replication site. This is in contrast to our results for the other intracellular 
components investigated, which all accumulate at the periphery of the cell at late stages of 
TMEV-infection. This suggests that BIG1 plays a role in the viral replication, probably by 
displacing Arf1 to the replication vesicles. These results were recently confirmed for PV 
infected cells by Belov and colleagues (2007). They demonstrated that Arf family members 
become membrane bound after synthesis of PV proteins 3A and 3CD, and associate with 
newly formed membrane RNA replication complexes in PV-infected cells. Furthermore, 
they showed that Arf1 colocalizes with the newly formed replication complexes in PV-
infected cells. Protein 3A and 3CD also independently recruit GBF1 and BIG1/2, members 
of the GEP family, to the newly formed replication complexes. This suggests that the 
recruitment of these GEPs is responsible for Arf activation and translocation to these 
membranes (Belov et al., 2007a, 2007b). 
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4.5. Conclusions 
? Protein 2C of several Picornaviruses, such as poliovirus and FMDV, has been proven 
to express to detectable levels for both immunofluorescence and western blot 
experiments. However, expressing TMEV protein 2C in mammalian cells has been 
very challenging. We were not able to express TMEV protein 2C to detectable levels. 
Nevertheless, TMEV has been proven to be an easy to replicate and easy to use virus. 
? TMEV protein 2C was localized in infected cells using an anti-TMEV-2C antibody. 
Tiny dots spread out in the cytoplasm representing newly synthesized protein can be 
seen early upon infection, which assemble into an ER-like pattern. Protein 2C 
redistributes to a juxtanuclear location, which represents the viral replication site, and 
spreads out through the cytoplasm as the viral replication site expands. 
? TMEV protein 2C partly overlaps with the Golgi complex during infection, however 
no co-localization can be observed. This suggests no direct function for protein 2C in 
the disassembly and disappearance of the Golgi complex. 
? TMEV protein 2C interacts with reticulon 3 in vitro. RTN3 is an ER-associated 
protein and the identified interaction may play a role in the intracellular changes in 
membrane trafficking observed during TMEV infection. 
? A previously identified interaction between TMEV protein 2C and AKAP10 could 
not be confirmed, possibly because of conformational constraints. Two mutations in 
the AKAP10 binding site, which inhibit the completion of the TMEV infectious 
cycle, were identified. IAP3 showed a granular pattern spread out in the cytoplasm, 
which may represent a mitochondrial localization. 
? TMEV protein 2C was expressed in E. coli as a GST- or a MBP-fusion protein. This 
allowed us to purify TMEV protein 2C in order to have a polyclonal antibody made 
against protein 2C. It was however not possible to express protein-complex 2BC in E. 
coli, presumably because of its toxic nature. 
? Actin filaments and microtubules undergo drastic rearrangements during TMEV 
infection. Accumulation of both cytoskeleton components at the cell periphery can be 
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observed during late stages of infection. TMEV protein 2C is highly similar to 
katanin, a microtubule-severing protein, suggesting protein 2C may exhibit a similar 
function in infected cells. 
? Endosomes concentrate near the cell membrane during late stages of TMEV 
infection, suggesting TMEV has a drastic effect on the endocytic pathway. 
? PKA redistributes to the verge of the cell during TMEV infection. The possible 
interaction between protein 2C and AKAP10 may partly cause this displacement. 
? The Golgi complex undergoes disassembly during TMEV infection, and eventually 
completely disappears as confirmed by live imaging of TMEV-infected cells. 
? BIG1 seems to locate to the viral replication site during TMEV infection, suggesting 
it may play a role during replication. The dispersion of the Golgi complex may in part 
be caused by the activation and displacement of Arf1 by BIG1. 
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